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A BSTRACT 
T\\ o ba teri phages were i olated from untreated ra\ waste water from AI -A in  
c\ "erage treatment p lant. Th se  h\ o phages were active against Salmonella 
IJphimurillJ17 and Escherichia coli \ h ich knO\ n to cause food poison ing d iseases i n  
ch icken feed . The opt imum concentrat ion of  the two phages used \ a s  found to  be 
1 010 p laques form ing unit ( PFU mr l ) .  Bacteriophage I (01) was isolated us ing S. 
f)phimuriul11 as a propagat ion host and was found to be monovalnet. On the other 
hand, bacter iophage number (02) isolated using E. coli as a propagat ion host was 
found to be pol a lent and lysed Gram posi tive bacteria i nc lud i ng Bacillus subtilis, 
Staphylococcus aurellS, Staphylococcus epidermidis and EnterococcZls faecalis and 
Gram negat ive bacteria i nc lud ing Proteus vulgaris, Pseudomonas aerllginosa and 
Shigella dysellteriae. Bacteriophage ( 01) fOnlled smal l c i rcular c lear p laques (0.5 
mm).  However. bacteriophage (02) formed sma l l  c i rcular c lear b lue p laques that 
lack the reddish color observed on the bacteria l  lawn(0.9 mm). egatively sta i ned 
part ic les of the bacter iophage (01) act ive aga inst S. fyphimurium and bacteriophage 
(0�) act ive aga inst E. coli fitted the Siphoviridae (8 I )  morphotype wh ich consisted 
of icosahedral heads and base p late. The i ncorporat ion of Ca(N03)2 into peptone­
yeast extract agar, nutrient agar and trypt ic soy agar was found to increase the 
number of PFU m r l on a l l  the three med ia  types compared to the same med ium but 
w ithout the add i t ion of calc ium n itrate. Bacteriophage (01) was found to be more 
sens i t ive to the treatments w i th phys ical  agents that inc lud i ng ( freez ing, refrigeration, 
heat ing, boi l i ng, ultrason ic treatment andUltra V iolet (UV) rad iat ion), and chemical 
agents inc lud i ng: (ch loroform, thymol, hydrogen perox ide, phenol, ethyl a lcohol, 
c lorox, i od i ne, and merth iolate) than bacter iophage ( 02).Fewer bacteriophage (01) 
vi 
v.ere obtai ned \'.hen propagat ion hosts were incubated for 0-3 h, in comparison to 
those incubated for 5 - 1 0 h. Meam h i le, fewer bacteriophages (02) were obta ined 
when propagat ion hosts were incubated for 0-3 h, in comparison to those i ncubated 
for 5- 1 0  h. Greater leve ls  of host inoculum resulted in greater phage t i ters for 
bacteriophage (01). A l so, greater levels of host inoculum resulted in  greater phage 
t i ters for bacteriophage (01). Greater phage inoculum s ize resulted in greater phage 
output for bacter iophage (0,). A l so, greater phage inoculum size resulted in greater 
phage output for bacteriophage (0]).The appl icat ion of bacteriophage (0,) in corn­
so d iet i nfested w i th S typhimurium or the appl icat ion of bacteriophage (0]) in 
corn-soy d iet i nfested \ i th E coli, or the appl icat ion of bacteriophage (0,) and 
bacteriophage (02) in corn-soy d iet i nfested with S typhimurilll?1 and E coli 
s ign ificant ly  (P < 0.05 ) reduced the populat ion densit ies of S. typhimllrium and the 
populat ion densit ies of E coli compared to the treatments wh ich inc luded the 
appl ication of Ii i ng E coli a lone, l iv ingS typhimllrium alone or l iv ing E. coli 
l i ving S typhifllurilll17. The treatment which rece ived the m ixture of the 1\\10 phages 
or the appl i cat ion of bacteriophage (01), or the appl icat ion of bacteriophage (02) was 
a lmost as effect ive as the ant ib iot i c  oxytetracyc l i ne app l i cat ions in reducing the 
inc idence of S typhimZlriZlJ17 and E. coli i n  the ch icken feed . In conclus ion the 
i solated bacteriophages have great potent ia l  in the field of bacteriophage therapy and 
ch icken feed i ndustry because they are se lf-rep l icat ing and can be targeted against 
bacter ia l  receptors that are essent ia l  for bacteria l  pathogenes is .  The 1\vo phages 
obta i ned in the present study can be used as a safe and alternat ive technique to 
erad icate bacter ia l  infections and chron ic  polym icrobia l  b iofi lm  caused by ant ib iot ic  
res i stant bacteria. 
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HAPT E R  I: INTRODUCT ION 
1 . 1  Pou l try ma rket i n  the  U n i ted A rab E m i rate  ( U A E )  
The pou ltry market in  the Un ited Arab Emirate (UAE) i a fast gro\ i ng and 
demand ing market. ccord ing to the G lobal Agricul tura l  I n fonnat ion Network 
(GAIN)  report, the total domestic product ion of pou l try meat in the UAE had rai sed 
to 41,000 Tons of Meat (TM) in 20 1 3  compared to 3 7,000 TM in 20 1 2 . The 
est imated i ncrease i attributed to the increase i n  demand for pou ltry products driven 
by the growth in UAE populat ion and the estab l i shment of a new production fac i l i ty 
i n  many emirates ( imon ef 01 . . 20 1 3) .  Genera l l y, pou ltry producers do not rece ive 
an) support from the UAE federal government. However, Abu Dhabi Emi rate gives a 
subsidy of 25% on feed to its pou l try fanners (S imon ef 01.. 20 1 3) .  
Poul try producers do not use growth honnones i n  the i r  production, s ince the UAE 
has out la\ ed the use of  growth hormones in the product ion of poultry, and th i s  sector 
geared to breed ing stock is the most ardent user of newer technologies. Ho\ ever, the 
fanners do use ant ib iotics to get safe poultry meat that meet the h igh standards 
( S imon et 01., 20 1 3) .  
A long with the i ncrease In production. the local consumption remains stable at 
about 290.000 TM of both imported and local l y  produced fresh poul try. Fresh loca l l y  
produced ch icken are genera l l y  consumed b y  the UAE nat ionals. consumers w ith 
high d isposable  i ncome and Moslems who prefer to consume products wi th 
guaranteed Hala l s laughter (S imon ef aI. , 201 3) .  
The UAE government has cont inuously p layed an important ro le in  guid ing and 
assuring consumers of the safety of consuming loca l l y  produced and imported 
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ch ickens. 1\ loca l ly produced chicken i ubject to trict super is ion and inspection 
to ensure fitne for human con umpt ion ( imon et aI. ,  201 3) .  
1 .2 Food poi o n i n g  in  ch ickens 
Zoonot ic d isease are common In many parts of the world and despite great 
improvement in food safety food po ison i ng remains a problem in Europe and USA, 
\\< i th numerous deaths each year caused by food-borne bacteria (A l isky ef al., 1998). 
F lock of  ch icken are frequent ly  i nfected wi th bacteria, l i ke Escherichia coli, 
Salmonella and Campylobacter which considered to be the most severe infective 
bacteria, which cause a h igh proport ion of cases of serious i l lness and fatal it ies 
espec ia l ly  when i ntensively ra ised for food (Projan, 2004). These bacteria can surv ive 
i n  ch icken meat or eggs, transm itt ing the d i seases to the people who consume them, 
ho\ ever an experimenta l  techn iques show some prom ise in  combating those three 
pathogens (Thacker, 2003 ; M i l ler e/ 01. ,  20 I 0). 
1.2.1 Salmonella in ch ickens 
Salmonella food poisoning is a bacterial food i l l ness caused by the Salmonella 
bacteri um (McCarthy e/ 01. , 2007; Harrison ef aI. , 2008) which resul ts i n  the swe l l ing 
of  the l i n i ng of the stomach and i ntest i nes (gastroenteri t i s) .  Domest ic and wi ld  
an imals, i nc l ud ing poultry, p igs, catt le, and pets such as  turt les, iguanas, ch icks dogs, 
and cats can transmit  this i l l ness and most people become infected by ingest i ng foods 
contaminated w i th s ign ificant amounts of Salmonella (Harrison et 01., 2008) .  
Enteric Salmonella i nfect ion i s  a global prob lem both i n  humans and animals, and 
has been attr ibuted to be the most important bacterial et io logy for enteric infections 
worldwide ( McCarthy el aI., 2007) .  Salmonel losis is an endemic d isease everywhere 
2 
and i ts importance, as p tent ia l  zoono is need no emphas is ( Barrow et 01.. 1 998: 
I [arri on et al . . 2008). 
Depend ing upon the spec ies of ind iv idual Salmonella serovars, these are e i ther 
grouped as ho t adapted (e .g . ,  S. /}phi in humans, S. choleraeslIis in p igs) or non-host 
adapted (e.g . . s. typhil11uriunJ . .  enteritidi ) ( M i le et al.. 1 99 1 ;  McCarthy et aI., 
2007). 
F locks of intens ively ra i sed ch ickens often carTY these infections, which can be 
passed with ch icken meat and eggs on to humans (Capita et al . . 2003). Because of 
the dramat ic increase of human salmonel losis and the grow ing numbers of cases wi th 
serious symptom resu l t ing from the enhanced in  asi veness of the dom inant species 
S. enteritidis, more effect i ve defense reactions against the spread of S. enteritidis are 
requ i red. The most important measure would be the general decontam ination of the 
m i xed feed just before send ing it to the farmer. Contam inated feed is the primary 
source of Salmonella i nfect ion to l i vestock and to man ( M i les ef 01.. [ 99 1; G uard­
Petter, 200 1 :  Mod i et aI. , 200 I ) . 
1 .2.2 Eschericllia coli i n  c h i c kens 
Enteri t i s  i s  an i nflammation of the sma l l  intest i ne caused by Escherichia coli. I t  
i s  t he  most common cause of  travelers' d iarrhea. Usua l l y  E .  coli is  part of nonnal 
flora of i ntestines of  humans and an imals  w ithout causing any infect ion most of the 
t ime. However, certain stra ins of E. coli can cause food poison ing, such as E.  coli 
stra in  (0  1 57:H7) that can cause a severe case of food poison ing (Cra ig et al., 2009) .  
Bacteria may get in to the food i n  d i fferent ways l i ke; ( i )  pou ltry meat that may 
come i nto contact w ith normal bacteria from the intest i nes of an animal  wh i le i t  i s  
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be ing proce ed. (i i )  food that is handled in  an unsafe way during transport or storage. 
Ithough not common, E. coli can be spread from one person to another (Sch i l ler el 
al., 20 1 0). 
)mptom occur \ hen E. coli bacteria enter the i ntest ine, after incubat ion t ime of 
2-l to 72 hour . The most common symptom is sudden, severe d iarrhea that is often 
b loody, a lso Fe er, floati ng, loss of appeti te, vom it ing and stomach cramping are 
other symptoms that resul t  from E. coli food po ison ing (Sodha el aI. , 2009). The 
goals of treatment are to re l ief the infected person from the symptoms and avoid 
dehydrat ion. Gett i ng enough flu ids  and managing the symptoms are steps fol lowed 
to treat the food poison ing from E. coli ( Sodha el al., 2009). 
1.2.3 Campy/obaeter in c h ickens 
Campylabaete,. spec ies are bacteria that commonly infect a broad range of 
l ivestock spec ies, pets and w i ld an imals .  I n  pou l try they tend to mult ip ly in  large 
numbers in the h i ndgut, pr inc i pal l y  in the caecae. Campylabaeters are a s ign ificant 
cause of enteri t i s  in  humans. I n fected poul try are a potent ia l  reservoi r  of th i s  
zoonos Is .  Campy/abaete)' jejuni is  the  commonest spec ies found in  pou ltry. A l l  
eampylabaeter spec ies are de l icate organisms that surv ive for re lative ly  short periods 
outside the host un less be protected by organic mater ia l ,  biofi lm or engu lfed by 
protozoa (Carva lho et al. , 20 1 0) .  
]n pr inc ip le, housed poul try can be  mainta i ned free of Campy/abaeter i nfection by 
consistent app l ication of exce l lent b io-security. Key aspects of th is inc lude effect ive 
san itation of dr ink ing water, sourc ing of water from h igh qua l i ty supp l ies, avoidance 
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of contact \\ i th pet and other farmed species, good hand hygiene by stockmen, and 
changing of 0 era l l  and boots on enteri ng bird areas (Carri l lo el 01., 2005) .  
In pract ice the success of reduction of Campy/obae/ers, w i l l  a lso depend upon the 
degree of env ironmental contamination by the organ ism. For th i s  rea on it may be 
d i fficu l t  to top the spread of infection between houses once i t  becomes estab l i shed in 
one house (Carri l lo el 0/., 2005 ). 
Many infection are introduced during th inn ing or other forms of part ia l  
depopu lat ion .  I nsects and rodents may act as a means of transfer of the i nfection from 
the general env i ronment i nto the pou l try bu i ld ings. Research i s  ongoing on the 
de e lopment of vacc ines, phage treatments and compet i t ive exc l us ion approaches, as 
\ e l l  as process ing p lant technologies to reduce carcase contam ination (Carvalho el 
01., 20 1 0). 
1.3 A n t i biotics and t h e i r  a ppl icat ions in the p reven t ion and t reat ment  of d iseases 
Ant ib iotics are \ ide ly used for human health to treat infect ions; moreover they are 
used for animals and p lants in order to prevent d i seases or to treat them against other 
d iseases which he lp growth promot ion in animal farm ing (Quiberon i el 01. , 20 1 1 ) . I n  
the U SA about 80% of total ant ib iot ic product ion i s  used i n  agriculture wi th a 
substant ia l  port ion of th i s  is used for non-therapeutic growth promot ion (N igam et 0/., 
20 1 4; M i l ler el a!. , 20 ] 0). 
Pathogens or bacteria are able to transfer from animal to humans through the food 
chain and if the bacteri um has an antib iotic res istant gene, thi s  gene can be 
transferred to other bacteria by transformat ion, conjugat ion or transduct ion 
(Bradbury, 2004) . 1 n  order to achieve that l ink between antibiotic use in  animals and 
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the exten ion of  re i tance to human bei ngs, an understand ing of the nature of 
ant i b iot ic res istance i s  requ i red (Adam ia el al., 1 990' Bradbury, 2004). Because of 
it effect on the i nten i e an imal  product ion. ant ib iot ics are nov" e tensi ely used for 
both pre ention and treatment of  an ima l  d iseases (Toro el al. , 2005) .  
ntib iot ic are emp loyed in  an imal  feed for many reasons; to  enhance growth, to 
e l im inate pathogen , to treat i nfections, to increase product ion performance and to 
increase the effic iency of the use of feed for growth or production output, which w i l l  
l ead t o  the production o f  healthy an imals. ]n return ant ib iotics w i l l  i ncrease growih 
rate and therefore the econom ic benefits ( M i l ler et al. , 20 1 0) .  
Us ing ant i b iot ics as feed add i t ives have become more common I n  animal 
husbandry nevertheless, these feed add i t ives must be of spec ific cond it ions such as; 
they must have a posi t ive resu lt  on l ivestock production, they must be safe for animal 
or human hea lth and to be easy to hand le and control (A l isky et aZ. ,  1 998). 
1 .4 A n t i biot ics in ch ickens feed 
Ch icken feed has been rout ine ly dosed with ant ibiot ics as a process of infection 
contro l .  However this has not provided a last ing so lut ion, as bacteria read i l y  mutate 
to acqu i re resistance to these ant ib iot ics (Bradbury, 2004). As new ant ib iotics are 
developed. and new res istant stra ins emerge, therefore many of the developed 
countries now l im it the use of ant ibiot ics in an imal  feed . However ant ibiot ics st i l l  
remains effect ive for treat i ng human i nfections (Johnke el al., 20 1 4) .  
There are many examples of ant i b iotics which are common ly used in  the animal 
feed; these inc l ude oxytetracyc l i ne, bambermycin, avi lamyc in  and bac itrac in (A l isky 
et al. , 1 998) .  
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Oxytetracyc l ine i s  used for human treatment aga inst d iseases caused by bacteria 
such as rickett iae, mycoplasma and spirochetes ( Wegener et 01., 2003). 
Oxyietracyc l i ne fa l l  under the tetracyc l ine group of ant ib iotics and is added to 
an imal  feed .  It is ut i l ized for prophylaxis and med ication of d i fferent types of 
d i seases, used I n  eteri nary med ic ine to prevent and control d iseases and added to 
an imals  feed such as; catt le, p igs, sheep, poul try and fish fann ing (Arikan et 01. , 
2007). Oxytetracyc l i ne has low act iv i ty and tox ic ity and good d i ffusion into the 
ti sues so i t  is ut i l ized for treatment of respi ratory, urinary and a l imentary tract 
infect ions ( Kowalsk i et 01., 2007). 
Agricu ltura l  Research Serv ice Researchers in  Brita i n  has stud ied the breakdown of 
oxytetracyc l i ne in  manure and found that th is breakdown slowed with i ncreased 
saturat ion of the manure because of a decrease in oxygen levels .  This shows 
ox)tetracyc l ine effects in an imal  feed on ant im icrobia l  res istance, bacteria and the 
envi ronment. I t  m ight a lso damage organs that are rich i n  ca lc ium l ike bones and 
teeth .  I n  add it ion, i t  sometimes causes nasa l cavit ies to erode ( Butaye et 01., 2003). 
Bambennyc in  is a phosphoglyco l i p id ant im icrobia l  ant ibiot ics formed by d i fferent 
stra ins of the act inomycete Streptomyces. I t  acts primari ly  aga inst Gram posi t ive 
bacteria because of the inh ib i t ion of transglycosylase ( Fal ler et 01. , 2006).  
Furthennore, i t  i s  employed as a feed add i t ive growth promoter I n  catt le, p igs, 
ch ickens, and turkeys but has no hea l i ng app l i cation in humans or animals and i t  does 
not k i l l  benefic ia l  bacteria that form part of the normal i ntest ina l  microflora. It is a lso 
reported that bambennyc in  reduces the colon izat ion and shedd ing of bacteria l  
pathogens such as Salrnonella spp. ( Fa l ler et 01., 2006). 
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A i lamyc in  belongs to the orthosomyc in group of antibiot ics. It i approved for 
use a a gro\\ th promoter w ith in the European Un ion (EU) i n  swine and pou ltry 
indu tries but not a l lowed for therapeut ic app l i cations. Its mechan i ms in  growth are 
not c lear and it i u ed a a po tu lated to involve a reduction of the intest inal  bacterial 
load (Sunderland el 01., 2004).  
Bac itrac i n  i a po l pept ide ant ib iot ic  and i s  active agai nst Gram posit ive and some 
Gram negat i ve bacteria .  In add it ion i t  has been used as an add i t ive in animals feed 
(Murph el al. , 2007). Bac i trac i n  i s  avai lable as a lyoph i l ized powder to admin i ster 
in food and drugs and i t  is appl ied in treatment of i nfections (Fal ler el al. , 2006) .  
1.5 Disadvan tages of a n t i biot ics i n  c h ic kens feed 
Ant ib iot ics have been used in a dramatic way s ll1ce the 1 940s, when i t  was 
d i scovered that the by-products of ant i biot ics can be added to animal  feed because 
they have a h igh Ie el of v i tam in  B 1 2, which is con idered to be a growth promoter, 
a lso it is widely used in pou ltry for th is  reason, and to treat and prevent infect ions 
(Wright el 01., 2009) .  Many sc ient ists c la imed that th i s  is considered as a risk 
because bacteria l  stra ins gain stronger res istances (Wright el al. , 2009; N igam el 01., 
20 1 4) .  Eventua l l y  r isks of  us ing ant ib iot ics were d iscovered, after seven decades of 
heavy use of anti b iot ics and arguments are increas ing rap id ly  about these risks to 
human, and actual examples are hard to corne by. However, the risk w ith s laughtered 
ch ickens is that pathogenic bacteria may be transmitted to humans who consume 
them (Bradbury, 2004).  For example, in  October 2000 the U.S .  Food and Drug 
Adm in i strat ion (FDA)  d i scovered two ant i b iot ics that are not useful in  treati ng 
d i seases i n  factory-farmed ch ickens. The FDA pu l led one from the market but the 
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other one. ca l l ed Ba} ri l wa not \ ithdra\\ n unt i l  2005 ( Hau ler, 2006; Wright ef 01., 
2009; Lim et 01., 20 I I ) . 
1 .6 P ro biotic metabol ites i n  c h ic kens feed 
Over the ears the word prob iotic has been u ed in se eral d i fferent ways. I t  was 
or igina l ly  used to descr ibe ubstances produced by one protozoan \\ h ich st imu lated 
by another, but it was later used to describe an ima l  feed supplements which had a 
benefic ia l  effi ct on the host an imal  by affect ing its gut flora (Weld e{ 01. ,  2004). A 
probiot ics is "a cu l ture of spec i fic l i v i ng microorgan isms (primar i ly  Lactobacillus 
pp. ) \\ h ich imp lants i n  the animal  to ensure the effective estab l i shment of  intest inal  
popu lations of both benefic ia l  and pathogenic organisms" . Fu l ler later gave a un ique 
defin it ion of probiot ics as " a  l ive m icrobial  feed supplement which benefic ia l ly  
affects the host an imal  by  improv ing i ts intest inal  microbia l  balance" (Fu l ler, 200 I ;  
Bradbury, 2004) .  
The US at ional Food I ngred ient Assoc iation presented, prob iotic (d irect fed 
m icrobia l)  as a source of  l i ve natura l ly occurring m icroorgan isms and th i s  inc ludes 
bacteria, fungi  and yeasts (A I isky et aI. ,  1 998) .  
Accord i ng to the current ly  adopted defin i t ion by FAOIWHO, probiot ics are: " I ive 
m icroorgan isms which when admin i stered i n  adequate amounts confer a heal th 
benefit on the host" ( FAO/ W HO, 200 1 ) . More prec ise ly, probiot ics are l ive 
m icroorgan isms of non-pathogen ic  and non-tox ic in nature, which when admin i stered 
through the d igestive route, are favorable to the host ' s  hea l th (FAO/ W HO. 200 I ) . 
I t  i s  bel i eved by most i nvest igators that there i s  an unsteady ba lance of benefic ia l  
and non-benefic ia l  bacteria in  the tract of normal ,  healthy, non-stressed pou ltry 
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( h iban i  ef al. ,  2004) . When a balance exi t . the b ird perfonns to its maximum 
effic iency, but i f  stres i s  imposed, the bene fic ia l  flora , e pec ia l ly  lactobac i l l i , have a 
tendency to decrease in numbers and an 0 ergrowth of the non-bene fic ia l  ones seems 
to occur. Th i s  occurrence ma pred ispose Frank d isease, i .e . ,  d iarrhea. or be 
ubc l i n ical  and reduce production parameters of growth, feed effic iency and others 
( Parker et al. . 1979). 
The protecti e flora which estab l i shes itse l f  in  the gut i s  very stab le, but i t  can be 
infl uenced by some d ietary and envi ronmental factors (Haus ler, 2006). The three 
most important are excessive hygiene, ant ibiot ic therapy and stress. I n  the w i ld, the 
ch icken would receive a complete gut flora from its mother's faces and would 
consequent ly be protected agai nst i nfect ion (Bradley, 1967). However, commerc ia l ly  
reared ch ickens are hatched in  i ncubators which are c lean and do not usua l ly  conta in 
organisms commonly found i n  the ch icken gut. There is an effect of she l l  
m icrobio logical contam i nation wh ich  may infl uence gut microflora characterist ics 
(Janez et al. . 20 1 3) .  
Moreover, a l so Hel  gastric secret ion, which starts a t  1 8  days of incubat ion, has a 
deep impact on m icroflora se lect ion (Bradbury, 2004) . Therefore, an immed iate use 
of probiotics supplementat ion at b i rth is more important and usefu l  in  avian spec ies 
than it i s  in other animals .  The ch icken is an extreme example of a young animal  
wh ich i s  deprived of contact w i th i ts mother or other adu l ts and which i s  therefore 
l ike ly to benefit from supp lementation w ith m icrobia l  preparat ions designed to 
restore the protect ive gut m icroflora (Bradbury, 2004) .  
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The p c le  current l) being u ed in probiotic preparat ion are varied and many. 
The e are most l y  Lactobacillus bulgariclls, Lactobacillu acidophilus, Lactobacillus 
casei, Lactobacillus he h·e ticus. Lactobacillus lactis, Lactobacillus salivarills. 
Lactobacillu ' plantam/ll, Streptococcus the rmophilZlS. Enterococcus jaeciunJ, 
Enterococcus jaecah , Bifidobacterium spp. and Escherichia coli. With two 
e:-.ceptions, these are a l l  intest ina l  stra ins .  The t\ 0 except ions, Lactobacillus 
blllgaricli and Streptococcus thermophilus, are yoghurt starter organisms. Some 
other probiot ics are m icroscopic fungi such as stra ins of yeasts be longing to 
Saccharol1lJ'ces cerevisiae ( Fu l ler eL af. , 1 989) . 
1.7 A renewal  of  i n terest i n  bacterioph ages 
The use of ant i b iot ics is current l y  be i ng reduced in animal product ion so 
alternat ive methods are needed to combat bacter ia l  d i seases in animals feed and to 
control transm i ssion to humans of the pathogens responsib le for foodborne i l lnesses. 
The excessi ve use of ant i b iot ics in agro-food and in  an imal  husbandry, contri butes to 
the occurrence and pers i stence of ant ibiot ic resi stant pathogens for humans and 
animals through the food chain (Nigam e t  01. , 20 1 4) .  
There i s  an urgent need for alternat ive methods to combat bacterial  d i seases of 
agr icu l tura l l y  important an imals .  Of the present poss ib i l i t ies, bacteriophages 
(phages) therapy shows promise (O'Flaherty et 01. , 2009). 
In the 1 980s, a Br i t ish bacteriologist, W i l l iam Smith, had conducted a series of 
exper iments in both m ice and farm animals .  Bacteriophages were shown to be more 
effective than a variety of ant ib iot ics i n  reduc ing the morta l i ty of m ice w ith 
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genera l i zed and itracerebral Escherichia coli i nfect ions and bacteriophage were 
ho\\ n to be mU l t iplying in the t i ssue (O'Flaherty e/ 01 . . 2009; N igam el 01 . . 20 14). 
Ver 10\\ doses of phages \ ere found to be a lmost effect ive than h igh doses. 
l i sk ef 01. ( 1998) e a luated the treatment of e, perimenta l l y  induced d iarrhea i n  
calve . p iglet and lamb due  to  several d i fferent stra ins of E. coli, and were able to 
succe fu l l y  treat and prevent infect ions' even when low doses of bacteriophages 
\ ere used ( A l i  ky, et 01., 1 998) .  
These demonstrat ions of the potent ia l  of the bacteriophages therapy, combined 
w ith the growing urgency of the ant ibiot ic cris is, led to renewed i nterest in th is  
approach i n  the 1 990s (A l isky e/  al., 1 998) .  Janez et  al. (2013)  showed that 
bacteriophages could prevent the destruction of sk i n  grafts in gu inea pigs and could 
protect m ice aga inst lethal leve l s  of bacteria l  infection (Janez et al., 20 1 3 ) .  
Combined w ith the cont inu ing increase i n  ant ib iot ic  res istance, work show ing that 
bacteriophages could be effect ive as a medical treatment. Th i s  led severa l groups to 
look at the poss ib i l i ty of bringing the therapeutic bacteriophage technology back from 
the former oviet b loc which was now access ib le  fo l lowing the fal l  of the old 
commun ist regimes severa l years ear l ier (O'F laherty el al. , 2009; Harper, 20 1 2) .  
Unfortunate l y, despite the apparent prom ise of  th is  technology, and desp ite the 
widespread use inc l ud ing a very large body of work i nvolv ing the treatment of many 
thousands of pat ients i n  local stud ies, the work which had been done was not enough 
to prove the case for the bacteriophage therapy for western use (Haus ler, 2006) .  
Under the d i fferent pressures that app l ied in  t he  Soviet era, part icu larly the desperate 
need for treatment options, th i s  work had not i nvolved the deta i led documentat ion, 
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and double-blind c ntrol requ i red for progress \ ith in  a modem regulatory 
framework . The e id nce was support ive, but not suffic ient ( L im el al . . 20 I I ) .  
s a result, much of the exc itements 0 er access to fonner Soviet sc ience in  the 
m id 1 990s pro ed unsupportable. Whi le cli n ics in Poland and Georgia offered 
bacteriophages treatment to tho e moti vated enough to travel to them for treatment, 
these could not be used i n  Western Europe or in the Un ited States (Bradbury 2004). 
Those companies that managed to surv ive in  the West generally d id so on the basis of 
other k inds of  applications, in part icular the somewhat less complex areas of food and 
agricultural appl icat ions ( Wong et aZ. , 20 1 4) .  
By 2007, fi e bacteriophage products \ ere likened in the Un i ted States. One was 
to prevent bacterial i nfect ions of tomatoes and peppers, two to destroy bacteria 
associated w i th food poison ing on food animals before slaughter, and two for the 
control of  L isteria lIIonocytogeses on ready-to eat food (Ch ibani  el al. , 2004) .  In th i s  
latter use, exposure of  humans to the  bacteriophages was accepted by the FDA which  
was an important step fon ard (Johnke el  al  . . 20 1 4). 
Clin ical work in  humans was slower to develop, not least due to the relatively h igh 
cost of such work. Some groups have focused on i nvest igat i ng the use of genetically 
mod ified (GM) bacteriophages, often with enhanced abili t ies to destroy the i r  bacterial 
target but w ith reduced ab i li ty to replicate, essent ially a gene vector approach ( L im et 
al., 20 1 2). H owever any use of GM technology brings w ith i t  very s ignificant 
add i t ional regulatory requ i rements (Jahnke ef aI. , 20 1 4) .  
I n  add i t ion, many researchers considered the abi  I i ty of bacteriophages to repl icate 
and thus to expand the i r  numbers at prec i sely those points where they are needed to 
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b a major trength of the approach, and thus quest ion the use of non-rep l icat ing 
bacteriophages or bacteriophages der i  ed vectors . Un I i ke gene therapy vectors, 
\\- here rep l icat i n appears to have the potent ial to cause problems, bacteriophages can 
on l rep l icate i n  the i r  prokaryotic target ce l l  (Thacker, 2003) 
1 .7. 1 Bacte,-ioph ages as t hera peut ic  age n ts 
The emergence of pathogenic bacteria resi stant to most, i f  not a l l ,  current ly 
a ai lable ant im icrobia l  agents has become a crit ical problem in modern med ic ine, 
part icu larly because of the concom itant increase in  immunosuppressed patients 
(Abdul-Hassan el al., 1 990; Harper et al. ,  2008). The concern that mankind is re­
entering the pre-ant i b iotics era has become very real and the deve lopment of 
a l temati e ant i - infection modal it ies has become one of the h ighest priorit ies of 
modern med ic ine and b iotechno logy ( Krylov, 20 1 4). 
Bacteriophages \ ere d i scovered before effective antibiotics and so i t  was hoped 
that the wou ld  be able to contro l  bacterial d i sease ( Projan, 2004). In 1 9 1 9, there 
were reports of the apparent ly  successfu l  treatment of typhoid i n  ch ickens and of 
dysentery i n  five humans.  I n  1 92 1 ,  bacteriophages were used against Staphylococclis 
aureus i n  sk in  d i sease (N igam et aI. , 20 1 4) .  
During the 1 920s both local ized and large-scale experiments were undertaken in  
many countr ies, i nc l ud ing the treatment of over a m i l l ion patients in  Ind ia  ( Wright et 
al. ,  2009) .  A w ide range of commerc ia l  preparations were sold in Europe and the 
USA.  The novel ( 1 925)  and fi lm ( 1 93 1 )  A rro\ sm i th presented a fict iona l i zed 
account of the i r  use (N igam el aI. , 20 1 4) .  
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Unfortunatel , under tand ing of the nature of bacteriophages \ as extremely 
l i m ited at the t ime .  I t  was not unt i l  1 939 when the use of early e lectron m icroscopes 
he lped to sett le an ongo ing argument as to whether they were v i ruses or some form of 
chemical to, in . ln consequence, much of the earl work u ing bacteriophages was 
deeply flawed because: ( i )  bacteriophages were used against d i seases w i th no 
bacteria l  component; ( i i ) i t  was assumed that bacteriophages were able to destroy a 
\ ide range of  bacteria, whereas they are h igh Iy speci fie. 
The were thus used against i nappropriate bacterial targets; ( i i i )  inappropriate 
growth cond i t ions or preservatives were used that l im i ted or prevented the inc lusion 
of i nfect ious bacteriophages; and (iv) methods of admin i strat ion were used that 
inacti vated any bacteriophages present (Projan, 2004' Hauer el 01. , 20 1 0). 
In 1 934. the Jou rnal  of the American Medical Assoc iation publ i shed the resu lts of 
a large study carried OLlt by the US Counc i l  on Pharmacy and Chem i try. I t  
concl uded that, apart from few restricted uses, there was no good evidence that 
bacteriophages actua l l y  worked in the therapeutic uses that had been e a luated 
(A l isky et al., 1 998) .  
I t  was further noted that most of the work carried out was deeply flawed, lacking 
proper controls,  adequate ly  purified therapeutic substance, or suffic ient numbers of 
pat ients. Desp ite th i s, therapeutic use of  bacteriophages cont inued through World 
War I I .  The German and Soviet arm Ies used many bacteriophage preparat ions, 
notab Iy aga inst dysentery ( Harper, 20 1 2) .  
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1 .7.2 Commercia l  bacterioph aae prod uct for the t reat ment  of h u m a n  di ea e 
Bacteriophage have a long history of safe therapeutic use i n  the former oviet 
Un ion part icu larl at the E l i a  a I nsti tute in  Georgia, \ here they have been used s ince 
1 923. Pat ients trave l led from al l over the oviet Un ion and bacteriophages became a 
rout i ne part of  treatment i n  c l i n ics  and hospita ls  (Wright el al., 2009). Phages have 
been app l i ed in o i ntments for the skin, p i l ls .  drops, and r inses and tons of phage 
product ha e been produced per week. The E l iava I nst itute continues to treat 
pat ients today, but on a reduced scale. Phage therapy is a lso avai lable in a very 
l i m i ted form in some European countries (such as Poland) for compassionate use, i n  
pat ients who have not responded to  ant i b iot ic treatment (Johnke e f  al . . 20 1 4).  
Howe er, none of the phage app l ications ment ioned above were tested 1 11 fu l l  
c l i n ical  tr ia ls. t o  the standards requ i red for Westem Med ic inal  products. In the 
Un i ted tates, certain phage products have been given a "Genera l l y  Recogn ized as 
Safe" (GRAS) rat i ng by the FDA, for use in food treatment (Bradbury, 2004) .  
However, for phage therapeutic treatments i n  humans, fu l l  c l i n ical tr ia ls  are sti l l  
requ i red. The process o f  produc i ng phage cockta i ls to cGMP (current Good 
Manufacturing Pract ice) standards must be deve loped and val idated before safety and 
efficacy stud ies in humans can begin (Monk et al. , 20 I 0). 
I n  order to fu l l y  explo i t  these natura l ,  b io logical a l ternati ves to ant ib iotics, 
ovo l yt ics, is a company that had a goal of explo i t ing the therapeutic potential  of  the 
bacteriophages, i n  a way that is commerc ia l l y  v iable and attract ive to its investors 
( Haus ler. 2006) .  Novolyt ics is p lanning such a series of c l in ical  tr ia ls .  The i r  fi rst 
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product i s  a phage cockta i l  target i ng Methylene resistant Staphylococcus oureliS 
(MR A)  (T onos ef al. , 20 13) .  
The use f bacteriophages was of  wide range in  many fields inc lud ing agricu l ture, 
aquacu l ture. veteri nary. food safety and human health which a lso inc lude 
ident ificat ion and detection of d i sease and therapeutics. Some examples are 
ovolyt ics for M R  A. GangaGen for taphylococcal infections, Ph ico Therapeutics 
and Amp l iph i  B iosciences for systemic use agai nst Pseudomona aeruginosa ( Monk 
et aI. , 20 1 0; Tsonos ef al., 20 1 3) .  
1 .7.3 Issues rela t ing  to t h e  use  of  bacteriophage to  replace a n t i biotics 
The first modem c l  i n ical  tr ia l  of a bacteriophage therapeutic was carried out In 
J 999 in London. U K, though this used healthy volunteers w ithout the targeted 
i nfect i on. and thus on ly  addressed safety issues (Tsonos et al. , 20 1 3) .  
The i ntended target was vancomycin resistant Enterococcus i nfections. After 
th is, add it ional safety tr ia ls were carr ied out, but it was not unt i l  2007 that the first 
modem c l in ica l  tr ia l  of the efficacy of a bacteriophage therapeutic was begun 
target ing Pseudomonas aeruginosa i nfections of the ear. The trial completed in 2007 
and larger. phase 3 tr ia ls are now p lanned. It w i l l  be necessary for these tr ials to be 
completed successfu l l y  and approved by the re levant regu lators such as The 
European Medic i nes Agency in Europe and the Food and Drugs adm istrat ion ( FDA) 
in the U SA, before any bacteriophage therapeutic can proceed to market. However i t  
seems that progress i s  be ing made (Tsonos et aI. , 20 1 3) .  
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1 .7A Adva n tage of u i n a  bacterioph age in  medic ine 
There are many advantages of us ing the bacteriophage in  the med ical fie ld as 
ugge ted by Johnke I!/ al. (20 1 4), these inc lude; ( i ) bacteriophages are h igh ly  
pec ific ,  he lp ing  to  a o id  ide  effects. Th i s  is in  l ine \'v ith an  increasing trend i n  
ant i b iot ic usage to  a o id drugs wi th broad spec ific ity; ( i i ) the use of rep l icat i ng 
bacteriophages a l  0 a l lowed for the use of ver 10\J input levels that can mu l t ip ly up 
at need . Th i s  can reduce both cost and tox ic i ty; ( i i i )  bacteriophages are unaffected by 
ant ib iot ic res istance, and there is ev idence that they may be able to work 
synergist i ca l l y  \ ith some convent ional ant ib iot ics; ( iv) bacteriophage preparations 
appear free of  gross tox ic i ty. Potent ia l  compl ications aris ing from the re lease of 
bacter ia l  endotoxins from lysed cel l s  but th i s  do not seem to be an i ssue at the dos ing 
levels now i n  use; (v) bacteriophages are re lat ively s imple to manufacture, a l though 
the h igh ly  regulated manufacturing process requ i red for c l i n ical  use adds to costs and; 
(v i )  bacteriophages themselves may be able to adapt to counter bacterial  resi stance 
(Johnke el al. , 20 1 4). 
1 .7.5 D isadvan tages of  us ing  bacteriophage in  med ici n e  
Moreover there are a lso several d i sadvantages of us ing the bacteriophages in  
med ic i ne as suggested by Johnke el al. (20 1 4), these inc lude; ( i )  h igh spec ific ity 
means that i t  i s  important to ident ify the pathogenic bacteria present and to ensure 
that they are respons ib le for the d i sease. Mu l t ip le  bacteriophages may be requ i red to 
obta i n  usefu l  levels of  coverage, though th i s  can i n  tum reduce the chance of 
res i stance; ( i i )  bacteriophages have l i m ited su itab i l i ty for system ic use s ince they can 
generate immune responses wh ich can reduce efficacy. This  can be avoided by the 
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use on i nfected p i t ioned on the bod urface or oral admin istration; ( i i i )  the 
mob i l ization of bacteria l genet ic materia l  that may be able to moderate v iru lence is to 
be avoided . For th is  reason, on ly lytic rather than lysogenic,  bacteriophages are used, 
and regu lators requ ire carefu l  mon i toring of a l l  forms of transduction or transfer of 
bacteria l  genes (Johnke et 01. , 20 1 4) .  
1. 7.6 Act ive and passive bacteriop hage thera py 
There are two types of bacteriophages therapy; ( i )  active bacteriophage therapy 
and ( i i ) pass ive bacteriophage therapy ( Wright et 01., 2009). The approach that re l ies 
on bacteriophage mU l t ip l icat ion to generate therapeutic doses of the bacteriophages 
aga i n  t the far larger numbers of bacteria that are present is ca l led the act ive 
bacteriophage therapy. On the other hand the use of h igher doses suffic ient to 
produce ant ibacteria l  effects w ithout re lying on bacteriophage repl ication is known as 
pass i e bacteriophage therapy (Janez et 01. , 20 1 3). 
1.7.7 A pplicat ion of bacteriophages in ch ickens feed 
It was a lways a matter of urgency to find al ternat ive ways of prevent ing and 
treat ing the ch icken i nfect ions that are a lso a risk to humans. Of the present 
poss ib i l i t i es ,  bacteriophage (phage) therapy shows prom ise ( Hausler, 2006). 
Bacteriophages are h igh ly  spec ific in k i l l i ng certa in stra ins of bacteria just l i ke 
ant ib iot ics, but wi th  the added benefit of mu l t ip lying as they consume the host, so 
they spread rap id ly. Recent work has shown that bacteriophages are h igh ly effect ive 
at c leari ng pathogens from pou ltry carcasses and at k i l l ing them i n  the intest ines of 
l i ve b irds and in  their eggs ( Hausler, 2006). 
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Barrow et 01. ( 1 998) a lso proved that a 1)1 ic bacteriophage, which was pre iously 
isolated from ewage and \vh ich attaches to the capsu lar antigen has been used to 
pre ent s pticem ia and a men ingit is- l ike infect ion i n  ch ickens caused by a bacterem ic 
stra in  of E. coli. Protect ion was obtained even when adm in istrat ion of the phage was 
dela ed unt i l  s ign of d i  ease appeared . The phage was able to mu l t ip ly  in the b lood . 
I n  ne\ Iy born colostrums-deprived calves given the E. coli ora l l y, i ntramuscu lar 
i nocu lat ion of  phage delayed appearance of the bacteri um in the b lood and 
lengthened l i fe span (Barrow et al. , 1 998). 
F iorent in (2005) stated that reduc ing Salmonella contam ination in poul try i s  of 
major i mportance to prevent the introduction of th i s  m icroorgan ism i nto the food 
cha in .  Salmonella may spread dur ing storage t ime (shelf l ife) whenever pre-harvest 
contro l  fa i l s or post-harvest contam ination occurs.  Therefore, preventive measures 
should a lso be used in the post-harvest level of pou ltry production in order to control 
Salmonella. Chicken sk in samp les were experimenta l ly contaminated by imm ers ing 
whole legs ( th ighs and drumst icks) i n  a suspens ion conta in ing 1 06 colony form ing 
un its per m i l l i l i ter (cfu m rl ) of Salmonella enteritidis phage type 4 (SE PT4) at the 
s laughter day. One day later, samples from one group were immersed in  a suspension 
poo l conta in ing 1 09 cfu m r l of each of three wi ld  Salmonella-lytic bacteriophages 
previous ly iso lated from feces of free range ch ickens ( F iorent in,  2005). Salmonella 
count ing \ as performed at three-day interva ls in the ch icken legs stored at 5°C and 
showed a s ign ificant reduction ( P<0.05) of SE PT4 in bacteriophage-treated cuts on 
days 3, 6 and 9 post-treatment (F iorent in, 2005) .  
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The e find ings suggest that the use of bacteriophages may reduce E PT -+ in 
ch  icken sk in .  Further stud ies are encouraged and m ight demonstrate the potent ia l  of 
thi approach as an e ffic ient and safe techn ique to be rout inely used for Sa/monel/a 
contro l  i n  ch icken product (F iorent in, 2005). 
Car alho el at. (20 I 0) concluded that pou ltry meat i s  one of the most important 
sources of human campylobacteriosis, acute bacterial enter i t is  wh ich is a major 
problem v orldw ide.  Campy/abaeter coli and Campy/obaeter jejllni are the most 
common Campy/abaeter spec ies assoc iated wi th th is d i sease. These pathogens l i ve 
in the i ntest ina l  tract of most avian spec ies and under commerc ia l  cond it ions they 
spread rap id ly  to i nfect a h igh proport ion of the flock, which makes the i r  treatment 
and pre ent ion very d i fficu l t  (Carva l ho et al. . 20 I 0). 
Carvalho et al. (20 1 0) tested the efficacy of a phage cockta i l  composed of three 
phages for the contro l  of pou ltry i nfected with C. coli and C. jejllni. They evaluated 
the effect i eness of two routes of phage admin i strat ion (by oral gavage and in feed) 
in order to provide add it ional  i nformat ion regard ing their future use in a pou ltry un i t  
(Carvalho et a/. , 20 1 0). 
The resu lts i nd icate that the b irds had no s igns of d isease even at the h ighest dose 
of Campy/abaeter adm in i stered. The phage cockta i l  was able to reduce the t i tre of 
both C. coli and C. jejuni i n  faeces by approximate ly  2 log 1 0  cfu g" when 
adm in i stered by ora l  gavages and in feed (Carvalho el ai. , 20 1 0). 
M i l ler  et al. (20 1 0) observed that several l yt i c  bacteriophages effect i ve at 
destroying a genet i ca l l y  d iverse popu lat ion of C/astridium perfringens were isolated 
from the env i ronment, extens ive ly characterized, and used to formulate a mu lt ivalent 
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bact riophage cockta i l  designated "TNT-40 I ". Two in vivo stud ies were conducted to 
determ ine the cockta i l ' efficacy in contro l l ing necrot ic enteri t i s  (NE) cau ed by C. 
peljringen . The first tud investigated the efficacy of INT -40 I and a 
bacteriophage-deri ed, toxoid-type acc ine in contro l l ing N E  i n  C. perfringens­
chal lenged bro i ler ch ickens. The study was des igned as a proof-of-concept battery 
cage tud wi th b i rds  reared unt i l  28 days old ( M i l ler el al. , 20 1 0). 
Compared " ith the morta l ity observed with the C. peljhngens-chal lenged but 
untreated ch ickens, oral  admin i strat ion of INT-40 1 s ignificant ly (P < 0 .05)  reduced 
the morta l ity of the C. perfi-ingens-chal lenged b i rds by 92%. Overa l l ,  INT-40 I was 
more effect i ve than the toxoid vacc i ne in contro I I  i ng active C. pelfringens infect ion .  
The second study was conducted to i nvestigate the effect iveness of the cockta i l  when 
adm in istered via oral gavage, feed or dr ink ing water ( M i l ler et aI. , 20 I 0) 
The tudy was conducted w ith b i rds reared to 42 days old. lNT-40 1 adm in istered 
by a l l  three methods s ign i ficantly ( P  < 0 .05)  reduced mortal ity. Weight gain and feed 
con ersion rat ios were s ign i ficantly better i n  the C. perfringens-cha l lenged chickens 
treated with lNT-40 I than in the C. pelfringens-cha l lenged and phage-untreated 
control b i rds ( M i l ler et ai. , 20 1 0). The data ind icated that del i vering INT-40 1 to 
bro i ler ch ickens v ia  the i r  dr ink ing water or feed may be an effect ive means for 
contro l l ing ecrot ic Enter i t is  (NE)  caused by C. perfringens and may improve weight 
ga i n  and feed convers ion rat ios in b i rds w i th c l i n ical or subc l i n ica l  NE ( M i l ler e{ al. , 
20 1 0) .  
L im el al. (20 I I ) a lso stated that Salmonella gallinarum (SG)-spec ific 
bacteriophage i so lated from sewage effluent was used to prevent horizontal 
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transmis  Ion of G in commerc ia l  layer ch icken . ix-\ eek-o ld ch ickens, each 
cha l lenged w ith 5 x 1 0  colony fonn ing un its of G, cohabi ted w ith contact ch ickens 
treated w ith 1 06 plaque-form ing un its kg- I of bacteriophage, prepared in  feed 
add i t ives, for 7 days before. and 2 1  days after chal lenge \0 ith SG. Mortal ity was 
observed for 3 \\ eek after chal lenge and SG was period ica l ly re- isolated from the 
I i  er, sp leen, and cecum of ch ickens. SG re- i so lation from organs was decreased and 
a ign ificant ( P  < 0.05) reduction in morta l ity was observed in contact ch ickens 
treated w i th the bacteriophage, as compared to untreated contact ch ickens, ind icat ing 
that bacteriophage adm in i strat ion i n  feed add i t ives s ignificantly prevented the 
horizontal t ransmission of SG.  These results provide important i ns ights i nto 
pre ent ion and control strategies aga inst SG infection and suggest that the use of 
bacteriophages may be a novel .  safe, and effect ively reasonable alternative to 
ant ib iot ics for the prevent ion of SG infection in poul try (L im ef al. , 20 1 1 ) . 
L im et af. (20 1 2) proved that bacteriophage <l>CJ07 \ ith broad host ranges for 
Salmonella stra ins iso lated from sewage effluent was used to reduce Salmonella 
enteritidis (SE)  i nfect ion i n  ch ickens. One-day-old ch icks chal lenged with 5 x  I 07 
colony fonn ing un its per b i rd of S E  were cohab itated wi th contact ch icks and treated 
\\- i th three concentrat ions ( 1 05, 1 07 and 1 09 plaque form ing un its (pfu) g- I ) of  
bacteriophage prepared as a feed add it ive for 2 1  days after cha l lenge. Salmonella i n  
t he  i ntest ine was q uantified and env i ronmenta l contam ination leve l was exam ined at 
1 , 2 and 3 weeks after cha l lenge (L im  et al. , 20 1 2). 
In the work carried out by Lim et aZ. (20 1 2), all treatments reduced intest ina l  SE 
colonization in  cha l lenged and contact ch ickens and reduced the env i ronmental 
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contamination leve l ,  but the reductions produced by 1 07 and 1 09 pfu g- I of 
bacteriophage were igni ficant ( P<0.05) a compared \ ith untreated controls .  I n  
add it ion, even out of 1 0  ( 70%) contact ch ickens treated w i th 1 09 pfu g- I of 
bacteriophage had no detectable intest inal  Salmonella at 3 weeks after treatment 
ugge t ing that bacteriophage therapy s ign i ficantly prevented the horizontal 
transm iss ion of E .  These resu l ts provide important ins ights i nto prevent ive and 
contro l  strategies agai nst SE i nfect ion in  poultry and ind icate that the use of 
bacter iophage cou ld reduce the i nc idence of Salmonella food poisoning ( Lim et aI. , 
20 1 2) .  
Janez et  al. (20 1 3) demonstrated that  s ince the ban on ant ib iotic use for growth 
promotion, bacteria l  i nfections of the i ntest i nes are an emerging problem in pou ltry 
and p ig  fann ing. I n  add i t ion, there i s  increasing pressure to find better alternat ives to 
ant ib iot ics i n  the batt le aga inst bacterial infections. The use of bacteriophages in  
an imal  feed m ight be such an a l ternat i ve .  I n  p igs and poul try a relat ively sma l l  group 
of bacteria  ex ists, wh ich fonn the major threat to intest ina l  heal th .  Therapeut ic 
phage/endolys in  treatment of some of these intest i nal  pathogens; i .e .  Brach}'spira ssp, 
C.perjringens, Clostridium difficile and Escherichia coli might be an option (Janez et 
al. , 20 1 3) .  
H owever, bacteriophages are not equa l ly  app l icable for al l these infections. 
Various phages have been i so lated, characterized and tested in vitro and sometimes in 
vivo. They vary greatly in ,  spec ific ity, v i ru lence, l yt i c  potent ia l  sens i t iv i ty (for l ight, 
p H-va l ue) per ind iv idual  phage aga inst the pathogenic bacteria .  Therefore, Janez et 
al. , (20 1 3) suggested that each phage has to be considered i ndependently for its 
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potent ia l  to sur ive re idency in an imal  feed, and the oral appl ication route and 
fi na l ly its e fficacy to reduce or e l im inate the spec i fic pathogen must be exam ined 
(Janez et al. , 20 1 3) .  
Furthermore, the di  t inct ive propert ies of targeted bacteria affect the sui tab i l ity of 
the therap . 0 era l l ,  the l im ited research, and not the poss ib j l j ty, has h i ndered the 
u e of phage for such therapeut ica l ly app l i cat ion. Wh i le bacteriophage treatment 
\\ i l l  probably never fu l l  rep lace ant i b iot ics, they can be a good add it ion to and m ight 
be used in combination w i th them, to combat the i ncreas ing bacteria l  i nfections i n  
p igs and poultry ( Wong e t  aI. , 20 1 4) .  
Tab le 1 . 1  The app l ications of  bacteriophages to compete E. coli and Salmonella i nfect ions. 
Table 1 . 1 . 1  Pre-harvest E. coli 0 1 57 :  H7 phage app l icat ions.  
Year Ani mal/product Phage(s) Strateg) Main outcome Reference 
Pre-harvest appl ication 
Poultry ( broi ler Air  Air sac inoculation pre\ ented ( Hu ff e( 2002 PR02 sac or mOl1al it) . Drinking water o ffered chicken) drinking water no protection al . 2002) 
Poultf) ( broi ler SPR02 Sign i ficant decrease of mortality ( I  l u ff e( 2002 chicken) and Sprayed but not complete protection al . 2002) DAF6 
Aerosol spray e ffecti\ e only w hen 
SPR02 appl ied 
im mediately aIler bird 
Poultf)' (broi ler prayed and i .m.  chal lenge with E. coli. A single i . m. ( Bach et 2003 chicken) and i nject ion injection reduced mortal i ty when al . 2003 ) DAF6 appl ied immediately and 24 and 48 
h after challenge 
Rumi nant No reduction of fecal sheddi ng ( Bach et 
2003 ( l amb) De22 
Oral del ivery over 30 days aI , 2003) 
e 1 1 /2 ,  Eradication in seven of n ine ( O'Flynn e( 
2004 Meat e41 l c, Appl ied on top samples al . 2004) 
ppO I 
Poultry (broi ler SPR02 
i .m .  inj ection Only high phage t i ters ( 1 08)  ( Raya et 
2006 chicken) 
and i nto the left reduced mOl1al ity al. . 2006) 
DAF6 thigh 
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2006 Rum inant CEY I Oral deher} 2 log c fu reduction \\ i th in 2 da) s ( HuIT et ( sheep) 0/ . 2006) 
No reduction 0 f c fu \\ hen appl ied 
2006 Rumi nalll Phage Oral/rectal oral I} . Combined oral/rectal ( heng et 
( catt le) cocktai l de l iver) treatment reduced cfu but d id not 0/ . 2006) 
eradicate it 
Fresh produce Phage 94% and 1 00% reductions in  c fu 
(Abduladz 
2008 ( tomato, cocktai l ppl ied on alier 1 20 h and 24 h in tomato and 0/. , spinach) and ( E  p - top/spray ed spi nach; 95% reduct ion in ground e et 
meat 1 00) meat aner 24 h at  1 0°C 2008) 
Phage Oral/rectal Small fecal shedding reduct ion of ( Rozema 2009 Ruminant (steer) 
cocktai l del ivery orallrectal compared to the rectal et a/. , 
treatment and control 2009 ) 
Fresh produce Phage (Ol ieviera cocktai l  igni ficant c fu reductions after 2 2009 ( lettuce, 
(ECP- prayed days at 4° et 0/. , cantaloupe) 
1 00) 201 0) 
Phage 
cocktai l Oral del iver) No reduction of fecal shedding of 
20 1 0  Ruminant (steer) ( vvY 8, (gelat in  capsules nal id ix ic  acid-resistant E. coli (R i  as et 
rY - ,  and in  feed) 0 1 57 : H7, but duration of 0/ , 20 I 0) 
\\ Y7.  shedding was reduced by 14 days 
\\ V I I ) 
Phage Oral del i\- ell Signi ficant reduction of mortalit) ( Stanford 20 1 0  Poultf) el 01. , cocktai l  and spray in large scale animal experiments 
20 1 0) 
Phage 
Rapid c fu decrease \\ i th in 24 to Ruminant cocktai l  ( Raya et 20 1 0  
( cattle) (e l l l2, Oral del i\ery 48 h.  but no decrease I n  fecal a/ , 2 0 1 1 )  
e41 I c )  shedding le\e ls  
Phage 
Cocktai l  eradicated (>99.9%) the Ruminant cocktai l  ( Raya et 20 1 1 (sheep) (CEY L Oral del i ,  ef) pathogen and is more effecti\ e than a/ , 20 1 1 )  
CEV2) CEY I alone 
Added to foods 
Fresh produce together with No surv ivors detectable after ( Raya et 20 1 1 ( lettuce, Phage trans- 1 0  min  of phage combi ned with the 
spinach) cocktai l  c innamaldeh) de TC treatment al. , 2 0 1 1 )  
(TC )  
Food surfaces Phage 4.5 log reduction c fu after 2 h of ( Raya et 20 1 1  ( spinach blades) cocktai l prayed phage 0/ . .  20 1 1 )  
Food surfaces Phage Eradication after 1 0  min  a t  3 7°C ( Raya et 20 1 1  (steel .  ceramic cocktai l Appl ied on top and after I h at 23°C a/ , 201 1 )  chips) ( BEC8) 
T bi l l  2 P h d t h a e :  re- arvest an pos - arves t S 1 a mane II h a p i ' c 1 ' 0  S age app 1 a I n 
Year Ani mal/product Phage(s) Strategy Main outcome Reference 
Preharvest appl ication 
Phage Oral del i very Reduction of c fu in cecal counts (Huff et 01. . 200 1 Poultry ( ch icken) cockta i l  (d i rect and via between 0.3 and 1 .3 log 2002) feed) compared to controls birds 
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200 1 II ine ( pig) Fel ixO I Oral del iver)' Reduction o r e fu in  the tonsi ls  ( l ;uff el 01 , and i .m.  and cecum 2002) 
CNPSA I 
Poultry ( broi ler , Reduction of cfu by 3 .5  orders ( HulT el aI. , 2005 P i\3 Oral del ivery chickens) of magnitude after five da) s 2006) 
CNPSA4 
Phage Oral del iver) Reduction of c fu in cecum and 
2005 Poult!") cocktail phage/com petit i  i leum after phage cockta i l  andlor ( Raya el aI , ( chickens) ( Sa2. 9. 2006) 
S I I )  \ c  exclusion competit ive excl usion treatment 
(1) 1 5 1 ,  Oral delivery Reduction of 4 .2 log and 2. 1 9  (Abdu ladze 
2007 Poultry ( broi ler (1)25, (antacid log 'with phages <I) 1 5 1  and (1)25 et 01 , .  chickens) <I) I 0 suspension) wi th in  24 h compared with 2008) control 
Phage Reduction of  cfu in cecal lonsi Is 
2007 Poultry ( broi ler cocktai l  Oral del  i very after 24 h. No sign i ficant ( Rozema el chi ckens) (CB4�, di fTerences at 48 h compered to 01. , 2009) 
WT45$) controls 
Oral del ivery Reduction of in test inal 
2008 Poulu)' Phage (coarse colonization of ten-day-old ( tan ford et (chickens) cocktai l spray/drinking experimental ly contami nated 01 , 20 1 0) 
water) b irds 
Phage Reduction of colonization by ( Stan ford el 20 1 0  Swine (pig) 99.0 to 99.9% in  the tonsi ls, cocktai l i leum. and cecum 01 , 20 1 0) 
20 1 1  S\vine ( weaned Phage Oral del ivery igni licant reduction of c fu in  ( Raya el 01. , pigs) cocktail the rectum 20 I I ) 
Poultry Oral del i very Phage prevented horizontal ( Ra) a el 0/. , 20 1 1 transm ission on six-week-old (chickens) (via feed ) infected chickens 20 1 1 )  
Postharvest a p p lication 
Processed food No surv i l al during 89 days in ( H u ff et of. , 200 1 (r i pened cheese) J2 Added to mi lk  pasteurized cheeses contai ning 2002) phages ( M O l  1 04 )  
Fresh produce Phage Signi ficant c fu reduction on ( Huff el 0/ . .  200 1 ( fresh-cut melon cockta i l  Added to foods melon but not on apple 2003) and apple) 
MOl I caused l ess than I log 
2003 Meat (chicken P22, 29C Appl ied on top 
reduction in  c fu; MOl 1 00- 1 ,000 ( Bach et 0/. , 
skin) caused 2 log reductions i n  c fu  2003) 
and eradicated resistant strains 
2003 Meat (chicken Felix 0 1  
Approx. 2 log reduction with a ( Bach et 0/. , 
fran k furters) M O l  of 1 .9 x 1 04 2003) 
Phage-A reduced cfu by 1 .37  
Fresh produce Appl ied by 
logs on mustard seeds. Cocktai l  (Bach e l  0/., 
2004 A, B resulted in a I .S-Iog reduction in  ( sprouting seeds) immersion c fu in the soaking water of 
2003) 
broccol i  seeds 
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Phage treatments reduced 
2005 iVleat ( broi kr. P I I L -I pray ed frequency of almonella ( RoLema el turJ...ej ) rcco\ cry as compared \\ ith aI , 2009) 
controls 
2008 leat P7 Appl ied on top Reduction in c fu of 2-3 log at ( Rozema el SoC and appro:>..  6 log at 2-1°C al. , 2009) 
Prevalence reduction of 
Fresh produce Phage Phage + E. intemal ized . Ja\ iana, although (R i \ as el 2009 asburiae JX I the major suppressing effect was ( tomatoes) cocktai l  added to food via antagonistic acth ity of E. al , 20 1 0) 
asburiae JX 1 
hesh produce Phage + E. Combi ned biocontrol \\ i th E. 
20 1 0  ( mung bean Phage asburiae JX 1 asburiae and phage suppressed ( R ivas el sprouts and cockta i l  added to foods pathogen growth on mung beans 01 . 20 1 0) al fal fa sceds) and a lfal fa seeds 
Phage Above 99% reduction in c fu for ( Raya e/ aI , 20 1 1 Meat ppl i ed on top Mai oI' 10 or above at 4° for cocJ...tai l  96 h 
20 1 1 ) 
At 8°C no v iable cel ls. At 1 5°C 
Ready-to-eat Added to foods reduction of c fu by S logs on ( Raya el aI. , 
20 1 1  foods and FO I -E2 and m i xed in turkey deli meats and in 
chocolate m i l k  m i l k  chocolate m i l k  and b y  3 logs on 
20 1 1 )  
hot dogs 
1 .7 .8 The  c u rre n t  ongoi n g  p roj ects for bacteriophages as an a l ternat ive to 
a n t i biot ics in ch i c ke n  feed and pou l t ry i n d us t ry 
There is a c urrent project funded by the European Un  ion ( EU) i n  order to produce 
massi e amounts of bacteriophages to be used in  the pou l try i ndustry to rep lace the 
app l ication of ant i b iot ics .  Th is project is ca l led the Phage Vet project . 
1 .7 .8 . 1 Phage Vet proj ect 
The Phage Vet project i s  a European-led mul t inational project to exam ine the 
effect iveness of bacter iophages at fight ing infect ions to rep lace the appl ications of 
ant ib iot ics in ch icken feed. 
The Phage Vet proj ect a l ln IS to establ i sh that bacteriophages can reduce or 
e l im inate Salmonella and Campy/obaeter from sma l l  flocks of l i ve ch ickens. The 
other s ign i ficant aim is to ensure that such b i rds then provide pou ltry products that 
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are fi t for human con umpt ion and have great ly reduced leve ls of contam ination b 
the e two pathogen . The Phage Vet project w i l l  iso late and produce h ighly lyt ic  
phages pec i fic to  Salmonella and Campy/abaeter and estab l i sh the most effect ive 
\\ ay to u e them to treat b i rd and ch icken feed as a lternati e treatments to antibiot ics 
(http ://ec.europa.eu/agricu l ture/antim icrob ia ls/phagevet). Contro l l ing the spread of 
bacter ia l  res i  tance to ant ib iot ics w i l l  benefit  human health as we l l  as animal welfare.  
Th i s  i nnovat ive techn ique cou ld prov ide new research techniques, as wel l as new 
bu i ness opportun i t ies (http://ec .europa.eulagricu I ture/antim icrobia ls/phagevet). 
The outcomes of the Phage Vet project wou ld be; ( i )  the estab l i shment of a 
prom is ing method for prevent ing bacteria l  infection of food that could be cheaper 
than other ant ib iot ic-free a lternatives; ( i i ) the se lection and production of h ighly lyt ic 
spec ific phages, and ( i i i )  estab l i shment of effect ive phage adm in i strat ion to l ive 
poul try (http ://ec.europa.eulagricu l ture/ant im icrob ia ls/phagevet). 
1 .8 Biology of  bacte riop h ages 
Bacteriophages are h igh ly spec ific  v i ruses that can target, i nfect and if correct ly 
selected destroy pathogen ic  bacteria ( Harper et aI. , 2008).  Antibacterial activ ity was 
first observed in the \ aters of the Gangs and J umna rivers by E rnest Hank in in 1 896. 
The causat ive agent was d iscovered i ndependently in 1 9 1 5  by Fredrick Twort and i n  
1 9 1 7  by F l e l  i x  d 'Heere I l e  who named them bacteriophages and who then expanded 
on h i s  i n i t i a l  find ing to estab l i sh many of the techn iques that form the bas is  of  
modem v i ro logy (Guttman et aI. , 2005 ; Ol ive ira et  al. , 20 1 4) .  
Bacteriophages are bel ieved to be the most numerous types of v i ruses account ing 
for the majority of  the 1 03 1  vi ruses present on Earth .  They can be found at h igh 
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concentrat ions in water, \ i th 0 er 1 08 per m i  I i i  l i ter be ing recorded from some other 
ources. More than 90% of characterized bacteriophages are c lass ified in  the order 
audo i ra le  ( I  l a Lis ler, 2006). These are the tai led bacteriophages, w i th large double­
tranded D A genome in the range of 33000 to 1 70000bp or even larger. Other 
fam i l ies of bacteriophages a lso exist, w i th range of morphologies, genome types, and 
genome s ize ( Harper, 20 J 2) .  
From the 1 940 onward, bacteriophages became one of the bas ic too ls of  
molecular b io logy. A vast ly increased understand ing of the  nature and act iv i t ies of 
the bacteriophage came a long wi th an understand ing of the processes of the ce l l  
(Janez e t  aI. , 20 1 3) .  
I t  soon became c lear that very large numbers of bacteriophages ex isted, and that 
the vast majority were spec ific to a s ingle host spec ies (and indeed usua l ly restricted 
to a l i m i ted range of stra ins  \ i th in  that spec ies) ( Lacey et a!. ,  2007). 
Wh i l e  many bacteriophages produced rap id lysis of the host cel l ,  other cou ld 
i ntegrate i nto the host chromosome, entering a latent state known i n  th i s  context as 
lysogeny. The inserted bacteriophage DNA is then known as a prophage ( Harper et 
al. , 2008). React ivat ion may occur in response to a variety of st imu l i , and is d i rect ly  
ana logous to the  chromosomal insert ion! react i vat ion cyc le  seen wi th the Retroviridae 
in eukaryotic ce l l s  (Tsonos el aI. , 20 1 3) .  
The ab i l i ty to enter the lysogenic state is assoc iated w ith a range of characterized 
genet ic functions wi th in  the bacteriophage genome inc lud ing a repressor of lyt i c  gene 
funct ion ( that prevents k i l l i ng of the host bacterial  ce l l) and DNA integrates (that 
insert the v i ra l  DNA into the bacterial  genome). When lysogenic bacteriophages 
30 
emerge from their latent tate they may pick up and transfer bacterial 0 A as part of 
th i  process. [n some cases these may be a soc iated wi th bacterial v i ru lence, but th is 
i s  n t un i  ersal ( Hau ler, 2006). 
F igure 1 . 1  Lytic and prophage pathways of the bacteriophages. 
1 .9 I so lat ion of bacteriop hages from t h e  env iro n m e n t  
Purdy e t  al. ( 1 984) showed that phages can be  recovered from large vo lumes of 
sewage water by add ing suspensions of the i r  host bacteria, a l low ing adsorpt ion to 
occur and harvest ing cel l s  by centrifugat ion.  The resuspended ce l l s  are then 
i ncorporated i nto agar overlays and on inocu lat ion; they produce lawns contai n ing 
p laques of  the bacteriophages ( Purdy ef al. , 1 984). 
The process of  iso lat ion of v i ruses by infect ing host explo i t ing the spec ific i ty of 
the v iruses i s  a lso emp loyed i n  the isolat ion of bacteriophage (Armon et aI., 1 993). 
The experiment determ ined to isolate bacteriophages from waste or sewage water by 
i ntroduc i ng them to 1 8-24 hours o ld  pre-grO\ n des i red spec ific phage pathogen [ i ke 
3 1  
Escherichia coli. Further teps inc lude add i t ion of chloroform for I hour then 
tran ferr ing the su pension tubes of soft (0 . 7%) nutrient agar that wou ld be poured to 
nutrient agar p lates (F l int el al. , 2000) . Double layer method to trap the 
bacteriophage in  between the two layers is \ e l l  known and effective method 
1ahony el al. , 20 1 0). 
Mo t recent methods to isolate bacteriophages is the use of select ive k i ts from 
pec ific compan ies, an example would be the Easy Phage kit deve loped by Scient ific 
Methods, I nd iana, U A. The new Easy Phage med ium is used to enumerate 
bacteriophages present i n  food or in a water sample .  The Easygel med ia contains 
i ngred ients to st imu late the growth of E. coli spec ies suscept ib le to spec ific co l i  
phages. The med i um a lso inc lude bacteria l  sta i n i ng solut ion to produce good contrast 
between p laques and host bacterial lawn. 
Easy Phage kit system produces better recoveries than the usua l double layer 
method because it does not need the use of molten agar. EasyPhage is a lso s impler 
than trad i t ional  S i ng le  Agar Layer method ( www.Sc ient ificmethods.com). 
1 . 10 Other  beneficial  uses of  v i ruses 
Whi l e  v i ruses are pr imari ly known as pathogens, they can be used for the benefit 
of mankind.  The most obvious benefit i s  i n  their ro le in  i ncreasing our understand ing 
of  b io logy. The first genome sequences to be revealed were those of  v iruses ( RNA 
bacteriophage M2S and DNA bacteriophage <l>X 1 74) ( Harper 20 1 2) .  
The bas ic  technology of  genet i c  manipu lat ion was developed from stud ies w ith 
bacteriophages and v iral e lements are sti l l  w idely used i n  such work. The reverse 
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110\\ of genet i c  information ( R  A to D A)  was d i  co ered from work \ i th I ruses 
from the fam i ly i nc lud ing I l I V  v i rus Relroviridae (Harper, 20 1 2) .  
There are al  0 a number of way in which v i ruses may produce d i rect benefit for 
human health.  The most ob ious of these are the production of vacc ines and vaccine 
vector ( Harper, 20 1 2) .  Vacc ines do not s imply protect agai nst infect ion w ith the 
am i ru . Relat ive ly  harm less v i ruses are used to provide protect ion from the ir  
more dangerous re lat ives (for example, the use of vacc in ia  v i rus to protect aga inst 
sma l l pox, or hope fibroma v irus to protect aga inst myxomatos is) ( Hauer el af . .  
20 1 0) .  The v i ra l  ectors may be  used to  deve lop cand idate vacc ines agai nst a range 
of d iseases both v i ra l  and non-v i ra l  in nature ( Hauer et al. . 20 1 0). 
There are four major beneficia l  appl ications of v i ruses which are (i) Gene therapy, 
( i i) Cancer contro l  and prevention, ( i i i ) Control of harmfu l  or damaging organisms 
and ( i )  bacteriophage therapy i n  both agricu ltura l  and med ical fie ld (Temp leton 
2008: Harper, 20 1 2) .  
1 . 1 0. 1  Beneficia l  v i ruses in  t h e  field of  gen e  tbera py 
The key e lement of  gene therapy is the introduct ion of function ing genes into the 
cel l s  of human pat ient, to express des ired functions or to correct defective or non­
operat ional  genes wi th in  those cel l s  ( Hauer el al. , 20 1 0). 
Del i very systems must be able to i ntroduce DNA i nto appropriate target cel ls .  Ex 
vivo gene therapy i nvolves removal of the ce l l s from the body, fo l l owed by thei r  
treatment and reintroduction. In vivo gene therapy is more cha l lenging and i nvolves 
target ing of target cel l s  wi th in  the body (Yata et af. , 20 1 3 ;  Krylov, 20 1 4).  
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Benefic ia l  I ru e are rout inely used in the genet ic mod i fication of model 
organi  ms for research purposes. The prod uction of transgenic plants and animals in 
agricu lture ha a lso been e tab l i shed. but germ l i ne mod i fication of humans has not 
been attempted for techn ical and eth ical reasons .  However, genet ic mani pu lation of 
omat ic  ce l l s of ind iv idual ha been under invest igat ion for many years. Th is is  
kno\\ n a gene therap ( L i m  e/ 01. , 20 1 1 ; Yata et 0/. , 20 1 3) .  
1. 1 0.2 Vi rus vector system 
V i rus ectors are used for ex vivo gene therapy, but are particu larly usefu l  where 
the target ce l l s  are i n  less access ib le  areas of the body. V i ruses prov ide h ighly 
effic ient s stem s  for gett ing fore ign nucle ic ac id into cel l s, and they are a lso h ighly 
su ited to protect a nuc le ic  ac id wh i le  transport ing it to the requ i red area of the body 
( Ha rper, 20 1 2) .  
1. 1 0.3 Com pl icat ions  of  gene thera py 
Whi l e  the pr inc ip les of gene therapy are apparently straight forward, there are 
man i ssues that compl icate the successfu l  use of gene therapy. Spec ia l izations of 
cel ls  (d i fferent iat ion) m ay resu lt in  variant gene express ion (Hauer el 01. , 20 ] 0). For 
example. l ung ce l l s  (targeted in attempts to treat cyst ic fibrosis) are h igh ly 
spec ia l ized. The l i m i ted numbers of cases where a s ingle gene defect produces 
serious i l l ness and is amenable to correct ion us ing such methods, are l i kely to provide 
the first examp les of human use (Tsonos et at. , 20 1 3) .  
1 . 10.4 Beneficia l  vi ruses in  cancer  con t ro l  a n d  p reven tion 
A number of v i ruses are assoc iated w ith cancer i n  humans. These v i ruses have 
prov ided the first i nstances of the prevention of cancers by vacc i nation; however, 
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v l ruse can a lso have benefic ia l  app l ications in the ontrol of cancer (O l i  e i ra et 01., 
20 1 4) .  
1 .  J 0.5 Vacc ines 
The most d i rect approach of us ing v i ruse to prevent cancers is s imply that of 
acc i nation again  t iru es that are assoc iated with cancer. Vacc ines for hepat it is  B 
I ru ( Hepadna ir idae: assoc iated w ith hepatocel l ua l r  carc i noma, and human 
papi lomavi rus ( Pap i l lomavi ridae: assoc iated w ith cerv ical  cancer are a l ready 
a a i lable and are in wide pread use ( H aus ler, 2006). 
A lthough many stud ies have been carried out, these are the only vacc l l1es 
approved to date by the U S  Food and Drug Admin i strat ion ( FDA) for the prevention 
of can cer (Johnke el a I. , 20 1 4) .  
1 . 1 0.6 V i r-oth era py 
It is a lso poss ib le  to use the cel l -k i l l i ng effects of v i ruses d i rect ly, rather than 
re ly ing on the i m m une system .  A range of v i ruses have been used in efforts to 
produce targeted k i l l ing of cancerous cel l s, and the approach as a whole is known as 
v i rotherapy ( Wong el 01. , 20 1 4).  
1 . 1 0.7  V i rus-d i rected enzy me p rod rug t he ra py ( VD E PT) 
V i ruses may also be used i n  v i rus-d i rected enzyme prodrug therapy (VDEPT) to 
i nsert i nto target ce l l  an enzyme that can activate an i nactive precursor of a cytotoxic 
drug ( prodrug) that i s  ad m i n i stered systemica l ly  ( Hauer el 01., 20 I 0). For examp le, 
an adenov irus express ing the thym id ine  k i nase (TK) enzyme of herpes s i mplex v irus 
can be combined w ith system ic adm i n i strat ion of gan ic lovir, which i s  converted by 
TK to i ts act ive fonn on ly in ce l l s  where th is  enzyme is present (Borie et 01., 2009). 
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1 . 1 0.8 Con t l'o l of h a rm fu l  or da maging orga n i  m i n  agric u l t u re a nd medici ne 
The u e of b io log ical organi  ms to control damag ing pests is  broadl known as 
b io logical  contro l ,  or b iocontro l  ( Harper, 2006) . Trad it iona l l  t h i s  has been used i n  
agr icu lture. but appl ication ex i  t in  the control of  agents important to human health as 
\\ e l l  ( Harper. 20 1 2). 
1 . 1 0.9 Benefic ia l  v i ru e to con t rol  i nsect pests 
Bacu loviruses ( Bac u lov i ridae) are a large group of v i ruses that i n fect i nsects and 
other arthropods ( Harper, 2006). A l l  tend to be qu i te spec ific in the species that they 
\\ i l l  i n fect. Bacu loviruses show a h igh level of env i ronmenta l stabi l ity due to the i r  
formation of  th ick prote i n  shel l .  They cause i nfection i n  the l arvae of butterfl ies and 
moths and usua l l y  resu lts in death in  4-5 days, a l though th i s  can take longer under 
fie ld  cond i t ions (N igam ef a1. , 20 1 4) .  
1 . 1 0. 1 0  Benefic ia l  v i ruses to con t rol  ra bbits  
V i ra l  agents a l so pro ided the most successfu l  approach to control the devastat ing 
numbers of  European rabbits i n  Austra l ia .  The myxoma v i rus is a member of the 
pQ)..Tiridae, and i t  resu l ted in  k i l l ing 90% to 1 00 % of European rabbi ts in i nfect ion 
kno\ n as myxomatosis (Meader el aZ. , 20 1 0). 
1 . 1 0. 1 1  Benefic ia l  i n sects v i ruses to con t rol  red pal m  weev i l  
Pa lm  trees had always been the most common plant i n  many countries as i t  
tolerates the hot and dry c l i mate. Being a source of  l iv i ng for many decades, the pa l m  
trees draws a lot of  attention t o  its health and wel l  being. The red palm weev i l  
(Rhynchophorlls ferrugineus) attacking palm trees trunk i s  a great chal lenge against 
mainta in ing the palm trees in a good health ( Lacey et al., 2007). The management of 
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the red palm \ ee i l  had been \ i th man methods inc l ud ing chemical and bio logical  
contro l .  V i ru e s  were used to control the red pa lm weev i l  and they showed 
prom i i ng re u l ts and out omes ( Kalha el al. . 20 1 4) .  
1 . 1 0 . 1 2  I n tegrated pest  managem e n t  ( IP M) 
I ntegrated pe t management or I PM i s  refered to the use of mul t iple, often low­
potency. control that together can reduce pest numbers to acceptable leve ls  ( Harper, 
2006). In this approach,  chemical  pest ic ides can a lso be used in combination w ith 
b io logical agents, provided that the b io logical  agents itse l f  is  not harmed by the 
chemica l  treatment used which makes v i ruses a good agent for th i s  approach ( Meader 
e/ al . . 20 I 0). 
1 . 1 1 Ai ms of the tudy 
The major a im of the present thes i s  was to  search for a safe method to red uce the 
r isk of Salmonella typhil11Z1riu177 and Escherichia coli in ch icken feed in the Un i ted 
Arab E m i rates (UAE)  poul try fanns.  The bacteriophages w i l l  then be cu l t ivated and 
used to treat ch icken feed in  order to el i m inate or reduce the appl ication of ant ib iot ics 
i n  the ch icken feed which  affect the food safety. 
The objective and  a ims  of the  cu rren t  thesis were to: 
1 .  I so late super lyt ic  bacteriophage that can k i l l  Salmonella fyphiJJ1Z1rium and E. coli 
in vitro. 
2. Test the effect iveness of the isolated bacteriophages i n  ch icken feed. 
3 .  Compare the isolated bacteriophages w ith the currently i n  use ant ib iotics 111 
ch icken feed. 
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2. 1 MATE R I A L  
C H APTER I I: MATE R I A L  A N D METHODS 
2. 1 . 1  U n t rea ted raw " a te water sa m ple 
ntreated ra\ wa te water samples were col lected from Abu Dhabi e\ erage 
en ice Company ( D C) A I  A in,  Un ited Arab Emirates (UAE) .  The two samples 
v" ere obta i ned from two d i fferent sewerage treatment p lants in AI A in, which are AI 
aad P lant and Seih Lehma Plant in February 20 1 3 . 
2. 1 .2 Bacterial  s t.·a i n  a n d  p ropagat ion h osts 
T pe stra in  of StaphylococcZls aurells (A TCC 292 1 3 ) StaphylococcZls 
epidermidis ( TCC 1 2228 0-5 ), Enterococcus faecalis (ATCC 5 1 299), Escherichia 
coli ( TCC 25922), Protells vulgaris (ATCC 33420), Pselldomona ' aeruginosa 
(A TCC 27853), Salmonella typhimuriwn (A TCC 1 4028) and Shigella dysenteriae 
(A TCC 1 33 1 3 ) were obtai ned from the M icrobio logy Laboratory, Tawam Hospital ,  
Al A i n .  UAE .  Bacillus sllblilis ( DSM 1 088)  " as obta ined from the cu l ture co l lection 
of Dr. Khaled E I -Tarab i ly, B iology Department, Facu lty of Sc ience, U A E  Un iversity. 
The cu lture of B. subtilis was obtai ned from Deutsche Sammlung von 
M i kroorgan i smen und Ze l l ku lturen GmbH,  (DSMZ), Braunschweig, Germany. 
2. 1 .3 Media 
utrient broth, nutrient agar, trypt i c  soy broth, and trypt ic  soy agar were a l l  
obta ined from Lab M L im i ted, Moss Ha l l  Road, Heywood, Lancash i re B L96 7jj, 
Un i ted K ingdom . A l l  these med ia  were prepared accord ing to the manufacturer 
recommendations. The Peptone-yeast extract calc ium n itrate ( PYCa) was prepared 
as described by Brad ley et af. ( 1 96 1 )  (Append ix  1 ) . 
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2. 1 04 Ea . ph age- 1 00 mediu  m kit fo r t h e  i o lat ion of coli  phage (E. coli ph age) 
A kit of ea phage 1 00-med i um for the isolation of co l i  phage (E. coli phage) 
\\ a obtai ned from c ient i fic  methods I nc . ,  Beck ley treet. Granger. i nd iana, USA. 
Th i "- i t  \ \  as used on ly to isolate the bacteriophages act ive aga inst E. coli from 
untreated ra\\ waste water amples .  
2. 1 .4. 1 I ng red ient  of  the easy p hage- 1 00 med i u m  kit  
The ea y phage- I OO med ium ki t  consisted of 
( i )- Trypt ic so broth med ium s ingle strength ( I  X) .  
( i i ) - C u lture of E. coli. In the current study E. coli (ATCC 25922) was used . 
( i i i )- ter i le  easy phage med ium ( 1 00 m l  per bott le) .  The med ium was kept in the 
fridge at ..f°C unt i l  use. The med i um was warmed up to room temperature and was 
m ixed we l l  before use. 
( iv)- Ster i le  bacteria l  sta i n  (0.7 ml of bacteria l  sta i n  for every bott le of 1 00 m l  
easy phage med i um) .  
(v ) - Steri le pretreated Petri d i shes prov ided by the Scient ific methods l nc . .  
Granger, I nd iana USA.  
(v i )- E. coli phage M S2 " as used as a pos i t ive contro l .  The MS2 E. coli phage 
\, as used to sp i ke the pos i t ive control water sample .  
2. 1 .5 T ra ns mission electro n  m ic roscopy 
Transmiss ion electron m ic roscopy (TEM) grids and u ranyl acetate were carried 
out in the E lectron M icroscopy Uni t, Facu lty of Medic ine and Health Sciences, A l­
A in, U n i ted A rab E m i rates Un iversity, U A E  w ith the assistance of Mr.  Saeed Tariq.  
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2. 1 .6 C h icken feed 
The corn- 0 bean d iet \ as prepared in the Facu l ty of Food and Agricu lture/A I 
Foha Farm, E nt ers i ty, AI - in, UAE .  The chemical composit ion of the diet is 
described i n  Table 2 . 1 
The d iet was prepared as fo l low s:  a l l  feed i ngred ients were ground to a su itab le 
s ize and m ixed in a commerc ia l  m ixer (Spar m ixer, 3 H P  Taiwan) for 20 m inutes. 
V i tam ins  and m i nera l s  prem ixes, fish meal and oil were gradua l ly added with 
cont i nuous m i x ing. The wet m i x  was then passed through a commerc ia l  m ixer ( S i l la, 
3 50L, I ta ly) for 1 5  m i nutes for a homogenous d i stri bution of the nutrients and part ic le 
ize . The com-soy d iet \ as p laced in large Erlenmeyer flasks and was autoc laved at 
1 2 1 °C for 30 m i nutes on th ree consecut ive days. 
T b l  2 1  C a e . .  omposlt lon 0 f I b t le corn-soy ean c IC en ee let 
I ngred ient Name Corn soybean d iet (Kg) 
Yel low com 59 .4 
SO) bean meal 32 
Sod i um ch loride 0.4 
L imestone 1 . 1  
Oi-ca lc ium phosphate 1 . 56  
V i tam in  + M i nera l  Prem i x  I 
Meth ionine 0.24 
Lys ine 0.02 
Corn o i l  2 
F ish meal 2 .3  
2 . 1 .7  A n t i biotic i n  ch icken feed 
The anti biot i c  used i n  the ch icken feed experiment w ith and w ithout the 
appl ication of  bacteriophages was oxytetracyc l i ne which I S  a broad-spectrum 
ant ib iot ic ,  act ive aga inst a wide variety of bacteria.  ] t was used in the concentrat ion of 
( 50g/ 1 00Kg).  
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2.2  M ET H OD 
2.2. 1 Wa te \ atel' a m ple 
The untreated raw wa te water samp les \ ere first ly centri fuged at a speed of 
2000 rpm for 1 5  m inute in order to prec ip i tate a l l  large part ic les. The supernatant 
\\ as then fi l tered steri l ized through steri le M i l l i pore membranes ( Pore s ize 0 .8 )lm, 
0.4 )lm and 0.2 )lm,  respecti e ly, M i l l i pore Corporat ion, MA, U A) and were 
co l lected i n  steri le bott les. The bacteriological ly fi ltered waste water samples were 
then used a a source for the isolation of bacteriophages in the easy phage- I OO 
med ium ki t  ( Burm el al . . 20 1 0) .  The raw waste water samples were stored i n  the 
fridge at 5°C unt i l  use (C lark, 1 965) .  
2.2.2 P ropagation hosts 
A l l  the type stra ins  were cu l t i vated on nutrient broth and nutrient agar med ium.  
The  p lates and  fla  ks were incubated a t  37°C for 48  hours i n  a dark incubator. 
2 .2.3 Isola tion of S. t),pliil1lllrilim p hage from waste water sa mple 
Erlenmeyer flasks (250  ml)  conta in ing 20 ml  of ster i le  peptone-yeast extract 
calc ium n itrate broth ( PYCa) (Bradley ef al. , 1 96 1 )  were inoculated w ith I ml of S. 
typhil71ur;um (ATCC 1 4028) suspens ion and wi th 25  m l  of raw-untreated 
bacteriologica l ly fi l tered waste water samples.  Th is PYCA was chosen s ince the 
yeast extract supports phage reproduction (Wal ton, 1 95 I )  and the d ivalent cat ion 
(Ca ++) i s  requ i red for adsorpt ion of phage to the receptors ( Lomovskaya et aI. , 1 972), 
and i t  has a lso been found to i ncrease the s ize and number of phage plaques obta ined 
( Gold,  1 95 9) .  The  flasks were then incubated in  a gyratory shaker ( Model G76, 
ew B runswick Scient i fic-Edi son, N .J . ,  USA) at 200 rpm at 3 7°C for 48 hours. 
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fler i ncubation, the u pensions from each nask were centr ifuged for 1 0  m inutes at 
4000 rpm and the supernatant \ ere fi ltered three t imes through steri le M i l l ipore 
membrane fi lters ( M i l l ipore Corporat ion, MA, U A) (0 .8 11m, 0.4 11m and 0.2 11m) 
respecti  e ly . and were col lected i n  steri le tubes. 
A l iquots (0.3 m l )  of S. typhimurium (ATCC 1 4028) ( host) were i nocu lated 
eparatel} onto PYCa agar p lates ( Brad ley el 01. , 1 96 1 ). The p lates were dried for 30 
m inutes in a lam i nar flow ( V ickers and W i l l iams, 1 987) .  After drying the p lates, 0.2 
111 1 of the raw-untreated bacteriological ly fi l tered waste water samp les \ as spotted 
onto the p lates as a centra l ly  p laced droplet (Brad ley el oZ. , 1 96 1 ) . The plates were 
then i ncubated i n  the dark for 4 8  hours at 37DC and examined for lyt ic  zones 
(p laques) ( W i l l iams el of. , 1 980). 
2.2A Iso lat ion of E. coli p hage from waste water sa m ple us ing the easy phage-
1 00 med i u m  k i t  met h od 
The protoco l  for the detect ion of bacteriophages in waste water samples using 
easypahe- I OO med i um developed by Scientific  methods I nc . ,  Beckley Street, 
Granger, I nd iana, U SA was used in the current study. 
Erlenmeyer flasks with trypt ic soy broth were steri I ized by autoc laving at 1 2 1  DC 
for 20 m inutes. These flasks were i nocu lated w ith E. coli (ATCC 25922) and the 
fl asks were i ncubated at 3 7DC for 24 hours in the dark. Each 1 00 ml of the M i l l ipore 
fi ltered raw waste water samp le  were inocu lated w ith 3 . 5  m l  of the E. coli cu lture.  
Accord i ng ly 40 m l  of trypt ic  soy broth were suffic ient to analyze 1 0  X 1 00 ml raw 
waste water samp les. 
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The eas) phage med i um and the tryptic soy broth (T B) \ ere warmed to 35°e 
prior the tart of the experiment.  The M i l l i pore fi ltered " aste " ater sample ( 1 00 m l )  
\\ a added into a bottle of  e a  y phage med ium.  Then 0 .7  m L  of bacterial sta in  and 3 . 5  
m l  of  log pha e E. coli (A Tee 25922) cu lture were added for every 1 00 m l  of  the 
ea y phage med i u m .  The so lut ion was mixed by sw irl i ng the bott le se eral t imes. A 
20 m l  of the m i xture was transferred i nto each pretreated Petri d ish using steri le 
)Tinges for a total of 1 0  Petri d i shes. 
The Petri d i shes were swirled gent ly  several t imes to sett le the bubbles on the 
edge of each pretreated Petri d ish .  The med ium m ixture was left to sol id ify on a 
horizontal bench for 1 hour. I I  the pretreated Petri d ishes were transferred to the 
37°e i ncubator and the pretreated Petr i  d ishes were incubated in the upright pos it ion.  
The pretreated Petri d ishes were i ncubated at 3 7°e i n  the dark for 48 hours. 
After the end of the incubation period. the b lue p laques on the background of red 
bacter ia l la\\ n were counted . 
2.2.5 Qual ify ass u ra n ce p roced u res i n  t h e  easy ph age k i t  met h od 
I n  order to demonstrate that the reagents employed dur ing the sample run of the 
easy phage k i t  were perform ing as expected ; a negat ive contro l  and a positive contro l  
were a lso processed and  ana lyzed. 
For the negati ve contro l ,  a 1 00 m l  of steri le water conta i n i ng no col i  phage was 
processed the same way the waste water sample  was processed . This sample 
produced no p laques and demonstrated that the procedura l  run employed in  the 
current study was va l id  and correct .  
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For th po i l i  e contro l ,  1 00 m l  water sample conta in ing v iable col i phage ( 1 00 
m l  w ater sample p iked \\ i th M 2 pure E. coli phage) \ as u ed as a pos i t i  e contro l .  
teri Ie water ( 1 00 m I )  was added to  a 1 00 m I easy phage bott le .  Then suffic ient 
amount of  stock o lut ion of  the E. coli phage M 2 \ as spiked to the ea y phage 
med ium m ixture to produce a countab le number of p laq ues as recommended by the 
c ient i fi methods protocol for the isolation of col i phages. 
The bacteria l  stai n  (0 .7  m l )  and log phase E. coli (ATCC 25922) cu lture (3 . 5  m l )  
\\ ere then added . The solut ion was m i xed by  sw ir l i ng the bott le several t imes. A 20 
m l  of the m ixture , as tran ferred i nto each pretreated Petri d ish us ing ster i le  syringes 
for a tota l of 1 0  d i shes. 
The pos i t i  e control sample  prod uced p laques and th is demonstrated that the 
analyt ical run was va l i d .  Th i s  pos i t ive control resu l t  was assoc iated with a l l  samples 
ana lyzed during the analyt ica l  run. 
Among the benefits of  us ing the easy phage kit were, i t  was capable of produc i ng 
quantitat i ve resu Its and qua l  i ty control schemes for in vest igati ng the prec is ion and 
accuracy of the m ic robiolog ical  assays. 
2.2.6 Pu rification of t h e  bacteriophages from t h e  p hage isolat ion plates 
A fter i ncubation, a s ing le p laque (s ingle ind iv idua l  lys i s  zone) on the lawns of the 
bacteria l  hosts ( from experiments 2 .2.3 and 2 .2 .4) was asept ica l ly  removed with a 
scalpel and re-suspended i n  1 00 m l  of host - inocu lated ( 5  m l )  PYCa broth and 
i ncubated for 48 hours at 3 7°C in the dark. The broth was fi l tered through Whatman 
paper o.  1 ( Whatman I nternational Ltd, Maidstone, U .K . )  and fi l tered aga in  through 
steri l e  0.22 f.1m M i l l i pore membrane fi lters. The puri fied phage suspens ions were 
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stored at ..f°C ( W i l l iam el al. , 1 980). ample of th is  puri fied phage suspensions 
were then fi ltered and spotted on the PYCa agar p late prev iously inocu lated w ith 
every prospective ho t alone in  order to determ ine the concentrat ion of the phage i n  
the u pen ion .  
To obta in  h igher concentrations, the same procedure was repeated by increasing 
the soak ing period i n  PYCa broth for an add i t ional 24 hours at 37°C in  the dark. The 
procedure was repeated unt i l  a h igh t i tre of 1 0 1 0  p laque-form ing un its (pfu) m r l of 
phage uspension \ as obta i ned . The purified phage suspension was stored at 4°C in 
order to m i n i m ize the bacteria l  growth which would impede fi l trat ion ( W i l l iams el 
al. , 1 980). These phages \ ere used i mmed iately in each experiment to avoid a 
decrease i n  the concentrat ion of the phage suspension.  
2.2 .7  P h age assay 
Phage assays were carried out uS 1l1 g the serial tenfold d i l ut ion (up to 1 0 1 2) 
prepared i n  PYCa broth .  A l iq uots (0.3 m l) of E. coli or S. typhimurium host 
suspens Ions were i nocu lated onto PYCa agar p lates and dried in a lam inar flow 
cab inet for 30 m i n utes. Bradley el al. ( 1 96 1 )  showed that excess ive moisture on an 
assay p late can create fa l se p laques or cause smearing and streaking of va l id p laques. 
A (0 .2  ml a l i quot) of  phage d i l ut ions were then p laced onto a p late and spread 
careful ly  wi th a g lass rod . Three rep l icate p lates were used for each d i l ut ion.  A l l  
p lates were i ncubated i n  the dark at 3 7°C for 48  hours.  After incubation, pfu were 
counted i n  order to know the t itre of  the phage suspension.  
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2.2.8 P laq ue  morphology 
Puri fied phage su p nsion of E. coli (0.2 111 1 )  or purified phage suspension of S. 
/yphil71l1rill/JI (0 .2  111 1 )  each conta in ing 1 0 10 pfu m r l  \ ere spotted onto PYCa agar 
eeded \\ ith the Eshericia coli host spec ies (X 1 0 1 0  C m r l ) or S. typhil11l1rillll1 host 
pec ies ( 1 0 1 0 c fu mrl ) .  The p lates \ ere then incubated for 48 h at 3 7°C and plaque 
morphology i n  the Petri d i  hes was noted. 
2.2 .9 Host ra n ge (Act iv i ty spectra of the  phage) 
A l l  bacteria l  ho ts were grown on nutrient agar p lates and the bacteria l  ce l l s  were 
har ested by scraping the surface of the p lates into 20 m l  of steri l e  20% (v/v) glycerol 
and stored at -20°C. 
The bacter ia l  hosts stud ied were the Gram pos i t ive bacteria B. Sliblilis ( D  M 
1 08 8), S. allrells (ATCC 292 1 3 ), S. epidennidis (ATCC 1 2228 D-5) and E. jaecalis 
(ATCC 5 1 299).  The Gram negat ive bacteria tested inc luded E. coli (ATCC 25922), P. 
vulgaris (A TCC 33420), P. aeruginosa (A Tee 27853), S. typhimuriufJI (A Tee 
1 4028), and S. dysenteriae (A Tee 1 33 1 3) .  
The host range of E. coli phage or S. typhil11l1riul11 phage were stud ied by spott ing 
0.2 ml  of each phage suspensions conta i n i ng 1 0 1 0 pfu m r l  onto pyea agar p lates each 
prev iously seeded , ith a glycerol suspension (X 1 0  10 cfu m rl ) of one of the type 
stra ins  mentioned above. Each phage suspension was added to the dried host seeded 
p lates, 30 m i n utes after seed ing the p lates. The p lates were then i ncubated at 37°e for 
48 hours and exam ined for lys i s  and p laques fonllation. 
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2.2. 1 0  E lect ron m i c ro cop 
In order to determ ine the morphology and the morphological features of E. coli 
phage or S. lyphil77uri/llll phage, us ing the transmiss ion electron m icroscopy (TEM), 
the n gat ive ta i n i ng techn ique using uranyl acetate ( S igma Chemical Co, St. Lou is, 
U A) as descri bed by Ackermann and He ldal  (20 1 0) was emp loyed . 
The negati e ta in ing method (Ackermann and Heldal ,  20 I 0) depends on some 
tain that remained around the edges of a v i rus and accord i ngly the deta i l s  of the 
irus 'V ere c learly defined.  However, the pos it ive sta in i ng method sta ins the v i rus 
itse l f  and accord ing ly the v i ruses appeared as dark objects aga inst a l ighter 
background. 
A I I  TEM photom icrographs taken i n  the current study were al l  taken by the use of 
the negative sta in ing  method . Th is  was the easiest sta in ing  method to be employed 
and yie lds resu lts su itable for analyzing the morphological  d i vers i ty of each v irus as 
described by Burm and teward (20 1 0) .  
Briefly, the uranyl acetate so l ution was fi ltered through M i l l ipore membrane 
syri nge fi lters ( Pore s ize 0.22 11m,  M i l l i pore Corporat ion, MA, USA) into a 2 m l  
screw cap tube. Th i s  removed any part ic les of uranyl acetate that had not fu l ly 
d i ssolved . 
A drop of  each phage suspens ion ( l O l a  pfu m r l ) was p laced on 200-mesh copper 
grids w ith carbon-coated formvar fi lms  and the excess drawn off with ster i le fi lter 
paper. A saturated so l ut ion of fi ltered uranyl acetate was then p laced on the grids and 
the excess drawn off as descri bed by Ackermann and Heldal  (20 1 0) .  The grids were 
left for 1 hour to dry and then p laced in the grid box in a desiccator unt i l  exam ination. 
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pec l lnen \'v ere then later b er ed \ ith a TEM (Ph i l  i p  CM I 0, The etherland ) 
operat ing at 80 K V  at a magn i fication of X 205,000. 
2.2. 1 1  E ffect of  med i u m co m po ition on phage p ropagation and viabi l i t)1 
I n  order to rudy the effect of med ium chem ical  composit ion on E. coli phage or 
f)phil7luriul7l phage, three d i fferent med ia were used. These three med ia were 
pept ne- ea t extract, nutrient agar and trypt ic soy agar supplemented w ith and 
" i thout calc i um n i trate Ca(N03)2 (0 .05%) ( S igma Chem ica l  Co, St. Lou is, USA) and 
\" ith two d i fferent concentrations of sod ium ch loride (NaC I) (0 . 1 M and 0.0 1 M) 
( igma) ( B ro\ ne l l  el al. , 1 967) .  These med ia were tested in order to determ ine the 
effects of these complex med ia on phage viab i l ity and propagation.  
2.2. 1 2  E ffec ts o f  ph sical  and chem ical  age n ts on phage p ropagation and viabi l i ty 
The effects of  selected physical  and chem ical  agents on the phage v iabi l i ty and 
propagat ion 'v ere tested accord i ng to the methods described by Brownel l  el af. ( 1 967). 
To determ i ne the effects of physical  treatments on phage propagat ion and 
v iab i l ity, PYCa broth-grown preparations of each phage was d i l uted 1 to l O i n  PYCa 
broth. A (0 . 1 m l )  sample  \ as added to 0.9 m l  PYCa broth, the physical  treatment 
appl ied, and v iab le  phage numbers were est imated i mmed iately after the treatment as 
pfu m r l . A s i m i l ar ly d i l uted but untreated PYCa broth preparation served as a control 
( B rowne l l  et aI. , 1 967).  
The physical treatments exam ined inc luded ( i )  freezing the phages for (30 
m i nutes, one hour, two hours, three hours four hours, five hours, s ix  hours, 1 2  hours, 
24 hours, and 4 8  hours), ( i i) refr igerating the phages at 4°C for ( 1  day, 7 days, 1 4  
days, 3 0  days, 4 5  days and 60 days), ( i i i ) heat ing the phages at 45°C for ( 1 5  m i nutes 
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and 30 m i nute ), heat ing the phages at 5 5°C for ( 1 5  m inutes and 30 m i nute ), heati ng 
th phage at 65° for ( 1 5  m inute and 30 m inutes), ( iv) bo i l i ng the phages at 1 00°C 
for C m i nute and 1 0  m i nutes), ( ) u l trasonic treatment for (60 seconds and 1 20 
seconds), (v i )  e:-. pos ing the phages to U ltra V io let rad iation ( UV)  for (30 seconds, 60 
seconds, 1 20 second , 1 80 seconds and 240 seconds) as described by Bro\ ne l l  el al. 
( 1 967). 
To detem1 i ne the effect  of the chem ica l  agents on phage propagat ion and 
v iabi l ity, PYCa broth grown preparations of each phage was d i l uted 1 to 1 0  in  water. 
A (0 . 1 m l )  samp le  was added to 0 .9 m l  of the reagent to be tested at the spec i fied 
concentrat ion in \\ ater. After 2 hours i ncubation at 37°C in the dark, the m ixtures 
\\ ere assayed for phage pfu m r I . A s im i lar ly d i luted but untreated PYCa broth 
preparat ion served as a control as described by Browne l l  el al. ( 1 967). 
The chem ica l  treatments exam i ned i nc l uded ( i )  ch loroform (0.5%, 1 % and 3%), 
( i i) thymol (0 .5%, 1 % and 3%), ( i i i )  hydrogen peroxide (0.5%, 1 % and 3%), ( iv) 
phenol (0 .5%, 1 % and 3%), (v) ethyl alcohol (30%, 70% and 1 00%), (v i )  C lorox 
(0 .5%, I % and 3%), ( v i i) iod ine in the form betad ine (0 .5%, 1 %  and 3%), ( v i i i )  
merth iolate (0 .5%, I % and  3%) as  descr ibed by  Browne l l  el af. ( 1 967). 
2.2 . 1 3  E ffec ts of h ost  age, p hage i n oc u l u m  size and the h ost  inoc u l u m  s ize on 
pbage p ropagat ion and v iabi l ity 
The effect of host age on phage propagation was tested by add ing sui table 
concentrat ions of  phage to the host which had been i ncubated for various t imes as 
described by B rowne l l  ef af. ( 1 967). The numbers of pfu m r I were counted as 
described by B rowne l l  el al. ( 1 967).  
49 
The effect of phage inocu lum s ize on phage propagat ion wa exam ined b m l x mg 
phage inocu la  at d i ffer nt concentration with a standard host concentrat ion and 
counting the numbers of PFU m r l as described by Brownel l  et 01. ( 1 967). 
The effect of the host- i noc u lum s ize on phage pro l i ferat ion \ as detenn ined by 
\ ary ing the ho t i nocu lum concentrat ion and assaying pfu m rl . 
For a l l  the abo e e periments the numbers of pfu m r l v ere detennined after 48  
hour at 3 7°C as described b y  Brownel l e t  01. ( 1 967). 
2.2. 1 4  Dete r m i n at ion of adsorption rate consta n t, late n t  period and b u rst size 
The adsorption rate constants of the two phages (E. coli phage and S. 0phimurium 
phage) \ ere determ i ned by measuri ng res idual  p laque-form ing abi l i ty in membrane­
fi ltered samples of an attachment m i xture as descri bed by Dowd ing ( 1 973).  Briefly, a 
250 m l  Erlenmeyer flask conta i n i ng 50 m l  of PYCa broth was i nocu lated with a host 
suspension. The host was incubated w ith shak i ng at 3 7°C for 3 hours to al low growth 
to occur. Each phage \\ as added separate ly at low mul t ip l ic ity of infect ion (0 . 1 )  and 
the i ncubat ion was cont i nued . 
At various t i mes, samples were removed, membrane fi l tered, d i l uted and p lated 
and the numbers of p fu m r l was counted . The rat io of the number of phages to the 
host was tenned as the m u lt ip l ic ity of i n fection and values much less than one are 
common ly used i n  k inetic stud ies on phage growth i n  order to ensure that each cel l  
was i n fected b y  a s i ngle v i rus ( Dowd ing, 1 973) .  
The adsorption rate constant, K ml  m in- I , was ca lcu lated as described by Sykes et 
al. ( 1 98 1 )  by us ing the equation K = 2.3 IBt X log 1 0 (PoIPI) where B is the host 
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concentrat ion (cfu m r l )� Po is the i n it ia l  phage concentrat ion (pfu m r l ) �  PI IS the 
phage concentrat ion at { m i n  (pfu m r l )� and I i the period of adsorption. 
In order to determ ine the latent period, ri e period and the burst ize for each 
phage, a one-step growth experi ment was determ ined as descr ibed by 00\ d ing 
( 1 973).  u pension ( I  X 1 0 1 0 c fu m r 1 ) of each propagat ion host (Eshericia coli or 
S. lyphil71urilllJl) was incubated i n  PYCa broth for 3 hours to al low growth .  A 
predetenn ined quant i ty of each phage was then added to give a low mul t ip l ic ity of 
i n fection (approx i mate ly 0. 1 )  and the incubat ion was cont inued for 20 m i n utes. A ( 1 0  
m l )  sample  of  the attachment m ixture was removed and membrane-fi l tered . Un­
adsorbed phages were removed from the  i n fected host ce l l s  on the  fi lter by  pass ing the 
1 0  m l  of the broth through the ft I ter to wash them. The ft I ter was transferred to a flask 
conta in i ng 50 m l  of PYCa broth at 37°C (first growth flask) and the i n fected ce l l s 
\vere re-suspended b agitat ing the flask. A 50-fold d i l ut ion was made to another 
fl ask held at 3 7°C (second growth flask) and the 1\ 0 flasks were re-i ncubated at 
37°C. Samples (0 . 1 m l )  \ ere removed ( from the first growth flask unt i l  time 35 m i n  
and then a l ternate ly  from the two flasks unt i l  1 20 m in), p lated i mmed iate ly and the 
numbers of pfu were counted after incubat ing the p lates at 3 7°C for 48 hours as 
described by Dowding ( 1 973) .  
2.2 . 1 5  The effect  of  i ncorporat ion of bacteriop hages on t h e  populat ion densit ies 
of S. typlzimuriu11l and E. coli i n  t h e  ch icken feed 
The a im  of  th i s  exper iment was to exam ine the effect of the i ncorporation of S. 
typhimurium phage or E. coli phage or both S. typhimurillm and E. coli phages on the 
5 1  
popu lation den i t ie  ( bacterial  count ) of  . /Jphilllllriul7I and E. coli in a ch icken d iet 
ontarn inated w ith the e bacteria.  
2.2. 1 5. 1  P re pa rat ion o f  the  stock p hage su pen ion 
The ho t E. coli or S. /yphil71l1riulIl wa grown on nutrient agar plates and 
i ncubated i n  the dark for 3 days at 3re.  Cel l s " ere harvested by scraping the 
urface of 20 p lates into 1 l i ter of ster i le  20% g lycero l and storing at -20ce . F ive 
large Er lenrneyer tla ks (5 l i ters capac i ty) were each fi l led with 2 l i ters of ster i le 
PYCa broth i nto which 250 ml of  propagat ion host suspension (x 1 0 1 0 cfu rn r l ) and 
250 rnl of phage suspen ion ( 1 0 10 pfu m rl ) were i nocu lated .  The suspension was 
i ncubated in the dark for 4 days at 37°e .  After incubation, the suspension was 
centr ifuged for 1 h at 2000 rpm and ser ia l ly  fi l tered through decreas i ng pore s ize 
fi lters cu lm inat ing with a 0.22 ,urn tubu lar membrane fi lter. After fi ltrat ion, the phage 
suspension was ca lcu lated to be (x 1 010 pfu mr l ) by serial d i lut ion.  A total of 1 5  l iters 
of every bacteriophage suspension was produced and stored at 4°e .  
2.2. 1 5.2 Preparation o f  E. coli or S. typitimurium i nocu l u m  
The host E. coli o r  S. f)phimurium i nocu lum was prepared b y  scraping 2 0  plates 
of bacteria l  cu ltures, grown on nutrient agar p lates, i nto I l i ter of ster i le  d ist i l led 
water. Two hundred m l  of th is  suspension was added to 5 l iters of ster i l ized ( 1 2 1 °C 
for 20 m in)  nutrient broth and incubated for 3 days in the dark at 37°e .  I nocu l um was 
used i mmed i ate ly.  Seria l  d i l ut ions were prepared and fi ve 0.2 m l  a l iquots were 
i nocu lated separate ly  onto nutrient agar p lates before use to con fi rm the i nocu lum 
density. The  i nocu lum density for E. coli or S. typhillluriwl1 was calcu lated to  be (x  
1 0 1 0 p fu m rl ) by  serial  d i l ut ion. 
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2.2 . 1 5.3 I i x i n g  t h e  ho t i n oc u l u m  and t h e  bacteriophage suspension and the ir  
amend m e n t  i n  t h e  ch icken feed 
l n  the current tudy, ind i v idual  phage of E. coli and ind iv idual  phage of S. 
typhimurilllJl each of about 1 0 1 0 pfu m r l were used to i nocu late the ch icken feed 
ind i  idual ly alone in order to study the i r  effects on the red uction of the popu lat ion 
densit ies of E. coli or S. typhilllllriulII. 
I n  add it ion a stock phage suspens ion of about 1 0 1 0  pfu m rl was prepared by 
m i x ing each of the two ind iv id ua l  h igh-t i ter phage suspensions. The resu l t ing t iter of 
the tock  phage suspension was 1 0 1 0  pfu m r l . Th is  stock phage suspension was also 
used to treat ch icken feed i n  order to study the effects of the combined two 
bacteriophage on the reduction of the popu lat ion densit ies of E. coli or S. 
fyphill7l1riuJ1/ i n  the ch  icken d iet. 
The ch icken com-so d iet \ as prepared by add ing 300 g of the ch icken com-soy 
d iet and 40 m l  of d ist i l led water into 1 l i ter Erlenmeyer flasks. The flasks were 
autoc l aved at 1 2 1 °C for 30 m i n utes on three consecut ive days . 
For the treatments \ h ich i nc l uded only the add i t ion of  the bacteria l  hosts alone, 
the com-soy d iet were then asept ica l ly i noc u lated w ith 40 ml of E. coli (x 1 0 1 0  cfu 
m r  1 )  or 40 m l  o f  S. f)phimurillnl (x  1 0 1 0  cfu m r I ) or 40 m l  of a m ixture of E. coli 
1 0  f - 1 ) d 
. 
d '  
. 
and S. typhimurium (x  1 0  c u m l  un er asept ic  con lt lOns. 
For the treatments which i nc l uded the add it ion of the bacteriophages alone, the 
com-soy d iet were asept ica l ly  inocu lated w ith 40 m l  of E. coli phage (x \ 0  1 0  pfu mr 
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I )  or 40 m l  of S. typhilllllrilllll phage (x  1 0 1 0  p fu m r l ) or 40 m l  of a m ixture of E. 
coli phage and S. typhimurillJ71 phage (x  1 0  1 0  pfu m l- I ) .  
For the treatment \ hich inc luded the combinat ion of bacteriophages and the 
bacterial  ho ts, the Corn- oy d iet were then asept ical ly i nocu lated w ith 20 ml of E. 
coli (x  1 0 1 0  c fu m r l ) or 20 m l  of S. typhimllriul11 (x 1 0 1 0  cfu m l- I ) or 20 m l  of a 
m ixture of E. coli and S. f)phimlirilll11 (x 1 0 1 0  cfu m r l ) combined with 20 m l  of E. 
coli phage (x  1 0 1 0  pfu m r l ) or 20 m l  of S. typhimllriul11 phage (x  1 0 1 0  pfu m l - I ) or 
20 ml of a m ixture of E. coli phage and S. typhimZlriZim phage (x 1 0 1 0  pfu m r l ) .  
Contro l treatments consi ted of  ch icken corn-soy d iet treated as above, but 
autoc laved twice at 1 2 1 °C for 30 m i nutes i mmed iately prior to use. The flasks were 
occas ional ly shaken to ensure un i fonn ity of colon izat ion.  After 2 hours, the content 
of each flask was spread over a steri l ized a luminum foi l  and dried in a lam inar flow 
cabinet for 45 m i n utes.  After dry i ng, the contents were returned back to i ts orig ina l  
steri l ized flask. 
In total there were 1 5  bacteria-phage combinations as descr ibed in  Table 2.2. The 
treatments w ith the broad-spectrum anti b iot ic oxytetracyc l ine (treatments number 1 3 , 
1 4  and 1 5) were i ncorporated i nto the corn-soy d iet at the manufacturer's 
recommended rate ( 50g/ I 00Kg). Treatments number 1 3 , 1 4  and 1 5  were i nc l uded as 
a comparison to a l l  treatments wh ich  involved the use of bacteriophages as b iological 
control agents. Each treatment was rep l icated e ight t imes and the experiment was 
repeated once. 
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I n  a l l  treatment , the fla k were incubated at 37°C for 3 da s, one .. eek and 
three \",eek in the dark in order to stud the effect of i ncubation t ime on the urv ival 
of the phage and the bacteria. The flasks were occasiona l ly shaken to ensure 
un iform it) of  colon izat ion.  
After 3 days, or one week or two weeks of incubation at 3 7°C in the dark. 1 0  
grams from every treatment were taken i n  order to determ ine the population densit ies 
of E. coli and S. typhilJlurilll1l and a l so to determ ine the persistence of the 
bacteriophages in the ch icken d iet at the end of the incubation period. 
In order to detenn i ne the popu lat ion densit ies of E. coli and S. typhimurillm, 1 0 9 
of the ch icken feed from every treatment were d ispensed i nto 1 00 m l  of steri Je 1 g 1- 1 
agar sol ut ion i n  de-ion ized \ ater. The suspension was shaken for 30 m i n utes at 
3 7°C.  Ten-fold d i l ut ions ( 1 0-2- 1 0-6) were made in ster i le deionized water and 0.2 
ml a l iquots were spread w ith a steri le g lass rod onto nutrient agar in  ster i le  p last ic 
Petri p lates. Ten p lates \ ere used per d i l ut ion and dried i n  a lam inar flow cab inet for 
30 m i n utes before incubation at 3 7°C in  the dark for 2 days. 
Colonies were counted and the popu lation densit ies of E. coli and S. typhil1lllriul71 
were expressed as ]og l O colony fonn ing un its (cfu) g- l  ch icken com-soy d iet as 
described by S ivasithamparam et af. ( 1 979). 
In order to determ i ne the concentration of the E. coli phage or S. typhimurium 
phage, 1 0 9 of the ch icken feed from every treatment were d ispensed i nto Erlenmeyer 
fl asks (250 m l )  conta in ing 1 00 m l  of ster i le PYCa broth .  The flasks were inocu lated 
w ith 1 0  m l  of S. typhimurium or 1 0  ml of E. coli. The flasks were then inc ubated in a 
gyratory shaker ( Model G76, New B runswick Scient ific-Edison, N.J . ,  USA) at 200 
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rpm at 3 r for 48 h ur . A fter incubat ion, the sllspensions from each fla k were 
cenlrifuged for 1 0  m i nute at 4000 rpm and the supernatant were fi l tered three times 
through ster i le  M i l l ipore membrane fi lters ( M i l l i pore Corporat ion, MA U SA) (0.8 
flm,  0.4 flm and 0.2 f.un), respecti e l  , and were col lected i n  steri le tubes. 
l iq uots (0 .3  m l )  f S. /yphimuriul1I o r  E. coli were inocu lated separate ly onto 
PYCa agar p lates. The p lates were dried for 30 m inutes in a lam inar flow (V ickers 
and W i l l iams, 1 987) .  After d ry ing the p lates, 0.2 ml of the bacteriologica l ly  fi l tered 
sample from every treatment was spotted onto the p lates ( Brad ley et al. , 1 96 1 ) . The 
so l ut ion was un i forn1 1y pread over the dried p lates us ing steri l ized spreaders. The 
p lates \ ere then incubated in the dark for 48 hours at 37°C and exam ined for lyt ic  
zones (p laq ues) ( W i l l iams e/ al. , 1 980). The p laques were counted and expressed as 
log l o p laque fonn ing un i ts (pfu)  g- l  ch icken corn-soy d iet as described by Browne l l  et 
al. ( 1 967). 
2.2. 1 6  Statistical a n a lysis 
A l l  treatments were arranged In  a randomized complete b lock design for a l l  
experiments. Data were subjected to analysis of variance (ANOVA) and Least 
S ign ificant D i fferences (LSD)  between means were detern1 i ned us ing F isher's 
Protected L S D  Test at P = 0.05 . Superanova@ (Abacus Concepts, I nc . ,  Berkeley, 
Cal i forni a, USA) was used for a l l  ana lyses. Values fo l lowed by the same letter w ith in 
a column are not s ign ificantly d i fferent (P > 0.05) accord ing to F i sher's Protected 
L SD  Test. 
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Table 2 .2  Di fferent treatment to study the effect of i nocu lation with Escherichia coli 
phage or , a/monel/a t)philllllriwll phage or a m i, ture of E. coli phage and S t}phimurium 
on the colony fonn ing un i ts (cfu) of E. coli or S typhifJIuriufJI in ch icken corn-soy d iet 
Treatments 
( I )  Control (autocla\ cd corn-so) diet) + ki l led aut elm ed E. coli alone 
(2 )  Control (autocl m  cd corn-so) d iet )  + k i l led autoclaved S typhimllrillm alone 
( 3 )  Control (autoclm ed com-so)' di t )  + ki l led alltoclaved E. coli + ki l led autoelaved S. typhilllurium 
(4)  Control (alltoc1aved com-so) diet) + E. coli phage alone 
( 5 )  Control (autoc1aved com-so) d iet)  + S. typhimurium phage alone 
(6) Control (autoclm ed com-soy diet) + E. coli phage + S. typhimuriulII phage 
( 7) Autoclaved com-soy d iet + l i v ing E. coli alone 
(8) AlItoc1aved com-so d iet + l iv ing S. typhimlirilll1l alone 
(9) Autoclaved com-soy diet + l iv ing E. coli + l i \  ing S. typhimllrillm 
( 1 0) Autoc1aved com-soy diet + l iv ing E coli + E coli phage 
( I I )  Autoc1aved com-soy diet + l iv ing S. typhimuriw/l + S. typhil11uriulJJ phage 
( 1 2 ) Autoclav ed com-so)' diet + l i ving E. coli + l i v ing S. typhimurillm + E. coli phage + S. typhil1lurium 
phage 
( 1 3)  Autoclaved corn-soy diet  + l i \  ing E. coli + oxytetracyc l i ne 
( 1 4) Autoclaved corn-so) d iet + l i v ing S typhil11uriul11 + oxytetracyc l i ne 
( 1 5) Autoclaved corn-soy d iet + l iv i ng E. coli + l i v ing S. typhil11uriul1I + oxytetracycl i ne 
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H A P T E R  I I I :  R E  U L  T 
3. 1 U n h 'eated raw wa te , a ter  a m p les 
The hv O untreated ra\ wa te water samp les obta i ned from two d i fferent sewerage 
treatment p lant in AI A in, ( I aad Plant) and ( e i h  Lehma Plant) gave d ifferent 
r u lt regard ing the isolat ion of the lyt ic  act ive phages aga i nst E. coli and S. 
lyphil17l1riul7I . 
The untreated raw waste water sample from AI  Saad Plant d id not conta in  any 
acti e phages against E. coli and S. typhil7lllrium. However, the hvo d i fferent phages 
u ed in the pre ent study were i solated and puri fied from untreated raw waste water 
samples obta ined from e ih  Lehma P lant. Bacteriophage number 1 (0 , ) was i solated 
us ing S. typhimurilll17 as a propagat ion host and bacteriophage number 2 was isolated 
us ing E. coli as a propagat ion host. 
3.2 Isolat ion of S. typhimllriul1l p h age from wa te water sa m ple 
Bacteriophage number I (0 , ) \ as i so lated us ing S. typhirnuriul7I as a propagat ion 
host. When 0.2 ml of the raw-untreated bacteriologica l ly  fi ltered waste water 
samples was spotted (as a centra l ly  p laced droplet) onto the PYCa agar p lates seeded 
w ith S. l)phil11l1riZlIll, a c lear lyt ic  zone (b ig  p laque) was produced after 48 hours of 
i ncubat ion at 3 7°C i n  the dark ( F ig .  3 . 1 )  
3.3 Isolation of E. coli p h age from waste water sa m ple  us ing t h e  easy p hage- l 00 
m ed i u m  ki t  meth od 
Bacteriophage number 2 (02) was i so lated from untreated raw waste water 
samples using E. coli as a propagat ion host. Th is  k i t  was used only to iso late the 
bacter iophages on ly  active aga inst E. coli as they used pretreated Petri d ishes. B lue 
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plaque were obtai ned on a red background ( lawn) at the end of the incubat ion period 
( F ig. 3 .2) .  
3.4 Q u a l i ty a u ra n ce proced u res i n  the  ea p h age kit  met hod 
o E. coli phages \ e re obta i ned \ hen the ster i le  water was used (negat ive 
control) .  0 blue p laque \\  ere obtained on a red background ( lawn) at  the end of the 
incubation period ( F ig. 3 .3 ) .  
The M 2 pure E. coli phage obta ined from Scient ific methods I nc . ,  Beckley 
Street Granger, I nd i ana, USA, (the pos i t ive contro l )  was very effective in attacking 
the E. coli cel ls  as ind icated b the formation of the typica l  b lue p laques on a red 
background ( lawn) at the end of the incubation period ( F ig. 3 .4). The MS2 pure E. 
coli phage ga e resu l ts very i m i lar to the unknown untreated raw waste water 
sample using E. coli as a propagat ion host. Th is was c lear from the very s im i lar 
typical  b lue p laques on a red background ( lawn) at the end of the i ncubation period 
( F ig .  3 .4).  
The reagents employed during the sample run of the easy phage k i t  were shown to 
be of h igh standard as expected. 
3.5 P u ri ficat ion of the bacteriophages from the p hage iso lat ion plates 
A fter incubat ion, a s ing le  p laque ( s ingle ind iv idual  lysis zone) of bacteriophage 
number 1 (0 } )  on the la\ ns of the bacter ia l  hosts was obtained us ing PYCa agar 
p lates previously i noculated w ith S. typhimurium ( F ig .  3 .5 ) .  
After incubat ion, a s i ng le  p laque ( s ingle i nd iv idual lysis zone) of bacteriophage 
number 2 (02) on the lawns of the bacterial  hosts us ing PYCa agar p lates previously 
inocu lated w ith E. coli was obtained ( F ig .  3 .6) .  
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3.6 Phage a ay 
The opt imum concentration of bacteriophage number I (0 1 )  act ive against S. 
lyphinlllriul11 w a  found to be 1 0 10 pfu m r l \ hen the serial tenfold d i l ut ion techn ique 
(up to 1 0 1 2) prepared in  PY a p lates was employed. i m i larly, it was a lso found 
that. the opt imum concentrat ion of bacteriophage number 2 (02) active aga inst E coli 
\ as found to be 1 0 10 pfu m l- I . 
3.7 Plaq u es morphology 
Bacteriophage number I (0 1 ) se lected to inh i b i t  the growth of the Gram negat ive 
bacter ium S. I)phimuriul77 fonned sma l l  c ircu lar c lear p laques (0 .5 mm) ( F ig. 3 .5) .  
However bacteriophage number 2 (02) selected to  inh ib i t  the  growth of  the  Gram 
negat ive bacterium E coli fomled sma l l  c i rcu lar c lear p laques (0.9 mm) (F ig. 3 .2) .  I n  
the c a  e o f  bacteriophage number 2 (02), the p laques were typica l ly round, b lue areas 
that lack the reddish color observed on the bacter ia l  lawn. The bacterial lawn 
produced reddish color and the p laques were b lue i n  color ( F ig .  3 .2) .  
3.8 H ost ra nge (Activity s pectra of the  p h age) 
Bacteriophage number I (0 1 ) i so lated us ing S lyphimuriunJ as a propagat ion host 
was found to be monovalent and lysed only S. /yphimurium (Table 3 . 1 )  .. 
Bacteriophage number I (0 1 )  fa i l ed to lyse the Gram posit ive bacteria  B. sublilis S 
aureus, S epidermidis and E faecalis. Bacteriophage number I (0 1 )  fai led a lso to 
lyse the Gram negat i ve bacteria E coli, P. vulgaris, P. aeruginosa and S. dysenteriae 
(Table 3 . 1 ) . 
Bacteriophage number 2 (02) i solated us ing E coli as a propagat ion host was 
found to be polyvalent and lysed the Gram pos i t ive bacter ia B. sub/ilis, S aureu , S. 
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epidermidis and E. faecalis (Table 3 . 1 ) . I n  add it ion bacteriophage number 2 (02) 
a ls  \'v as found to be polyvalent agai nst the gram negat i ve bacteria. I n  add it ion to its 
abi l it to I se E. coli, it was a lso able to lyse S. typhimuriuJ77 (Table 3 . 1 )  and P. 
vulgaris, P. aeruginosa and S. dysenteriae (Table 3 . 1 ) . 
Tab le 3 . 1 :  Host range o f  bacteriophages number I and 2 isolated from untreated 
ra\ \Va te \ ater amp les on d i fferent Gram pos it ive and gram negative bacteria. 
Bacterial spec ies bacteriophage bacteriophage number I number 2 
Bacillu lIbtilis (DSM 1 088) - + 
Staphylococclls epidermidis (ATCC 1 2228 D-5) - + 
Staphylococcus at/reus (ATCe 292 1 3) - + 
Enterococcus faecalis (A Tee 5 1 299) - + 
Salmonella typhimuriun7 (A Tee 1 4028) + (PH)  + 
Pseudomonas aeruginosa (A Tee 27853) - + 
Escherichia coli (A Tee 25922) - + ( PH) 
Proteus vulgaris (A Tee 33420) - + 
Shigella dysenteriae (A Tee 1 33 1 3 ) - + 
( +) = host species suscept ib le  to phage lysis '  ( -) = host species not suscept ib le to phage 
lysis;  P H  = propagation host. 
3.9 E lectron microscopy 
egat ively sta ined part i c l es of the bacteriophage number 1 (0, )  active against S. 
typhimurium fitted the Siphoviridae ( B  1 )  morphotype (Francki ef af. , 1 99 1 )  which 
cons isted of i cosahedra! heads (F ig .  3 . 7) .  On the other hand, negatively stained 
part ic les of the bacteriophage number 2 (02) acti ve against E. coli fitted also the 
Siphoviridae (B 1 )  morphotype ( Franck i  et af. , 1 99 1 )  wh ich cons isted of i cosahedral 
heads ( F ig. 3 .8 ) .  
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3. 1 0  E ffect  of  med i u m  com po i t ion on p hage propagation a n d  iab i l ity 
For the bacteriophage number 1 (01) acli ve aga inst S. fyphimuriun7, peptone-yea t 
extract agar \\ a the opt imum med i um for phage propagat ion fo l lO\ ed by nutrient 
agar and tryptic soy agar (Table 3 .2) .  There was no ign i ficant d i fference between 
nutrient agar and tryptic so agar on phage propagation and v iab i l i ty (Table 3 .2) .  
The i ncorporat ion of  0.05% Ca(N03)2 into peptone-yeast extract agar, nutrient 
agar and trypt ic  soy agar was found to increase the number of p laques on a l l  the three 
med ia types compared to the same med i um but without the add i tion of ca lc ium n itrate 
(Table  3 .2) .  Increased NaC l concentrat ions reduced the numbers of congruent pfu m rl 
on a l l  the three med ia  types (Table 3 .2) .  The i ncorporation of 0. 1 M NaCl to the 
med ia  used k i l led the bacteriophage number 1 (01 )  and yie lded no pfu (Table 3 .2) .  
For the bacteriophage number 2 (02) act i ve aga inst E. coli, peptone-yeast extract 
agar was the opt imum med i um  for phage propagat ion fo l lowed by tryptic soy agar 
and nutrient agar (Table  3 .2) .  Trypt ic soy agar was found to be s ign i ficantly better 
than nutrient agar as a med i u m  for bacteriophage number 2 (Table  3 .2) .  
The i ncorporat ion of 0.05% Ca(N03):? i nto peptone-yeast extract agar, nutrient 
agar and trypt ic soy agar " as found to i ncrease the number of pfu m r l on a l l  the three 
med ia types compared to the same med i um but w ithout the add i t ion of ca lc ium n itrate 
(Table 3 .2) .  I ncreased N aC I  concentrat ions reduced the numbers of congruent p laq ues 
on a l l  the three med ia  types (Table 3 .2) .  The i ncorporation of 0. 1 M NaCI to the 
med ia  used k i l led the bacteriophage number 1 (01) and yie lded no pfu (Tab le 3 .2) .  
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Tab le 3 .2 :  Effect of d i fferent complex media on the iab i l i ty and propagat ion of the 
h\ 0 phage . 
Supplement ( Ioglo pfu mrl) of ( Iog lo pfu mrl) of 
ledium 
Phage number I Phage number 2 
Peptone-) east extract agar + 0. 1 M NaC I 0.00 a 0.00 a 
Peptone-yeast e tract agar + 0.0 1 M NaCI 3 .89 c 4 .3 l c 
Peptone-yeast extract agar + 0.00 M NaCI ( W/y) 5 . 5 1 e 5 .85/ 
Peptone-yeast extract agar + 0.00 M NaCI + 0.05% 7 .4 l g 7.9 \ g 
( W/Y) Ca(N03)1 
Nutrient agar + 0. 1  M NaC I 0.00 a 0.00 a 
Nutrient agar + 0.0 1 M NaCI 3 .36 b 2.25 h 
Nutrient agar + 0.00 M NaCI ( W/y) 4.6 1 d 2 .8 1 c 
Nutrient agar + 0.00 M NaCI + 0.05% 5 .69/ 3 . 1 3  k 
( W  ) Ca(N03):! 
Tryptic soy agar + 0 . 1 M NaCI 0.00 a 0.00 a 
Tryptic soy agar + 0.0 1 M NaCI 3 .29 b 3 . 7 1  b 
Trypti c  soy agar + 0.00 M NaCI (W/y) 4 .55  d 4 .67 d 
Trypt ic  soy agar + 0.00 M NaCI + 0.05% 5 .7 1 /  5 .2 1 e 
( W  ) Ca(N03)2 
Val ues are means of 5 rep l Icates for each treatment and the values w Ith the same letter 
w ith i n  a col umn are not sign i ficantly ( P  > 0.05)  d i fferent accord i ng to F i sher's 
Protected L S D  Test. 
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F igure 3 . 1 :  Lysi s  of Salmonella typ!7irnuriul11 by bacteriophage number 1 .  Plate on the 
left hand, is the contro l .  Note the central lyt i c  zone (p laque) in the midd le  of the 
peptone-yeast extract agar amended \ i th cal c i um n i trate at the end of the incubation 
period (48 hours) at 3 7°C . 
F igure 3 .2 :  Lys is  of Escherichia coli by bacteriophage number 2 .  Note the b lue 
p laques on a red background ( lawn) at  the end of the i ncubation period (48 hours) at 
3 7°C. 
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F igure 3 . 3 :  egat ive control  p late wi thout the add i t ion of phage number 2. Note the 
red background ( lawn) at the end of the incubation period (48 hours) at 3rc. 
F igure 3 .4 :  Lys i s  of  Escherichia coli by MS2 pure E. coli phage (pos it ive contro l ) .  
Note the b l ue p laques on a red background ( lawn)  at  the end of the i ncubat ion period 
(48 hours) at 3rc .  
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F igure 3 . 5 :  Sing le  p laq ue format ion of bacteriophage number 1 act i ve against 
Salmonella typhimllrium on peptone-yeast extract agar amended w ith ca lc ium n itrate 
after 2 days of i ncubation at 3 7°C . 
F igure 3 . 6:  S ingle p laque formation of bacteriophage number 2 act i ve aga i nst 
Escherichia coli on peptone-yeast extract agar amended w ith ca lc ium n itrate after 2 
days of incubat ion at 3 7°C. 
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.. � �1 S }� D. C. E·. :.-..". 
F igure 3 . 7  E lectron m ic roscopy of bacteriophage number I act ive aga i nst Salmonella 
fJphilJ7Z1riZlI71. Magn i fication 205 ,000 X. 
F igure 3 . 8  E lectron m icroscopy of bacteriophage number 2 active aga i nst 
Escherichia coli. Magn ification 205 000 X.  
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3. 1 1  E ffect of  ph ica l agents on phage p ropaga tion and  iab i l ity 
Bacteriophage number I (0 1 )  active aga in  t S. typhill1uriul/1 was sensit ive to the 
treatment \ ith freezi ng, refrigerat ion, heat ing, bo i l i ng, u l t rasonic treatment and U ltra 
V iolet rad iation (Table 3 .3) .  A l l  these phys ical agents greatly reduced the numbers of 
pfu (Table 3 .3 ) .  
Freezing Bacteriophage number 1 (0 1 ) for 30 minutes, one hour, two hours 
showed s l ight adverse effect on the v iab i l i ty of the v i rus (Table 3 .3) .  However, 
freezing for 3 hours, four hours, fi e hours, s ix  hours 1 2  hours, 24 hours, and 48  
hours had an adverse effect on Bacteriophage number I (0 1 )  t i tre. 
At 4°C bacteriophage number I (0 1 )  numbers decreased marked ly with t ime 
(Table 3 .3 ) .  Heat ing the bacteriophage number 1 (0 1 )  at 45°C for 1 5  minutes and for 
30 minutes d id not show any adverse effect on the v i rus v iab i l ity(Table 3 .3) .  Heat i ng 
bacteriophage number I (0 1 ) at 5 5°C for 1 5  minutes and for 30 m inutes a lso d id  not 
shO\ any ad erse effect on the v irus v iab i l i ty(Table 3 .3) .  However, heat i ng the 
bacteriophage number I (0 1 ) at 65°C for 1 5  m inutes and for 30 minutes had an 
adverse effect on phage t itre and reduced the numbers of pfu (Table 3 .3 ) .  
Boi l ing bacteriophage number 1 (0 1 ) at  1 00°C for 5 m inutes and  for 1 0  minutes 
completely; k i l led the phage as evident with no pfu formation (Table 3 .3) .  
Bacteriophage number 1 (0 1 )  was able to res ist the u l trasonic treatment for 60 
seconds and 1 20 seconds but with a red uced rate compared to the control treatment 
(Table 3 .3 ) .  Expos i ng bacter iophage number 1 (0 1 )  to U l tra V io let rad iation for 30 
seconds and 60 seconds showed no adverse effect on the page v iab i l ity. However, the 
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e po ure to Itra V iolet rad iation for 1 20 seconds, 1 80 econds and 240 seconds 
reduced bacteriophage number I (01) viab i l ity and reduced the pfu (Tab le 3 .3) .  
Bacteriophage number 2 (OJ) active agai nst E. coli was sens i t ive to  the  treatments 
\\ ith freezi ng, refrigerat ion, heat i ng boi l ing, u l trasonic treatment and U l tra Vio let 
rad iation (Tab le 3 .3) .  A l l  these physical  agents greatly reduced the  numbers of pfu 
(Table 3 .3 ) .  
Freezi ng Bacteriophage number 2 (02)  for 3 0  m inutes, one hour, two hours, 3 
hour howed s l ight adverse effect on the v iab i l ity of the v irus (Table  3 .3) .  However, 
freezi ng four hours, fi e hours, s ix  hours 1 2  hours, 24 hours and 48 hours had an 
adverse effect on bacter iophage number 2 ( 02) t iter. 
At '-l°e bacteriophage number 2 (02 )  numbers decreased marked ly w ith t ime 
(Table 3 .3 ) .  Heat ing the bacteriophage number 2 (02) at 45°C for 1 5  m inutes and for 
30 m inutes d id not shO\ any adverse effect on the v i rus v iab i l i ty (Table 3 .3 ) .  Heat i ng 
bacteriophage number 2 (02) at 5 5°C for 1 5  m inutes and for 30  m inutes a lso d id not 
show any adverse effect on the v irus v iab i l ity(Table 3 .3 ) .  However, heat ing the 
bacteriophage number 2 (02) at 65°C for 1 5  m inutes and for 30 m inutes had an 
adverse effect on phage t iter and reduced the numbers of pfu (Table 3 .3 ) .  
Boi l ing bacteriophage number 2 (02) at  1 00°C for 5 m inutes and  for 10  m inutes 
completely; k i l led the phage as evident with no pfu fonnation (Table 3 .3) .  
Bacteriophage number 2 ( 02) was able to  res ist the  u ltrasonic treatment for 60 
seconds and ) 20 seconds but  w ith a reduced rate compared to  the  control treatment 
(Table 3 . 3 ) .  Exposing bacteriophage number 2 (02) to U ltra V iolet rad iation for 30 
seconds, 60 seconds and 1 20 seconds, showed no adverse effect on the phage 
69 
iabi l i t . However, the e posure to U ltra V io let rad iat ion for 1 80 seconds and 240 
econd reduced bacteriophage number 2 (01) viab i l i ty and reduced the pfu (Table 
3 .3 ) .  
Table 3 .3 :  Effect of phys ical  agents on the iab i l i ty and propagat ion of the two 
phages. 
(Joglo pfu ml "l) of phage ( log lO pfu mrl) of Medium number 1 phage number 2 
Untreated control 8 .25 b 7.82 b 
Freezi ng (30 Minutes) 7 .45 c 7 .5 1 c 
Freezing ( I  hours) 7 . 1 1  d 7 .38 c 
Freezing (2 hours) 6.55 e 7. 1 1  d 
Freezing (3 hours) 4 .52 c 7.05 d 
Freezing (4 hours) 3 .88  k 6 .42 e 
Freezing (5  hours) 3 .2 1 I 5 .5 1 f 
Freezing (6 hours) 2 .75 m 4 .35 R 
Freezing ( 1 2  hours) 0.00 a 0.00 a 
Freezing (24 hours) 0 .00 a 0.00 a 
Freezing (48 hours) 0.00 a 0.00 a 
4°C for 1 day 8 . 1 1  b 7 .45 c 
4°C for 7 days 6 .54 e 7 .2 1 d 
.foe for 1 4  days 6. l l f 6.35 e 
4°C for 30 days 5 .76 R 5 .23 f 
4°C for 45 days 2 . 1 5  11 4.25 R 
4°C for 60 days 1 .25 0 1 .56 h 
45°C for 1 5  minutes 8 .20 b 7.55 c 
45°C for 30 minutes 8 . 1 8  b 7 .25 d 
55°C for 1 5  minutes 8.05 b 6 .5 1 e 
55°C for 30 minutes 8 .00 b 6.43 e 
65De for 1 5  minutes 5 .25 h 3 .25 I 
65°C for 30 minutes 4 .75 c 2.98 k 
Boi ling 1 00°C for 5 mi nutes 0 .00 a 0.00 a 
Boi ling 1 00De for 1 0  minutes 0 .00 a 0.00 a 
U ltrasonic treatment for 60 seconds 7.25 c 7 . 1 5  d 
Ul t rasonic treatment for 1 20 seconds 7 .05 d 6 .88 e 
U V irradiation for 30 seconds 8 .20 b 7 .79 b 
UV irradiat ion for 60 seconds 8 .03 b 7 .7 1 b 
U V irrad iation for 1 20 seconds 6 .53  e 7 .5 1 c 
UV i rradiation for 1 80 seconds 6 .2 1 f 5 .45 f 
U V i rradiation for 240 seconds 5 .75 R 5 .23 f 
Values are means of 5 rep ! Jcates for each treatment and the va l ues with the 
same letter with i n  a column are not s ign i ficantly (P > 0.05) d i fferent 
accord ing to F isher's Protected LSD Test . 
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3. 1 2  ffect o f  chem ical agent  o n  ph age propagat ion and  viabi l ity 
Bacteriophage number I (0 1 )  active agai nst S. typhil71l1rillm was sens i t ive to the 
treatments w i th ch loroform (0 .5%, I % and 3%), thymol ( J  % and 3%), hydrogen 
peroxid ( I  % and 3%), phenol ( 1  % and 3%), eth I alcohol ( 70% and 1 00%), Clorox 
( 1 %  and 3%). iod i ne ( 1 % and 3%), merth io late ( 1 %  and 3%) (Table 3 .4) .  A l l  of these 
hemicals great ly reduced the numbers of pfu (Table 3 .4) .  However, the 
bacteriophage number I (0 1 )  showed some degree of res istance to these chemicals in  
these concentrat ions thymol  (0 .5%),  hydrogen peroxide (0. 5%), phenol (0 .5%), ethyl 
alcohol ( 30%), Cl orox (0 .5%), iod i ne (0 .5%) and merthio late (0 .5%) (Table  3 .4) .  
Chlorofonn (3%),  thymol  (3%), hydrogen pero. ide (3%) phenol (3%) Clorox ( 3%), 
iod i ne (3%), merth io late (3%) completely k i l led bacteriophage number 1 (0 1 )  (Tab le 
3 .4) .  
Bacteriophage number 2 (02) act ive aga i nst E. coli was sens i t ive to the treatments 
\" ith ch loroform (0 .5%, 1 % and 3%), thymol (3%) hydrogen perox ide (3%), phenol 
( l  % and 3%), ethyl alcohol ( 70% and 1 00%), Clorox (3%), iod i ne (3%), merth io late 
( 1  % and 3%) (Table 3 .4) .  A l l  of these chemicals greatly reduced the numbers of pfu 
(Table 3 .4).  However, the bacteriophage number 2 (0�) showed some degree of 
resistance to these chem ica ls  i n  these concentrat ions thymol (0.5% and 1 %), hydrogen 
peroxide (0 .5% and I %), phenol (0 .5%) ethyl alcohol (30%), C lorox (0 .5% and 1 %), 
iod i ne (0 .5% and ] %) and merth io late (0 .5%) (Table 3 .4) .  
Chlorofonn (3%), thymol (3%), hydrogen peroxide (3%), phenol ( 1  % and 3%), 
ethyl a lcohol ( 70%), C lorox ( 3%), iod ine  (3%), merth io late (3%) completely k i l led 
bacteriophage number 2 (02) (Table  3 .4). 
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able 3 .4 :  E ffect of chem ical  agents on the iab i l ity and propagat ion of the two phages. 
Med ium ( log l O  pfu mr
l ) of phage ( loglo pfu mr l ) of 
number I phage number J 
Untreated control 8 .25  b 7.82 b 
Chloroform (0.5%) 7 . 55  c 4 .05 e 
Chlorofon11 ( 1 %) 3 . 54  d 2 . 1 5  g 
Chloroform (3%) 0.00 a 0.00 a 
Thymol (0.5%) 8 .20 b 5 .42 d 
Thymol ( 1 0 0) 7 .48 c 4 . 1 1  e 
Thymol (3%) 0.00 a 0.00 a 
Hydrogen peroxide (0.5%) 8 . 1 5  b 5 .28  d 
Hydrogen peroxide ( J  %) 7 .50 c 4.22 e 
Hydrogen perox ide (3%) 0 .00 a 0.00 a 
Phenol (0 .5%) 8 . 1 7  b 4.32 e 
Phenol ( 1 %) 3 .44 d 0.00 a 
Phenol (3° 0) 0.00 a 0.00 a 
Ethyl alcohol (30 %) 8 . 1 1  b 5 . 5 5  d 
Ethyl alcohol (70 %) 3 . 3 8  d 0.00 a 
Ethyl alcohol ( 1 00 %) 7.44 c 5 . 3 1 d 
Clorox (0.5° 0) 8.22 b 5 .39  d 
Clorox ( 1 ° 0) 3 .2 1 e 3 .75/ 
Clorox (3° 0) 0.00 a 0.00 a 
Iod ine (0.5%) 8 .08 b 6.87 h 
Iod ine ( 1 %) 3 . 1 6  e 5 .3 1 d 
Iod ine (3%) 0.00 a 0.00 a 
Merthiolate (0.5%) 8 .03 b 6.7 1 h 
Merthiolate ( I  %) 3 .05/ 4.22 e 
Merthiolate (3%) 0.00 a 0.00 a 
Values are means of 5 rep l icates for each treatment and the values w ith the same letter 
\ ith in  a column are not s ign ificant ly (P > 0.05 ) d i fferent accord i ng to F i sher's 
Protected LSD Test . 
3. 1 3  E ffects of host age o n  p hage p ropagation a n d  v iab i l i ty 
Fewer bacter iophage number 1 (0 1 ) act i ve against S. typhimurium were obtained 
when propagation hosts were incubated for 0-3 h, in comparison to those incubated 
for 5- ] 0  h (Table  3 . 5 ) .  More pfu where obta ined when the propagation hosts were 
i ncubated for 1 0  hours. Meanwh i le, fewer bacteriophage number 2 (02) act i ve aga inst 
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E. coli \\ ere obta ined v, hen propagat ion hosts \\ ere incubated for 0-3 h in comparison 
to tho e incubated for 5 - 1 0  h (Table 3 . 5 ) .  
3. 1 .t  E ffect of h o  t i nocu l u m  size on ph age p ropaga tion and  v iab i l i ty 
G reater leve l s  of ho t i nocu l um resu lted in greater phage t i ters (Table 3 .6) for 
bacteriophage number I (0 1 ) act i e against S. /yphilllllrilllll (Table 3 .6) .  Propagation 
ho t at 1 07 cfu m ! " 1 yie lded the h ighest pfu m rl compared to 1 06 cfu m r l and 1 05 cfu 
mr 1 (Table 3 .6) .  
Iso. greater level  of host inoculum resul ted in  greater phage t i ters (Table 3 .6) 
for bacteriophage number 2 (02) active against E. coli (Table 3 .6).  
Propagation host at 1 07 cfu m! " 1 y ie lded the h ighest pfu mr l compared to 1 06 cfu 
I11 r l and 1 05 cfu m r l (Table 3 .6) .  
3. 1 5  E ffects o f  p hage i n oc u l u m  s ize  on ph age p ropagat ion a n d  v iabi l i ty 
G reater phage inocu lum size resu lted in  greater phage output (Tab le 3 .7) for 
bacteriophage number 1 (01) active against S. typhimllrillnl (Table  3 . 7). Phage 
inocu l um s ize of 1 07 pfu mr 1 gave the h ighest pfu m r 1 compared to I 06 pfu m !" 1 and 
1 05 pfu m r 1 (Table 3 . 7) .  
A lso greater phage inocu lum size resu lted in  greater phage output (Tab le 3 .7 )  for 
bacteriophage number 2 (02) act ive against S. typhimlirilll71 (Table  3 .7 ) .  Phage 
inocu lum s ize of 1 07 pfu mr l gave the h ighest pfu m r l com pared to l 06 pfu m !" 1 and 
1 05 pfu m r l (Table  3 . 7) .  
3. 1 6  Dete r m i n a tion  o f  adsorpt ion rate constant,  latent period and b u rst  s ize 
Adsorption rate constant (K) of bacteriophage number 1 (0 1 ) ar is ing from S. 
typhimllrillm was 1 .22 X 1 0.6 m l  m in' } (Tab le 3 .8) .  The Adsorption rate constant of 
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bacteriophage number 2 (02) aris ing from E. coli was 1 .4 1  1 0-6 m l  m in- I  (Table 
3 .8 ) .  
oun l  from samples taken a fter 35 -40 min  sugge ted that i n fected cel ls  \ ere 
lys ing and l i berat ing phage. Latent period val ues obta i ned for the bacteriophage 
number I (0 1 )  ari ing from . /yphillluriufII was 40 m inutes (Table 3 . 8 ) . Latent period 
\ a lues obtai ned for the bacteriophage number 2 (0 1 )  aris ing from E. coli was 3 5  
m inute (Tab le  3 .8 ) .  
The rise periods of the bacteriophage number J (0 1 )  aris ing from S. typhimurium 
\ as 30 m inutes (Table  3 .8) .  The rise periods of the bacteriophage number 2 (02) 
ar is ing from E. coli was 40 m i nutes (Table 3 .8 ) .  
The a erage burst s izes of bacteriophage number 1 (0 1 )  ansll1g from S. 
typhil11urilllJ1 was 2 ] .5 v i r ions/ce l l  (Table 3 . 8) .  The average burst s izes of 
bacteriophage number 2 (02) aris ing from E. coli was 1 5 .2 v irions/ce l l  (Tab le 3 . 8) .  
The second burst began at around 70-80 m inutes; nearly 30-40 min after the fi rst burst 
began w h ich con fi nned the m i n i mum latent period of 30-40 m i n  for the two phages 
(Table 3 .8) .  
Table  3 .5 :  Effect of incubation t ime of host ( in  hours) prior to inocu lation (host 
age) on the phages product iv ity and y ie ld  of phages. 
I ncubation t ime ( i n  hours) at ( Jog l o pfu mr l ) of phage ( Iog l o pfu ml- I ) of phage 
3TC of host pnor to number 1 number 2 
inocu lation w ith the phage 
0 6. 1 4  a 7 .78 a 
3 6 . 1 1  a 7 .92 a 
5 6 .5 1 b 9. 1 4  b 
1 0  8 .38  c 9.44 c 
Values are means of 5 rep l 1cates and the val ues w ith the same letter w ith 111 a column 
are not s ign i ficant ly  (P  > 0.05) d i fferent accord ing to F isher's Protected LSD Test. 
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fab le  3 .6:  Effect of propagat ion host i nocu lum s ize on the phages 
product iv i ty and ie ld of phages 
Propagat ion host inoc u l um ( [ag i o pfu mrl) of ( logl O pfu m rl) of phage 
size ( cfu mr l of ho t phage number 1 number 2 
suspension) 
1 0' 6 .8 1 a 6.4 1 a 
1 06 5 .90 b 5 .32 b 
1 05 5 . 1 6  C 4 .8 1 c 
1 04 4.62 d 4.35 d 
Values are means of 5 rep l i cates and the values w ith the same letter 
wi th in  a column are not s igni ficantly (P > 0.05) d i fferent accord ing to 
F i sher's Protected LSD Test. 
Tab le 3 . 7: E ffect of phage i nocu l um size on the phages product iv i ty 
and yie ld of phages. 
Phage i nocu lum size (pfu mrl ( loglO pfu m rl) of ( Iog lO  pfu mrl ) of phage 
of phage suspens ion) phage number I number 2 
1 0' 6.42 a 6. 1 9  a 
1 06 6 . 1 1  b 5 .9 1 b 
1 05 5 . 77  c 5 .23 c 10"1  5 .23 d 4.89 d 
1 03 4 .76 e 4 .35  e 
1 02 3 . 25 [ 3 .93 ( 
1 0 1 2 .3 1 g 2 .2 1 J? 
Val ues are means of 5 rep l icates and the val ues With the same letter 
wi th i n  a column are not s igni ficant ly (P > 0.05) d i fferent accord ing to 
F isher's P rotected LS D Test. 
Table 3 . 8 :  B io logical propert ies of phage number I (0, )  act ive aga i nst Salmonella 
typhimurilln7, and phage number 2 (02) active aga inst Escherichia coli. 
Phage number Adsorption Lat Rise Burst s ize re lative 
rate constant ent period I ncrease 
K (mL min) pen (min) (v ir ions/cel l s) 
od 
(mi 
n) 
Phage number 1 (01 )  act ive 1 .22x l O  -6 40 30 2 1 .5 
agai nst S. typhimurium 
Phage number 2 (02) active l A l x l 0 -6 35 40 1 5 .2 
agai nst E. coli 
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3. 1 7  The  effect of incorporat ion of bacteriophage on t h e  populat ion densit ie  of  
. (ypl, il11uriul1t and E. coli in  t h e  c h i c ken feed 
3. 1 7. 1  E ffec t  of m ix i n g  t h e  two p h age on bacterial grow th  
hen bacteriophage number 1 (0 1 )  selected to  inh ib i t  S. typhimurillm and 
bacteriophage 2 (02) e lected to i nh ib it E. coli \ ere m ixed together, there were no 
inh ib itory effects of the two phages on each other's .  The two phages in one m ixture 
\\ ere sti l l  able to inh ib i t  the growth of S. typhimuriwlI and E. coli. 
3. 1 7.2 T h e  effect of i n corporation of S. typhimurilll1l and E. coli bacteriophages 
on t h e  populat ion den it ies of S. typltil1luriul1l and E. coli in t h e  c h ic ken feed 
In control  treatments which contained the k i l led E. coli alone (treatment I ) , k i l led 
S. lJphimllrill171 alone (treatment 2) and k i l led E. coli + k i l led S. typhimurilll71 
(tr  atment 3 ), no bacter ia \ ere found at the end of the incubation period after 3 days, 
or after 7 days or after 2 1  days (Tab les 3 .9, 3 . 1 0  and 3 . ] ] ) . 
I n  control treatments \ h ich contai ned the E. coli phage a lone (treatment 4), S. 
typhillluriZlll1 phage alone (treatment 5 )  and E. coli phage + S. typhimurilll1l phage 
(treatment 6), the bacter iophage number 1 (0 1 )  act ive against S. typhimurium and 
bacteriophage number 2 (02) active aga inst E. coli were found to be at h igh leve ls  at 
the end of the incubat ion period after 3 days, or after 7 days or after 2 1  days (Tables 
3 .9, 3 . ] 0 and 3 . 1 1 ) . The 10g I Q  p l aque form ing un i ts (pfu) g- l ch icken com-soy d iet of 
the two phages were found to be w ith h igh t it res (Tables 3 .9, 3 . 1 0  and 3 . 1 1 ) . No 
bacteria were observed in treatments 4, 5 and 6 (Tables 3.9, 3 . 1 0  and 3 . 1  1 ) . 
I n  the treatments which contained the l i v i ng E. coli alone (treatment 7), l i v ing S. 
/;phimurium alone ( treatment 8 )  and l i v ing E. coli + l iv ing S. typhimllrillm (treatment 
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9). the bacteria were found at the end of the incubation period after 3 days, or after 7 
days or a fter 2 1  days (Tables 3 .9, 3 . 1 0  and 3 . 1 1 ) . The populat ion densit ies of E coli 
and s. iJphill1l1rilll11 e, pres ed as log l o  colon form ing un its (cfu) g- I ch icken corn-
oy d iet \\ as found to be s igni ficantly h igher compared to other treatments 
(treatm nts 1 0, 1 1 and 1 2 ) \\ h ich contained the bacteria and the phages together. No 
bacteriophages were detected in treatments 7 8 and 9 (Tables 3 .9, 3 . 1 0  and 3 . 1 1 ) . 
The app l i cation of bacteriophage number 1 (0 1 )  selected to inh ib i t  S. 
lyphil71l1riZlJll i n  autoc laved corn-soy d iet i nfested with S. typhimllriwl1 (treatment 1 1 ), 
or the appl ication of bacteriophage number 2 (0�) selected to inh ib i t  E coli in  
autocla ed corn-soy d iet i nfested w ith E coli (treatment 1 0), or the appl ication of 
bacteriophage number 1 (0 1 )  se lected to i nh ibi t  S. ryphilllllrium and bacteriophage 
number 2 (0�) selected to i nh ib it E coli in autoc laved corn-soy d iet infested with S. 
0phimllrium and E coli (treatment 1 2) s ign i ficantly (P < 0.05)  reduced the 
popu lation densit ies of S. typhi1l111rillm i n  t reatment 1 1  and the popu lation densit ies of 
E coli i n  treatment 1 0  and the popu lat ion densit ies of S. typhiJllurium and E coli in  
treatment 1 2  compared to the treatments which inc luded the appl ication of l iv ing E 
coli alone (treatment 7). l i v ing S. typhimurium alone (treatment 8) and J i v i ng E coli 
+ l iv ing S. 0phimurillll7 (treatment 9) (Tables 3 .9, 3 .  J 0 and 3 . 1 1 ) . Treatment ] 2 ( the 
1\\ 0 bacteriophages together + l i v i ng E coli + l iv ing S. 0phimllrillm) in E coli + S. 
0phimurium amended ch icken feed gave the best contro l  and s ign i ficantly (P < 0.05 ) 
reduced the populat ion densit ies of S. typhimurium and E coli compared w ith other 
treatments (Tables 3 .9, 3 . 1 0  and 3 . 1 1 ) . 
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' I he treatment \\ hi h recei ed the mixture of the two phages (treatment 1 2) or the 
app l i cation of bacteriophage number I (0 , )  selected to inh ib i t  S I)phitllllrillm 
(treatment I I ), or the app l ication or bacteriophage number 2 (02) selected to inh i b it 
E. coli (treatment 1 0) \\ a a lmo t a effect ive a the oxytetracyc l i ne appl ications 
(treatment 1 3), or (treatment 1 4) or ( treatment 1 5) in  reduc ing the inc idence of S 
IJphill1l1riull1 and E. coli in the ch icken feed (Tables 3 .9, 3 . 1 0  and 3 .  I I ) . 
There were however no s ign i ficant (P > 0.05) d i fferences between the bacteria l  
levels of the  phage treated ch ic ken feed (treatments 1 0, 1 1  and 1 2) and the 
ox)tetrac 'c l i ne treated ch icken feed (treatments 1 3 , 1 4  and I S ) (Tables 3 .9, 3 . 1 0  and 
3 . 1 1 ) . 
The same trends of  the reduction of the popu lation densit ies of S typhimuriwl1 
and E. coli were observed after 3 days, or after 7 days or after 2 1  days of i ncubation 
\\  ith bacteriophage number I (0 , ) or bacteriophage number 2 (02)  or both 
bacteriophage (0 , ) + bacteriophage (01) (Tab les 3 .9, 3 . 1 0  and 3 . 1 1 ) . 
There were more reduction in the popu lat ion densit ies of  S typhimllrium and E. 
coli at 2 1  days of i ncubation more than 7 days of incubat ion and 3 days of 
i ncubat ion. 
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Tab le 3 .9 rrect of i ncorporation of bacteriophages on the population den i t ies of S. 
lyphilllurilllJl and E. coli (expressed as log I 0 cfu g- I ch icken corn-soy d iet) and on the 
popu lation densit ie of . lyphilllurillll1 and E. coli phages (expressed as 10gJO  pfu g- I 
ch icken corn-soy d iet) after i ncubation at 37"C for 3 days . 
l ' reatments Phage population densities as Bacteria population 
loglo (pru)  g- I  chicken corn- densities as log lo (cfu)  g- I 
SO} diet chicken com-soy diet 
( I ) Control (autoc1a\' ed com-so} diet) + 0.00 a 0.00 a 
ki l led autocla\ ed E coli alone 
( 2 )  Control (autoclm ed com-so) diet) + 0.00 a 0.00 a 
k i l led aUloc la\ eJ S typhimllrilllll alone 
(3 ) Control (autocl m  ed com-soy diet) + 0.00 a 0.00 a 
k i lkd autocla\ed E. coli + k i l led autoc1aved 
S tvphimllrilll11 
(4 )  Control (autoc1a\'ed com-soy diet) + E  7.3 1 b 0.00 a 
coli phage alone 
( 5 )  Control (autoc1a\'ed corn-so)' diet) + S 6.88  c 0.00 a 
nphilllllrillm phage alone 
(6) Control (autocla\ ed com-so} diet) + E. 8.5 1 d 0.00 a 
coli phage + S lyphilJlllriulll phage 
( 7 )  Control (autoc1aveJ com-so) d iet) + 0.00 a 8.42 b 
l i \  i n g  E. coli alone 
( 8) Control (autoc1a\'ed com-soy d iet) + 0,00 a 8 ,8 1 c 
l i \  ing S f)phimuriulII alone 
(9)  Control (autocla\ ed com-so) diet) + O.OOa 9.3 d 
I i \  i ng E. coli + l i \  ing S (1phimllrilll1l 
( 1 0) Control (autocla\ ed com-so) d iet) + 7.25 b 4,2 1 g 
l i \  i ng E coli + E coli phage 
( I I )  Control (autocla\'ed com-so) J iet) + 6.79 c 3.54/ 
l i \  ing S typhimuriu/ll + S l)'phimllriul11 
phage 
( 1 2 ) Control (autoc1m ed com-soy d iet) + 8.4 1 d 3 . 1 5  e 
l i \  i ng E coli � l i \  ing S ,>phimurium + E 
coli phage + S /)-phimllrillm phage 
( 1 3 ) Control (autoc1a\ ed com-soy d iet) + 0.00 a 4 ,05 g 
l i \  i ng E coli + oxytetrac) c l ine 
( 1 4) Control (autoc1aved com-soy d iet) + 0,00 a 3.6 1 /  
l i \  i ng S f1phimurium + oxytetracyc l i ne 
( 1 5 ) Control ( autoc1aved com-so) d iet) + 0.00 a 3 .05 e 
l i \ i ng E coli + l iv ing S typhimurium + 
oX)1etracycl ine 
Val ues are means of  8 rep l icates and the values With the same letter Wi th In  a column 
are not sign i ficantly (P > 0.05) d i fferent accord ing to F isher's Protected LSD Test. 
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fab le J . l 0 Effect of incorporation of bacteriophage on the popu lation densit ies of S. 
typhilliurilllN and E. coli (e:-..pressed as 10g l O cfu g- I ch icken com-soy d iet) and on the 
popu lation densit ies of S. fyphimllriulI7 and E. coli phages (expressed as log l o  pfu g- l  
ch ic,,"en corn-soy d iet) a rter i ncubation at JTC for 7 da 's . 
' 1 reatments Phage population den i t ies a Bacteria population 
10glO (pfu)  g- I chid,en corn- nsities as loglo (cru )  g- I 
50\ diet chicken corn-so) d iet 
( I ) Control (autocIa\ ed corn-so) d iet) + 0.00 a 0.00 a 
ki l led autoc la\ ed E coli alone 
t 2 )  Control (autocla\ cd corn-so) d iet) + 0.00 a 0.00 a 
ki l led aUlOcl:l\ ed S f)phimllrillm alone 
( 3 )  Control (autoda\ed corn-so) diet) + 0.00 a 0.00 a 
k i l led autoclayed E. coli + ki l led 
autocla\ ed S f)phil11l1rilll11 
(4 )  Control (autocla\ed corn-soy d iet) + E 8.5 1 b 0.00 a 
coli phage alone 
( 5 )  Control (autoclav ed com-so) d iet) + S 6.95 c 0.00 a 
tvphimlirillln phage alone 
(6) Control (autoclU\ ed corn-so) d iet) + E. 8.9 1 d 0.00 a 
coli phage . S f)phil1lllrilll11 phage 
( 7 )  Control (aulOclU\ ed corn-soy diet)  + 0.00 a 8.83 b 
l i \  ing  E coli alone 
(8) Control (autocla\ ed com-soy d iet) + 0.00 a 9. 1 5  c 
l i \  ing S IJphimllrilllll alone 
t9) Control ( autoclU\ ed corn-so) diet) + O.OOa 9.6 1 d 
l i \  i ng E coli T l i \  i ng S. f)phimlirilll7l 
( 1 0) Control (autocla\ ed com-so) d iet) + 8 .75 b 3 .05 g 
l i \  i ng E coli + E coli phage 
( I I )  Control (autoclaved corn-so) d iet) + 7.05 c 3 .34f 
l i \  i ng S f)phimurillm + S. lyphil71l1rilllll 
phage 
( 1 2) Control (autoclU\ ed corn-so) d iet) + 9.05 d 2 .58  e 
l i \  ing E coli - l i v i ng S IJphimurilll71 + E 
coli phage ;- S. t}philllurillll1 phage 
( 1 3 )  Control (autoclaved corn-soy d iet ) + 0.00 a 2.95 g 
l i \  i n� E coli + o.X) tetrac) cl ine 
( 1 4) Control (autoclaved com-soy d iet) + 0.00 a 3.29f 
l i \  ing S r.phillluriu/ll + o�) tetracyc l i ne 
( 1 5 ) Control (autoclaved com-soy d iet) + 0.00 a 2 Ag e 
l i \ i ng E coli + l i \  i ng S typhil71urilll71 + 
0\.) tetrac) c l ine 
Val ues are means of  8 rep l icates and the val ues With the same letter \ I thm a co lumn 
are not  s ign ificant ly (P  > 0.05)  d i fferent accord i ng to F isher's Protected LSD Test. 
Tab le  J . l 1 Effect of incorporation of bacteriophages on the population densit ies of S. 
/Jphimurium and E. coli (expressed as 10g IO c fu g- I  ch icken com-soy d iet) and on the 
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popu lation den it ies of S. f}phill7l1riuJ11 and E. coli phages (expressed as log l o pfu g- l  
ch icken corn-soy d iet) after incubation at 37"C for 2 1  days. 
Treatments Phage population densities Bacteria population 
as IOglO (pfu) g- I chicken densities as loglo (c fu)  g- I 
com-so) d iet chicken com-soy diet 
t I )  Control (autoclaved com-so) d iet) + 0.00 a 0.00 a 
ki l led uutoclm'ed E coli alone 
(2 )  Control (uutocluved com-soy d iet) + 0.00 a 0.00 a 
ki l led autoclm ed S. fyphimurillm alone 
( 3 )  Control (autoclav ed com-so) d iet) + 0.00 a 0.00 a 
k i l led autocla\ ed E coli + k i l led 
autoclm ed S (vphill1urilll71 
(4 )  Control (aut c la\ ed corn-so) d iet) + E 8.85 b 0.00 a 
coli phage alone 
(5) Control ( autoc laved com-soy d iet) + S. 7. 1 1  c 0.00 a 
fyphil7lllrium phage alone 
(6) Control (autoclaved com-soy d iet) + E 9.08 d 0.00 a 
coli phage + S. f)pilil7lllriul71 phage 
( 7 )  Control (autoc1aved com-soy d iet) + 0.00 a 9.25 b 
I h  i ng E coli alone 
(8 )  Control (autocl aved com-soy d iet) + 0.00 a 9.55 c 
l i \  i ng S l1phil71llrilll7l alone 
(9) Control (autoclaved com-soy d iet) + O.OOa 9.9 1  d 
l i \  i ng E coli + l i \  i ng S. typhimurilll71 
( 1 0) Control (autoclaved com-soy diet)  + 8.95 b 2. 1 5  g 
l i \  i ng E coli + E coli phage 
( 1 1 )  Control (autocla\ ed corn-soy diet)  + 7.2 1 c 2.4 1 / 
l i \  i ng S typhimuriul11 + S. typhimurium 
phage 
( 1 2) Control ( autoclaved com-soy diet)  + 9. 1 7  d 1 .77 e 
l i \  i ng £. coli + l i \  ing S. ophimurium + E 
coli phage + S. I).phimllrium phage 
( 1 3 ) Control (autoclaved com-soy d iet) + 0.00 a 2.25 g 
l i \  ing E coli + 0:-") tetracy cl ine 
( 1 4) Control (autocla\ ed corn-soy d iet) + 0.00 a 2.35/ 
l i \  ing S. f)philllllrilim + oxytetracycl ine 
( 1 5) Control (autoclaved corn-soy diet) + 0.00 a 1 .85 e 
l i \ ing E coli + l i\ ing S typhimurium + 
OX) tetracycl ine 
Values are means of  8 rep l icates and the val ues With the same letter wlthm a column 
are not  s ignificantly (P > 0.05) d ifferent accord ing to F isher's Protected LSD Test . 
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H A PT E R  I V :  D I  C U  1 0  
Diaz e /  01. ( 1 989) i nd icated that the isolation and ident ification of bacteriophages 
are of interest for a ariety of  reasons, which inc lude: ( i )  the problems they cause to 
fermentation indu tries (Chater. 1 986), ( i i ) their va l ue for m ic robial  ident i fication 
LI ing the bact riophage typ i ng techn ique ( Korn-Wend ish and chneider, 1 992), ( i i i ) 
the ir  u e for the detect ion and understand ing of  host contro l led restriction-
mod i fication systems (Diaz ef 01. , 1 989), ( iv) their ut i l izat ion as too ls for genetic 
exchange and analys i s  in bacteria (Herron and We l l i ngton, 1 990), (v) the study of 
bacteriophage genera l  and molecular b io logy and ecological  characterist ics 
( Lomovskaya e/ 01. , 1 980: W i l l iams et 01. , 1 987), and (v i )  the i r  recent ro le 111 
bacteriophage therapy to rep lace the app l ication of ant ibiot ics ( Brussow, 2007). 
The object ives of the present study were to: ( i )  isolate super l yt ic  bacteriophage that 
can k i l l  almonelfa typhifllllrillJII and E. coli in vitro; ( i i )  test the effectiveness of the 
i o lated bacteriophages in ch icken feed ; ( i i i )  compare the isolated bacteriophages 
\\ ith the current ly in use ant ib iot ics in ch icken feed . 
I n  the current study and in  an attempt to iso late lyt i c  bacteriophages active 
agai nst Gram negat ive bacteria Salmonella Iyphimurium and Escherichia coli known 
to cause food poison ing d iseases in ch icken feed two bacteriophages were isolated 
from untreated raw waste water samples co l lected from A I-A i n  sewage treatment 
factory. The opt imum concentration of  the two phages used was found to be 1 0 10 pfu 
I - I  m . 
Bacteriophage number I (0 1 )  was isolated us ing S. typhimllrium as a propagation 
host and was found to be monovalnet and on ly  lysed S. typhimurillfll. Bact r iophage 
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(01 ) fa i led to lyse the Gram po i t i  e bacteria B. slIblilis, , .  allreus, S. epidermidis 
and E. faecali · and fai led a l  0 to I se the Gram negat ive bacteria E. coli, P. 1'ulgari , 
P aerllgino a and S. (0'Senleriae. On the other hand, bacteriophage number (01) 
isolated us ing E. coli as a propagation host was found to be polyvalent and lysed the 
Gram po i l i ve bacteria (B. ublilis, S. aurellS, S. epidermidis and E. faecalis), and the 
Gram negat ive bacter ia (P. l'u/garis, P. aeruginosa and S. dysenteriae). 
Bacteriophages act ive agai nst bacteria are read i ly detected i n  sewage and i t  appears 
that bacteriophages are \ idespread in the sewage env i ronment (Tartera and Jofre, 
1 987� R icca and Cooney, 2000). 
The i nab i l ity of  bacteriophage number 1 (01 ) to k i l l  G ram posit ive bacteria and a l l  
Gram negat ive bacteria except S. typhimllriul1I i nd icates the importance o f  spec i fic 
receptor s i tes on the bacterial ce l l  wal l and a lso ind icates that the structural 
d i fferences in the ce l l  wa l l  between Gram pos i t ive and negat ive bacteria are crit ical . 
These find ings i n  our study are in agreements w ith those reported by R icca and 
Cooney (2000) and K i mura e/ al. (2008). 
The i ncrease i n  the (pfu m l" l ) of bacteriophages when Ca(N03)1 was added, 
confinned the find ings of Adams ( J  959) who conc luded that d i valent cations such as 
Ca"-" are requ i red for adsorption of phage to the i r  receptors. Gold ( 1 959) a lso noted 
that add i t ion of d ivalent cations to the med ium increased the s ize and number of  
p laques produced by phage. The  increased N aC I  concentrat ions used i n  th is study 
reduced the numbers of congruent p laques on the three med ia  types. These find ings 
a lso agreed w i th Walton ( 1 95 1 )  who conc luded that certa i n  concentrations of a lka l i ne 
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cations. od ium.  potass ium and ammon ium complete ly inh ib i t  mul t ip l ication of 
phage that attack bacterial ho t (Walton, J 95 J ) . 
The phys ical and chemical  treatments used 1 11 the study reported in  th is  
i nve tigat ion had adverse effect on the two phages used, with bacteriophage (0 1 )  
i olat d again t S. Iyphimllrillfll was the most affected. Bacteriophage (0 1 )  was 
ensit ive to the treatments w ith freezing, refrigerat ion, heat ing, boi l ing, u ltrasonic 
treatment and U V  rad iat ion. Freezing bacteriophage (0 1 ) for 30 m inutes, one hour, 
h 0 hours (but not 3 hours, four hours, fi ve hours, s ix  hours, 1 2  hours, 24 hours, and 
48 hours) ho\ved l ight adverse effects on the v iab i l i ty of the bacteriophage. At 4°C 
bacteriophage (0 1 ) numbers decreased marked ly w i th t ime. Heat ing the 
bacteriophage (0 1 )  at 45°C, 5 5°C (but not at 65°C) for 1 5  m inutes and for 30 m inutes 
d id  not sho\ any adverse effect on the v irus v iab i l ity and the numbers of pfu .  
Boi l ing bacteriophage (0 1 ) at 1 00°C for 5 m inutes and for 1 0  m inutes complete ly ;  
k i l led the phage as evident w i th no pfu formation. Bacteriophage (0 1 )  was able to 
res ist the u ltrasonic treatment for 60 seconds and 1 20 seconds but  w ith a reduced rate 
compared to the control treatment. Exposing bacteriophage (0 1 )  to U V  rad iation for 
30 econds and 60 seconds (but not 1 20 seconds, 1 80 seconds and 240 seconds) 
sho\\ed no adverse effect on the bacteriophage v iab i l ity. A l though most phages are 
resistant to detergents and other chemical  and phys ical  agents, their inact ivation by 
these agents is  commonly observed (Goyal ,  1 987) .  
Bacteriophage (02) was sens i t ive to the treatments with freezing, refrigerat ion, 
heat ing, boi l i ng, u ltrasonic treatment and UV rad iat ion.  Freezing bacteriophage (02) 
for 30 m i nutes, one hour, two hours, 3 hours (but not four  hours, five hours, six hours, 
84 
1 2  hour , 24 hour , and 48 hours) sho\\ ed s l ight adverse effect on the iab i l ity of the 
bacteriophage. At 4°C bacteriophage (02) number decrea ed marked ly with t ime.  
I l eat ing the bacteri phage (02) at  45°C, and 55°C for 1 5  m inutes and for 30  m inutes 
(but not 65°C for 1 5  m inute and for 30 m inute ) d id not show an adverse effect on 
the iru iab i l it) . 
Boi l ing bacteriophage (02) at 1 00°C for 5 m inutes and for 1 0  m inutes 
complete l) ; k i l led the phage as evident with no pfu formation. Bacteriophage (02) 
\ as able to res ist the u l trason ic treatment for 60 seconds and 1 20 seconds but w ith a 
reduced rate compared to the control treatment .  Exposing bacteriophage (02) to U V  
rad iat ion for 30  seconds, 60 seconds and 1 20 seconds (but not J 8 0  seconds and 240 
seconds), shO\ ed no adverse effect on the page v iab i l i ty. 
Man phages have been reported to be res istant to many phys ical agents as 
suggested by Goyal ( 1 98 7) .  Th i s  supports the find ing in the present study wh ich 
demonstrated that bacteriophages (0 1 )  and (02) showed some degrees of  res istance to 
phys ical agents. 
Bacteriophage (01 ) was sens i t ive to the treatments w ith ch loroform (0.5%, 1 % 
and 3%), thymol ( l  % and 3%) hydrogen peroxide ( 1  % and 3%), pheno l ( J  % and 
3%), ethyl alcohol ( 70% and 1 00%), C lorox ( 1  % and 3%), iod i ne ( I  % and 3%), 
merth io late ( 1 %  and 3%). However the bacteriophage (0 1 )  showed some degree of  
resistance to  these chemicals  i n  these concentrations thymol (0 .5%), hydrogen 
peroxide (0 .5%), phenol (0 .5%), ethyl alcohol (30%), C lorox (0.5%), iod ine (0.5%) 
and merth io late (0 .5%).  Bacteriophage (02)  was sens i t ive to the treatments w ith 
ch lorofoml (0 .5%, 1 % and 3%), thymol (3%), hydrogen perox ide (3%), phenol ( 1  % 
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and 3%), ethy l a lcohol ( 70% and 1 00%), lorox (3%), iodine (3%). merth io late ( 1 % 
and 3% ). I I of these chem icals greatly reduced the numbers of pfu .  Ho\\ ever, the 
bacteriophage (02) showed some degree of res istance to these chem icals in  these 
c ncentrations thy mol (0 .5% and I %), hydrogen perox ide (0 .5% and 1 %), phenol 
(0 .5%), eth) I a lcohol (30%), C loro (0.5% and I %), iod i ne (0 .5% and I %) and 
merthio late (0 .5%) .  Many phages have been reported to be res istant to many 
chemical agents as suggested by Goyal ( 1 98 7) .  Th i s  supports the finding in the 
present study w h ich demonstrated that bacteriophages (0 1 )  and (02) showed some 
degrees of res istance to chem ica l  agents. 
Th i s  degree of res istance of the two bacteriophages aga inst phys ical and chemica l  
agents \\ i l l  strengthen the  appl ication of the  bacteriophages as  a b io logical product as 
bacteriophages can nO\ tolerate adverse effects during storage and app l i cation of the 
bacteriophages product in the ch icken feed i ndustry. 
In the current stud , fewer bacteriophage (01) were obtai ned when propagation 
hosts were incubated for 0-3 h, in comparison to those i ncubated for 5 - 1 0  h .  
Meam h i le, fewer bacter iophage (02) were obta i ned when propagat ion hosts were 
i ncubated for 0-3 h, in comparison to those i ncubated for 5- 1 0  h. Greater levels of 
host inocu lum resu lted i n  greater phage t i t res for bacteriophage (0 1 ) . A l so, greater 
levels of host i nocu lum resu lted in greater phage t i tres for bacteriophage (01). 
Greater phage i nocu lum s ize resulted in greater phage output for bacteriophage 
(0 1 ). A l so, greater phage i nocu lum s ize resu lted in greater phage output (Table 3 . 7) 
for bacteriophage (02). Adsorpt ion rate constant ( K )  of bacteriophage (0 1 )  and (01) 
were 1 .22 X 1 0-6 ml m in- I and 1 .4 1  X 1 0-6 ml m in' l , respect i vely.  Latent period 
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\ a lue obtai ned for bacteriophage (0,) and (02) \ ere 40 m i nutes and 35  m in utes, 
re pect i  e ly .  The rise period of the bacteriophage (0 ,)  and (02) were 30 m i nutes 
and 40 m inutes, re pect ively. The average burst s izes of bacteriophage ( 0 , )  and (02) 
w ere 2 1 .5 v i r ions/ce l l  and 1 5 .2 i r ion /ce l l ,  respect ive I . 
The bur t izes obtai ned for the 1\ 0 phages used in th is  study were lower than the 
one obta i ned by DO'v\ d ing ( 1 973) but h igher than some of the values obtai ned by 
ykes e/ al. ( 1 98 1 )  for phages ut i l i s ing neutroph i l ic hosts. However, many factors 
such as the nature of the ho t, and host age can i nfluence phage burst s ize ( Brad ley et 
al. , 1 96 1 ) . For e. amp le, Dowd ing ( 1 973) i nd icated that act i nomycetes, inc lud ing 
treptomycetes, do not  genn inate synchronously, so that by the t ime a h igh enough 
proport ion of spores ha e germ i nated, some of them w i l l  be large c l umps of 
myce l i um .  Therefore, the one-step growth experiments , n th is  study agree with 
Dowd ing ( 1 973 ) who suggested that tbe concept of  mu l t ip l i c ity of i n fection w i l l  
remain  mean ing less i n  host-phage systems unt i l  a method i s  found t o  cause 
synchronous and un i form spore germ inat ion . 
The negati e l  sta i ned part ic les of the  bacteriophage number 1 (0 , )  active aga inst 
S. typhilllur;zlJn and the bacteriophage number 2 (02) act ive agai nst E. coli fitted the 
Siphoviridae ( 8 1 )  morphotype ( Francki  et al. 1 99 1 )  wh ich consisted of icosahedral 
heads (F ig .  3 .8 ) .  Many bacteriophages are known to  cons i st on ly  of  icosahedra l 
heads w ith tai l s  and ta i l s fi bers. Some bacteriophages a lso are s imple  in structure 
\\; i thout the formation of the head and tai Is as suggested by Ackermann and Heldal  
(20 1 0) .  
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Bacteria \v h ich are resistant to mo t or a l l  currentl  avai lable antibiotics in  the 
market arc causing increa ingly serious problems, ra is ing widespread fears of 
returning to a pre-ant ibiotic era of untreatable i nfections and epidemics ( BrussO\: , 
2007; H an lon, 2007; K im ura el 01. , 2008). Despite intensive work by drug 
compan ,e , no ne\\ c lasses of antib iotics have been found in the l ast 30 years 
( B ru SO\\ , 2007; Han lon, 2007). There are hopes that the new found abi l ity to 
sequence ent i re m icrobia l  genomes and to determ ine the molecular  bases of 
pathogenic ity v i l l  open new avenues for treat ing infectious d i seases, but other 
approaches are a l so being sought with increas ing fervor (Sooth i l l  el 01 . . 2004; 
Su lak el idze, 2005;  Han lon, 2007). One resu l t  i s  a renewed interest in the 
poss ib i l i t ies of bacteriophage therapy which can be defined as "the appl ication of a 
spec i fic k i nd of bacterial  v i ruses 'phages or bacteriophages" that attack only bacteria 
to k i l l  pathogenic m icroorganisms ( Barrow and Sooth i l l , 1 997;  Su lakvel idze et 01. . 
200 1 '  B russow 2005; Su lakvel idze, 2005 ). 
I n  the current study, the appl ication of bacteriophage (0 , )  i n  corn-soy d iet 
infested w ith S. typhimuriulII, or the appl ication of bacteriophage (02) i n  corn-soy 
d iet i nfested with E coli, or the appl ication of bacteriophage (0 , )  and bacteriophage 
(02) in corn-soy d iet i nfested w ith S. typhimllrium and E coli significantly (P < 0.05) 
reduced the popu lation densit ies of S. typhimurium and the popu lat ion densit ies of  
E.coli compared to  the  treatments wh ich  inc luded the  appl ication of l iv ing E coli 
a lone, l i v ing S. typhimurium alone and l iv ing E coli + l iv ing S. typhimurium. The 
treatment wh ich  rece ived the m ixture of the two phages or the appl ication of 
bacteriophage (0 , ), or the appl ication of bacteriophage (02) was a lmost as effect ive 
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as the oX;1etracyc l i ne app l i cations in reduc i ng the i nc idence of S. lyphilllllrilll17 and 
E. coli in  the chicken feed. There v ere, ho\' ever, no s igni ficant (P > 0.05) 
d i fference bet\\ een the bacterial levels of the phage treated ch icken feed and the 
oX)1etracyc l i ne treated ch icken feed. Resu l ts show that there i s  a potential  to use a 
m ixture of these t\\ O bacteriophages rather than ant i biotics for the prevent ion of S. 
/yphilllurilllll and E. coli food poison ing d iseases in ch icken feed and in poultry 
product ion. 
Bacteriophages are h ighly spec i fic i n  k i l l ing certa in stra ins of bacteria, j ust l ike 
ant i b iot ics, but wi th  the added benefit of mu l t ip ly ing as they consume the host, so 
they spread rap id ly .  Recent work has shO\ n that bacteriophages are h ighly effect ive 
at c learing pathogens from pou ltry carcasses and at k i l l ing them in the intest i nes of 
Ii e b i rds and in the i r  eggs (Haus ler, 2006). 
lany stud ies have shown that the appl icat ion of bacteriophages in ch icken feed 
reduced the i nc idence of Salmonella spp. in the feed ( M i l ler et al. , 20 1 0 ; L i m  e/ al., 
20 1 1 :  Janez et al . .  20 1 3 ; Wong e/ al. , 20 1 4).  F iorent in  (2005)  demonstrated that 
ch icken skin samples \\ ere experi menta l ly  contaminated by immersing whole legs 
(th ighs and drumsticks) in a suspension conta i n i ng J 06 c fu m r l of Salmonella 
enteritidis phage type 4 (SE  PT4) at the s laughter day. One day later, samp les from 
one group were immersed i n  a suspension pool conta in ing  J 09 cfu m r l of each of 
three w i l d  Salmonella l yt ic  bacteriophages previously isolated from feces of free 
range ch ickens ( F iorent i n, 2005 ) .  Salmonella count ing was perfonned at three-day 
i ntervals in the ch icken legs stored at 5°C and showed a s ign i ficant reduction 
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( P<0.05) of E PT4 in  bacteriophage-treated cuts on day 3,  6 and 9 po t-treatment 
( F iorentin, 2005). The e finding upport the work obtained in  the present study. 
ar a lho el (II. (20 I 0) te ted the efficacy of a phage cockta i l  composed of three 
phages for the contro l  of poul try i n fected \ ith C. coli and C. jejl/lli. They eval uated 
the effecti  eness of t\\ 0 routes of phage adm in i stration (by oral gavage and in feed ) 
in ord r to provide add it ional i nformation regard ing their future use i n  a pou ltry un i t  
(Carva lho et  01 . . 20 1 0) .  They reported a reduction i n  the popu lation dens i t ies of the 
pathogen ic bacteria .  These fi nd ings support the work obta ined i n  the present study. 
Phage therap is the therapeutic use of lyt ic  bacteriophages to treat pathogen ic 
bacteria l  i n fect ions (Chopra et 01.. ] 997). Bacteriophages or "phages" are v i ruses 
that i nvade onl) bacteria l  ce l l s and, in the case of lyt ic phages, cause the bacter ium to 
burst and d ie, thus re leas ing more phages (Carl ton, 1 999). Phage therapy is one of 
the v iable a l ternati ves to ant ib iot ics, be ing developed for c l i n ical  use in the 2 1  st 
century by man) research groups in Europe and in the Un i tes States of America 
(U  A) (Brussow, 2005 ). After hav i ng been extens ively used and developed main ly  
i n  fonner Soviet U nion countries for about 90 years ago, phage therapy i s  now 
becoming more ava i l ab le  in other countries such as USA for a variety of bacteria l  
and poly-microbial  b iofi l m  i nfect ions ( Levin and Bu l l ,  1 996; Sm ith and H uggins, 
1 987 ;  Su lakvel idze, 2005 ) .  Phage therapy has many app l ications in human med ic ine 
as wel l  as dent i stry veteri nary sc ience and agricu lture (Brussow, 2005) .  An 
i mportant benefi t  of phage therapy i s  that  bacteriophages can be much more spec i fic 
than more common drugs, so can be chosen to be hann less to not only the host 
organ ism ( human, an imal  or p lant), but a lso other beneficia l  bacter ia, such as gut 
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flora, reducing chanc for opportun i  t ic i n ti ctions ( u lak el idze, 2005) .  The a lso 
have fe\\ i f  any ide effects as opposed to drugs, and do not stress the l i ver 
( u la"-vel idze el al. . 200 I ) . Because the rep l  icate in vil'o, a s ingle, sma l l  dose is 
somet im  s uffic ient. On the other hand th is  pec i fic i ty is  a lso a d i sadvantage, as 
phage w i l l  on l)  k i l l  a bacteri um if i t  i s  matching to the spec i fic subspec ies. 
ccord i ng l)  a m ixture of more than one phage are often appl ied to improve the 
chances of success rather than using indiv idual  phage in  the phage therapy 
( u lakve l idze e/ 01. , 200 1 ;  Brussow, 2005) .  This  supports the findi ngs of the present 
tudy \\ h ich demonstrated that a m ixture of two phages was m uch better than using 
indi  idual  phage a lone in  red ucing the popu lation densit ies of S. typhimurillnJ and E. 
coli. 
Phages are current ly be ing used therapeut ica l ly to treat bacteria l  i nfect ions that 
do not respond to con entional ant ib iot ics (Brussow, 2007; Han lon, 2007). They 
tend to be more successfu l  where there is a microb ia l  biofi l m  covered by a 
polysaccharide capsu le  l ayer that ant ib iotics typical ly cannot penetrate ( Han lon, 
2007). Other m icrobial  b iofi lms  inc lude those on medical i nstruments and devices, so 
an enzyme added to a phage can effect ively and se lectively w ipe out even bacteria 
beneath these fi lm s  ( Brussow, 2007; Han lon, 2007). 
Phages have been exp lored as means to e l i m inate pathogens l ike Campylobacter 
In ra\ food and Listeria i n  fresh food or to reduce food spo i lage bacteria. I n  
agr icu l tura l  practices, phages were used to fight pathogens l i ke Campy/abaeter, 
Escherichia and Salmonella in fann animals, Lac/acocclis and Vibrio pathogens i n  
fish from aquacu lture and Envinia and Xanthomonas i n  p lants of  agricultural  
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im portance ( Han lon. 2007). McKenna et al. (200 I )  reported that a h ighl, vi rulent 
and pol a lent Streptomyces phage i olated from potato fie ld in Austral ia \ as able to 
ign i ficantl, red uce the inc idence of potato cab d isease caused b Streptomyces 
scabies. The) propagated and cu l t i  ated the phage using new novel m in i-bioreactors 
(McKenna et al. . :WO I ) . 
Phage \ ere used again t d iarrheal d i seases call ed by Escherichia coli, Shigella 
or Vibrio and against \ ound infections caused by facu l tative pathogens of  the sk in 
l i ke staphylococci  and streptococc i  (Sooth i l l  ef al. , 2004; Brussow 2007; Hanlon,  
2007). 
A c lear benefit of phage therapy is  that it does not have the potent ia l ly  very 
se ere ad erse effects of antibiotics ( Hanlon, 2007). It can be fast-act ing, once the 
exact bacteria are ident i fied and the phages can be adm i n istered . Another benefit of 
phage therapy is that a l though bacteria are able to develop res istance to phages the 
resistance is much ea ier to overcome (Su lakve l idze, 2005 ; Han lon, 2007). As a 
consequence phage therapy is devoid of problems s im i lar to ant ib iot ic  res istance 
( u lakve l idze, 2005; Han lon,  2007). Bacteriophages are often very spec ific, 
target ing only one or a few stra ins of  bacteria .  Trad it iona l ant ib iotics usua l ly have 
more w ide-ranging effect, k i l l ing  both harmful  bacteria and usefu l  bacteria such as 
those fac i l itat ing food d igestions. The spec ific i ty of bacteriophages reduces the 
chance that usefu l  bacter ia are k i l led when fight ing an i nfection (Su lakvel idze, 2005 ; 
Hanlon, 2007). 
Research groups in the West are engineering  a broader spectrum phage and a lso 
target meth ic i l l i n resistant Staphylococcus aureus (MRSA) treatments in  a variety of 
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form inc l ud ing:  impregnated wound dre s i ngs, preventat ive treatment for burn 
v ict im , phage-impregnated sutures (Han lon, 2007� K imura e/ al. , 2008) .  
I n  the U , the Food and Drug Admin i strat ion ( FDA) approved spray ing meat 
and pou ltry product \ ith phages ( Brussow, 2007). Phage therapy is used for the 
treatment of a ariety of bact rial i n fections inc lud ing:  laryngit is, sk in  i n fections, 
d) entery, conj unct i  i t i s, periodont i t is, g ingiv i t i s  s inus i t is, uri nary tract i nfect ions 
and i ntest ina l  i n fections, burns, bo i l s, and a lso poly-m icrobial  b iofi lms  on chron ic 
wounds, u lcer and i nfected surg ical  s i tes (Brussow, 2007; Hanlon,  2007). 
I solat ion of phages from d i fferent substrates and neglected env i ronments w i l l  
i ncrease our knO\ l edge on the ecology o f  species, genus and fam i ly spec i fic phage as 
wel l a pro ide add i t ional i n formation on phage ecology and phage-host interact ions 
( W i l l iams and Lanni ng, ( 984). 
The resu lts obta ined i n  the present i nvestigat ion w i l l  open the door to fi nd a new 
a l ternative drug that can be used to k i l l  ant ib iot ic-res istant bacteria for which 
ant ib iot ics are no longer effective. Th i s  w i l l  a lso i ncrease the pub l i c  awareness about 
food safety and about the necess ity of hav ing our foods free from any ant ib iotic 
res idues. 
I n  conc l usion, the i so lated bacteriophages have great potent ia l  in  the field of 
bacteriophage therapy and ch icken feed industry because they are se l f-rep l icat ing and 
can be targeted against bacteria l  receptors that are essent ia l  for bacterial 
pathogenesis.  The phages obtained can be used as a safe and a l ternative techn ique to 
erad icate bacteria l  i n fect ions and chronic  poly  m icrobial b iofi l m  caused by ant ib iot ic 
res istant bacteria .  
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Future work i needed to e tab l i sh that bacteriophages obtai ned i n  the present 
study can red uce or e l i m i nate Salmonella and E. coli not only in ch .icken feed but 
a l o i n sma l l  nocks of Ii e ch ickens. The future s ign i ficant aim is to ensure that such 
b i rds fed on feed treated \ j th bacteriophages can prov ide pou ltry prod ucts that are fi t 
for human consumption and ha e great ly reduced levels of contami nat ion by these 
t\\ O pathogen . I f  these tr ia ls demonstrate s igni ficant reductions in bacteria i n  the 
b i rds and their  products, the stage w i l l  be set for larger tr ia ls i nvolv ing several 
hundred b i rds. 
The poss ib i l i ty of the emergence of  phage-res i stant stra ins, quant i ty of phages 
requ i red for adm i n i strat ion, route and t im i ng of admin i stration, and destruction of 
phages by stomach ac id i ty fo l low i ng oral adm in i stration w i l l  a lso need to be 
investigated in future work using l i ve b i rds.  
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ONC LUS ION 
1 - Two pow erfu l  ly t ic  bacteriophages de ignated bacteriophage number I (0 1 ) 
and bacteriophage number 2 (02) \vere isolated from untreated ra\ waste 
w ater amples c l Iected from 1- i n  sewage treatment p lant .  
2- Bacteriophage number I (01) \ as shown to be a monovalent lytic phage and 
only I sed i t  propagation host Salmonella typhimllrilltll. 
3- Bacteriophage number 2 (01) was shown to be a polyvalent lyt i c  phage and 
I) ed its propagat ion host Escherichia coli and many other Gram posi t ive and 
Gram negative bacteria .  
-t- The opt imum concentrat ion of the 1\ 0 phages used was found to be 1 0 1 0 
p laques form ing un i t  (PFU m rl ). 
5- Peptone- east extract agar amended with ca lc ium n itrate was the best med ium 
for phage propagat ion and cu l t ivation. 
6- Bacteriophage (0 1 )  \ as sens i t ive to the treatments with freezing, 
refr igerat ion,  heat i ng, bo i l i ng, u ltrason ic treatment and U ltra V iolet (UV)  
rad iat ion .  Ho\ ever. bacteriophage (01) was much more res istant compared to 
bacteriophage (01 ) .  
7- The app l ication of bacteriophage (0 1 )  111 corn-soy d iet i nfested w ith S. 
typhimurilll11, or the appl i cat ion of bacteriophage (02) i n  corn-soy d iet 
i n fested w ith E coli, or the appl ication of bacteriophage (0 1 )  and 
bacteriophage (01) in corn-soy d iet i nfested wi th S. typhimurium and E coli 
s ign i fi cant ly reduced the popu lation densit ies of S. typhimurilll11 and the 
popu lation densit ies of  E coli compared to the treatments which inc luded the 
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appl ication of Ii i ng E. coli a lone, l i v ing S. Iyphi/J/llrill/J/ alone and I i  ing E. 
coli + I i  i ng S. typi1il1lllrilllll. 
8- The treatment \\ hich rece i  ed the m i . ture of the two phages or the appl ication 
of bacteriophage (0, ). or the appl ication of bacteriophage (01) was a l most as 
effect i ve a the o;..ytetracyc l i ne appl ications in reducing the inc idence of S. 
tJphilJlurilllJ7 and E. coli in the ch icken feed . 
9- These t\: 0 bacteriophages obta ined in the present study can rep lace the 
appl ication of  ant ibiotics in  ch icken feed ind ustry as they gave a lmost 
equi a lent red uction in the population densit ies of S. typhimurium and E. coli 
as the broad spectrum ant ib iotic oxytetracyc l ine. 
1 0- The iso lated bacteriophages have great potentia l  i n  the fie ld of bacteriophage 
therapy and ch icken feed industry because they are se l f-rep l icating and can be 
targeted aga inst bacterial receptors that are essentia l  for bacterial 
pathogenesis. 
1 1 - The phages obtai ned can be lIsed as a safe and a l ternative techn ique to 
erad icate bacterial  i n fections caused by any anti biotic res istant bacteria.  
96 
REFERENCE 
Abdu ladze, T., L i ,  M ., Menetrez, M . , Dean, T., Seneca l ,  A. ,  and Sulakvel idze, A.  
(2008). Bacteriophages red uce exper imental contaminat ion of hard surfaces, tomato, 
p inach, brocco l i , and ground beef by Escherichia coli 0 1 5 7 : H7 .  Journal of Applied 
and Environmental Microbiology, 74, 6230-6238.  
Abdu l -Ha an, H .  . ,  E l -Tahan, E . .  Massoud, B . ,  and Gomaa, R.  ( 1 990). 
Ba teriophage therap) of pseudomonas bum wound sepsis .  Annual Mediterranean 
Burn Club, 3 ,  262-264. 
Ackermann. H . -W. ,  and Heldal ,  M.  (20 1 0) .  Basic e lectron m ic roscopy of aquatic 
\ i ru es. I n :  W. W i lhe lm,  M. G. Weinbauer, and C. A .  Sutt le [eds . ] :  Manual of 
Aquatic Viral Ecology., Taxas, U SA, American Society of Limno logy and 
Oceanograph) . 
Adamia, R .  S .  Matita h i l i , E. A. ,  Kvachadze, L. 1 . ,  Korinte l i ,  V .  1 . ,  Matoyan, D. A. ,  
Kutate ladze, M. 1 .  and Chanishv i l i , T. G .  ( 1 990). The v i ru lent bacteriophage I RA of 
Salmonella typhilllllriulIl: c loning of phage genes v hich are potent ia l ly  letha l for the 
host cel l .  Journal of Basic Aficrobiology, 1 0, 707-7 1 6 . 
Adams, 1 .  ( 1 959). Bacteriophages. Wi ley I nterSc ience, ew York, U .S .A .  pp 1 69-
1 72 .  
l isky J . , Iczkowsk i ,  K . ,  Rapoport, A . .  and Tro itsky, N.  ( 1 998) .  Bacteriophages show 
promise as ant im icrobia l  agents. Journal of Infection, 36, 5-1 5 .  
Ar ikan, 0 . ,  S i kora, L . ,  M u lbry, W .  Khan, S . ,  and Foster,G . (2007). Compost ing 
rap id ly reduces levels  of  extractable Oxytetracyc l i ne in  manure from therapeut ica l ly  
treated beef calves. Bioresollrce Technology, 98 ,  1 69- 1 76. 
Armon R. and Kott Y.  ( 1 993) .  A s imple, rap id and sens i t ive presence/absence 
detection test for bacteriophage in dr inking water. JOlfrnal of Applied Bacteriology, 
74 490- 496. 
Bach, S., McA l l i ster, T., Yeira, D.,  Gannon, Y., and Ho l l ey, R. (2003 ) .  Effect of  
bacteriophage DC22 on Escherichia coli 0 1 5 7 : H 7  in an  art ific ia l  rumen system 
( Rusitec) and inoculated sheep. Animal Research 52, 89- 1 0 1 .  
97 
BarrO\v , P. . , and J .  ooth i l L  ( 1 997).  Bacteriophage therapy and prophylaxis :  
red isco\'ery and rene\\ ed a es ment of potentia I .  Trends ill Microbiology, 7, 268-
27 1 .  
Barr \\I. P . ,  Lo e l l .  M . .  and Berch ieri, A.  ( 1 998) .  Use of Lyt ic Bacteriophage for 
ontrol of Experi mental Escherichia coli Septicemia .  Clinical and Diagnostic 
LaooratolY iml71ulloIOf!J', 5 ,  294-298. 
Borie, c. ,  anchez, M . L . ,  Navarro, c . ,  Ram irez, S . ,  Morales M.A . .  , Retama les, J . ,  
and Robe on ,  J .  (2009). Aeroso l spray treatment with bacteriophages and  compet i t ive 
exc lusion red uc Salmollella enteritidis i nfect ion in  ch ickens.  A vian Disease, 53, 
250-254. 
Bradbury. J .  (2004) .  M enemy's enemy i s  my friend. Us ing phages to fight bacteria .  
Lancel, 363, 62+-625 .  
Brad ley. B .  E .  ( 1 967). U l tra trLlcture of  bacteriophage and bacterioc ins .  Bacteriology 
Re)'ieH'. 3 1 ,  230-3 1 4 . 
Brad ley , . G . ,  Anderson, D. L, and Jones, L. A .  ( 1 96 1 ) . Phylogeny of 
actinomycetes as revea led by suscept ib i l i ty to acti nophage. Developments in 
industrial Microbiology, 2. 223-237 .  
Brov, ne l l .  G .  H . ,  Adams, J .  N . ,  and Brad ley S .  G .  ( 1 967).  Growth and 
Characterizat ion of nocard iophages for Nocardia canicruria and Nocardia 
erythropolis mating types. Journal of General Microbiology 47, 247-256 .  
Brussow, H .  (2005) .  Phage therapy: the Escherichia coli experience. Microbiology, 
1 5 1 , 2 1 33-2 1 40. 
Brussow, H. (2007). Phage Therapy: The Western Perspective. Bacteriophage: 
Genetics and Molecular Biology. Norfo lk  U K, Caister Academic Press. 
98 
Bunn, R ., and t ward. G .F .  (20 I 0). lorphological characterization of viruses in the 
trat i fied \v ater column of a lkal ine. hy persal ine Mono Lake. Microbial Ecology. 60, 
636-643 .  
Butaye, P . .  Devriese, L . .  and Fredd , . (2003) .  Ant im icrobial  Growth Promoters 
ed in n ima l  Feed : Effects of Less Wel l  Kno\ n Anti biotics on Gram-Posit ive 
Bacteria. Clinical ,'vficrobiology Reviews, 1 6, 1 75 - 1 88 .  
Capita. R. ,  A l arez-Astorga, M. ,  A lonso-Cal leja, C .  Moreno, M ., and Garc ia­
Fernandez, M. (2003). ccurrence of salmonellae i n  reta i l  ch icken carcasses and the i r  
products in  pai n .  International Journal of Food Microbiology, 8 1 ,  1 69- 1 73 .  
Carlton. R M .  ( 1 999). Phage therapy: past h istory and future prospects. Archivw1'1 
111117lullologiae et Therapia Experimentalis, 5, 267-274. 
Carri l lo, C. L., Atterbury, R. J . ,  and E I -Sh ib iny, A.  (2005) .  Bacteriophage therapy to 
red uce Campylobacterjejllni colon ization of bro i ler ch ickens. Journal of Applied and 
Environmental Microbiology. 7 1 ,  6554-6563 . 
Carval ho. c. .  Gannon, B .. Ha lfll ide' D.,  Santos, S . , H ayes, c.,  Roe, J . , and Azeredo, J .  
(_0 1 0). The in vivo efficacy of  two adm in i stration routes o f  a phage cockta i l  to 
reduce numbers of Campylobacter coli and Campylobacter jejl/ni i n  ch ickens. BMC 
Microbiology. 1 0. 232-250. 
Chater, K .  F .  ( 1 986) .  Streptomyces phages and their applications to Streptomyces 
genetics. New York, U . S .A, Academ ic Press. 
Ch iball i , S., S idot i ,  J . ,  Bruttin ,  A. Kutter, E . ,  Sarker, S .. and Brussow, H .  (2004). In 
vitro and in vivo bacterio lyt ic act iv i t ies of Escherichia coli phages: imp l ications for 
phage therapy. A ntimicrobial Agents and Chemotherapy, 48, 2 5 5 8-25 69. 
Chopra, 1 . , Hodgson, J ., Metca lf, B. ,  and Poste, G .  ( 1 997). The search for 
ant im icrobial  agents effect ive against bacteria resistant to m u l t ip le  ant ib iotics. 
Antimicrobial Agents and Chemotherapy, 4 1 ,  497-503.  
C lark, F. E .  ( J  965) .  The Concept of Competition in Microbial Ecology. In: Ecology 
of Soil-borne Plant Pathogens. Berkeley U .S.A, Un ivers ity of Cal i fornia Press. 
99 
mig, . ,  and Zich,  D. (2009). Ro en 's Emergency Medicine: Concepts and Clinical 
Practice. 7th ed. Ph i lade lph ia,  U A, ELS I V ER.  
Diaz. L.  A . , Hard i s  on. c . ,  and Rod ic io, M .  R .  ( 1 989). I so lat ion and characterization 
of actinophage i nfect i ng Streptomyces spec ies and the i r  i nteraction \ ith host 
restriction-mod ification tem . Journal of Genetic Microbiology, 1 35 ,  1 847- 1 856. 
Dowd ing, J .  E .  ( 1 973) .  Characterizat ion of bacteriophage v iru lent for Streptomyces 
coelicolor A3 (2). Journal of General Microbiology, 76, 1 63- 1 76. 
Fal ler, P . ,  and M ichael, A.  (2006) . F lavophosphol i pol  use in animals :  Posi t ive 
impl icat ions for ant im icrobia l  resistance based on its m icrob iologic propert ies. 
JOllrnal of Diagnostic Microbiology and Infectious Di ease, 56, 1 1 5- 1 2 1 .  
FAO/WHO, (200 1 ) . H ealth and nutrit ional propert ies of probiotics in food inc l ud ing 
po\vder m i l k  w ith I i  e lactic acid bacteria; Report of a Jo int FAO/W HO Expert 
Consu l tation on Evaluation of Health and Nutrit ional Propert ies of Prob iotics in Food 
I nc lud ing Powder M i l k  w ith L ive Lactic Acid Bacteria; Amerian C6rdoba Park Hote l ,  
C6rdoba, Argent i na :  F AO/W HO. 
F iorent in,  L . ,  V ie i ra, N .  D. ,  and Barion i, W .  (2005) .  Use of Lyt ic Bacteriophages to 
Reduce Salrnonella enteritidi in Experimenta l ly Contaminated Ch icken Cuts.  
Journal of A l'ian Disease. 7, 255 - 260. 
F l i nt, S . J . ,  L .W.  Enqu ist, R . M .  Krug, Y . R. Racan ie l lo  M. and Skalka. A .  (2000). 
Principles of Virology. F i rst edit ion, Washington DC, USA, American Society of 
M icrobiology Press. 
F ranck i .  R. 1 .  B., Fauquet, C .  M. Knudson, D. L. ,  and Brown, F .  ( 1 99 1 ) . 
C lassification and nomenc lature of v iruses. F i fth report of  the I nternat ional 
Committee on Taxonomy of Y i ruses. Arch Virology Supplement, 2 ,  ] 6 1 - ] 66. 
Fu l ler, R .  ( 1 989). Probiotics in man and an imals .  Journal of Applied Bacteriology, 
66, 365-378 .  
100 
Fu l ler, R. (200 1 ) . The ch icken gut m icroOora and probiotic supplements. JOllmal of 
POllltlY Science, 3 8, 1 89- 1 96. 
old,  W. ( 1 959).  Effect of the med ium and its compos It Ion on the act iv it ies of 
act inophage for Streptomyces grise us. Annuals of the New York Academy of Science, 
8 1 .  995 - 1 0 1 6 . 
Go): a ! . . M .  ( 1 987) .  fethods ill phage ecology. New York, U .S .A, John W i ley and 
ons I ncorporat ion . 
Guard-Petter. J . , (200 I ) . The ch icken, the egg and Salmonella enteritidis. Journal of 
Applied and Environmental Aiicrobiology, 3 , 42 1 -430. 
Guttman, B., Raya, R., and Kutter, E. (2005 ) .  Bacteriophages: Biology and 
Application . Chapter 3 ,  F lorida, USA.  CRC Press. 
Han lon, G. W. (2007). Bacteriophages: an appraisal of the i r  ro le in the treatment of 
bacteria l  i nfections. in/emotional Journal of Antimicrobial Agents, 30, 1 1 8-28.  
Harper, D .  (20 1 2) .  Virus 's biology. application and control. F i rst ed it ion .  London, 
U K ,  Garland Sc ience. 
Harper, D. R .  (2006). Biological control by micro-organism . I n  Encyc loped ia of 
L I fe Sciences. C h ichester, U K, John Wi ley & Sons.  
Harper, D. R . ,  and Kutter, E.  (2008).  Therapeutic lise of bacteriophages. I n  
Encyc loped ia of  L i fe, Ch ichester U K. Sciences. John Wi ley & Sons. 
Harri son W.A. .  Gr iffith c.J . ,  Tennant D., and Peters A.c. (2008). I nc idence of 
Campylobacter and Salmonella i so lated from reta i l  ch icken and associated packaging 
in  South Wales.  Letters in Applied Microbiology, 33 ,  450 - 454. 
Hauer, J . ,  H acein-Bey-Abina, S. ,  and Lim, A .  (20 1 0). Efficacy of gene therapy for X ­
l i nked severe combined immunodeficiency. National Engl ish Journal of Medicine, 
363, 3 5 5-364. 
101 
Hau ler. T. (2006). Viruses l·S. Superbugs: A Solutioll to the Antibiotics Crisis. 
London, K .  Mac m i l lan. 
J l erron, P. R . .  and Wel l i ngton. E.  M.  H. ( 1 990). New method for extraction of 
streptom}cete pore from soi l  and appl ication to the study of lysogeny in  ster i le  
amended and non steri le so i l .  Journal of Applied Environmental Microbiology, 56, 
1 406- 1 4 1 2 . 
http://ec .eu ropa.eu/agricu Iture/anti m icrob ia ls/phagevet . 
J l uff. W .. H u ff. G . ,  Rath. J .• Ba log, R, and Donoghue, M .  (2002). Prevent ion of 
E cherichia coli i n fection i n  broi ler ch ickens w ith a bacteriophage aerosol spray. 
Joumal of Poultry Science, 8 1 ,  1 48� 1 49 1 .  
H u ff. W . .  H u ff. G ., Rath. J . •  Balog, R . ,  and Donoghue, M .  (2003). Eva luat ion of 
aerosol spray and i ntram uscu lar inj ection of bacteriophage to treat an Escherichia coli 
resp iratory i nfect ion .  Journal ofPoliltry Science, 82, 1 1 08- 1 1 1 2 . 
H uff. W. ,  H uff, G . ,  Rath, J . ,  Balog, R. ,  and Donoghue, M .  (2006). Evaluation of the 
influence of bacteriophage t i ter on the treatment of  co l i bac i l los is in  broi ler ch ickens. 
Journal of POllltl), Science, 85 , 1 3 73- 1 377 .  
Jand, . .  and  Loc-Carri l lo. C .  (20 1 3) .  Use of  phages to  contro l Campylobacter :pp. 
Journal of Microbiological Methods, 95, 68-75 . 
Johnke, J . ,  Yossef, c . ,  Mari na, D.,  Arie l ,  K . ,  Edouard, J . , and Antonis, E .  (20 1 4) .  
M u l t ip le  m icro-predators contro l l i ng bacterial  commun it ies i n  the environment. 
Current Opinion in Biotechnology, 27, 1 85- 1 90 .  
Kal ha. c . ,  S ingh, S . ,  Kang, M . ,  Hunjan, V. ,  Gupta, R.,  and Sharma, S.  (20 1 4) .  
Entomopathogen ic  V i ruses and Bacteria for I nsect-Pest Contro l .  Integrated Pest 
Management. 1 2, 225-244. 
K i mura, Z., Nakayama, N., and Asakawa, S. (2008). Ecology of v i ruses in so i l s :  Past, 
present and future perspectives. Journal of Soil Science and Plant Nutrition, 54 1 -32 .  
102 
Kom-Wend ish. F . ,  and chneider, J .  ( 1 992). Phage typing - a usefu l  tool In  
act ino ll1) cete ystematics.  Gene, 1 1 5 , 243-247.  
Kow al k i ,  C . ,  Pomorska, M . .  Lebkow ska, B. ,  and la\  ik, T. (2007). Determ ination of 
Ox)tetracyc l i ne in  Biological Matrix. Journal of Liquid Chromatography & Related 
Technologies, 64, 277-280. 
KI') lov, V . .  (20 1 4) .  Bacteriophages of P. eudol17onas aeruginosa:  Long-Term 
Prospect for Use in Phage Therap . Advances in Virus Research, 88, 227-278 
Lace) , L .A. ,  and Kaya, H . K .  (2007). Field Manual of Techniques in Invertebrate 
Pathology: Application and Evaluation of Palhogens for COlltrol of Insecl and Other 
Invertebrate Pests. j etherlands, Springer. 
Lev in .  B . .  and 1. J. B u l l  ( J  996). Phage Therapy Revisited : The Population B iology of 
a Bacterial I n fection and i ts Treatment w ith Bacteriophage and Antib iotics. The 
American Naturalist, J 47, 88 1 -898. 
Lim, TH . .  K im,  M S., Lee, DH . ,  Lee, YN., Park, J K . ,  Youn, HN., Lee, HJ . ,  Yang, SY.,  
Cho, YW., Lee, JB . .  Park, SY.,  Choi,  I S . ,  and Song, CS.  (20 1 1 ) . Efficacy of 
bacteriophage therapy on horizontal transm ission of Salmonella ga/linarlllJ/ on 
commercia l  l ayer ch ickens. A vian Disease 55 , 43 5 -43 8 .  
L I ITI , TH. ,  K im,  M S . ,  Lee, DH. ,  Lee, YN. ,  Park, J K ., Youn, HN. ,  Lee, H l ., Yang, SY. ,  
Cho, YW. ,  Lee, l B . ,  Park, SY. ,  Choi ,  IS . ,  and Song, CS .  (20 1 2 ). Use of bacteriophage 
for b iological  control of Salmollella enteritidis infect ion in ch icken. A vian Disease, 
56, 1 43-70 1 .  
Lomovskaya, . D . ,  Chater, K .  F . ,  and Mkrtum ian, N .  M .  ( J 980). Genetics and 
molecu lar b io logy of  Streptomyces bacteriophages. Journal of Microbiology Revie'w, 
44, 206-229. 
Lomovskaya N. D., M krtum ian, N. M.,  Gost imskaya, N. L., and Dani lenko, V. N .  
( 1 972). Characterisation o f  temperate acti nophage C 3 1  isolated from Streptomyces 
coelicolor A3 (2) .  Journal of Virology, 9, 258-262. 
103 
l ahon),. J .. M u l i ffe. 0 .. Pau l  Ro , R . ,  and inderen, D. (20 1 0). Bacteriophages as 
biocontrol  agent of food pathogen . Opinion in Biotechnology, 22, 1 5 7- 1 63 .  
lcCarth) , M . ,  Brennan. M. ,  Kel l y .  . ,  R i tson, c. ,  d e  Boer M . ,  and Thompson, N .  
(2007). Who i at r i  k and w hat do the) know ? egment i ng a popu lation on the i r  food 
afety knO\v ledge. Journal oj Food Quality and PreJerence, 1 8, 205-2 1 7. 
Mckenna F . ,  E I -Tarabi l  . K. A . ,Hard , G . E. t .  J . .  and Del l ,  B .  (200 1 ). Novel in vivo 
use of a poly alent treptomyces phage to d is i nfest Streptomyces scabies i nfected 
seed potatoes. Plant Pathology, 50, 666-675 . 
Meader, E . ,  Mayer, M . ,  Gasson, M . ,  Ste erd ing, D. ,  S imon, R. ,  and Narbad, C .  
(20 1 0). Bacteriophage treatment s igni ficantly red uces v iable Clostridium difficile and 
prevents toxin product ion in an in vitro model system .  A naerobe, 1 6, 549-554.  
M i les, RD. ,  and Boot\�al la,  SM. ( 1 99 1 ) . Direct-Fed Microbials in A nimal Production. 
Iowa, U A ational Food I ngred ient Assoc iat ion.  
M i l ler, R .  W. ,  Skinner, EJ . ,  Su lak el idze, A . ,  Math is, G F. ,  and Hofacre, CL. (20 1 0) .  
Bacteriophage therapy for control o f  necroti c  enter i t is  of  bro i ler ch ickens 
experi menta l l  i n fected w i th  Clostridium perJringen . A vian Disease, 54, 33-40. 
Mod i R . .  H i r  i Y . .  H i l l  A., and Gr iffiths M . W .  (200 1 ) . Effect of Phage on Surv ival  of 
Salmonella enteritidis dur ing Manufacture and Storage of Cheddar Cheese Made from 
Ra\\ and Pasteurized M i lk .  Journal oJFood Protection, 64, 927-933 .  
Monk, C .  Rees, Barrow, P .  Hagens, S .  and Harper, D. (20 1 0) .  Bacteriophage 
appl ications: vv here are we now? Letters oj Applied Microbiology, 5 1 , 363-369. 
Murphy, T., Parra, R . .  Radman, R .. , Roy, 1 . , Harrop A., Dixon, K., and Tajal l i  
Keshavarz T .  (2007). ovel appl ication of o l igosaccharides as e l i c i tors for the 
enhancement of  bac i trac i n  a production i n  cu l tures of Bacillus lichen iform is. Enzyme 
and Microbial Technology, 40, 1 5 1 8- 1 523 .  
igam, A . ,  G upta, D. ,  and Shanna A.  (20 1 4) .  Treatment of i n fectious d isease : 
Beyond ant ib iot ics .  Journal oj Microbiological Methods, 69, 83-88 .  
104 
O'F lahert) , .. R , R .P . ,  and offey. . (2009). Bacteriophage and the ir I ins for 
e l i lll inat i  n of infe tiou bacteria.  Federat ion of European ocieties Microbiol 
Reviell'. 33 ,  80 1 - 1 9 . 
O'F ly nn,  G. ,  Ros . R . ,  F i tzgera ld,  ., and Coffey, A. (2004). Evaluation of a cockta i l  
o f  three bacteriophages for b iocontrol of  Escherichia coli 0 1 5 7 : H 7. Journal of 
Applied and Environ/llental Microbiology, 70, 34 1 7-3424. 
O l ive ira, A. ,  ereno, R. ,  and Azeredo, J .  (20 I 0). In vivo effic iency eva luat ion of a 
phage cockta i l  i n  contro l l i ng severe col ibac i l losis i n  confi ned cond it ions and 
experimental pou ltry houses. Journal of Veterinary Microbiology, 1 46, 303-308.  
Ol i  e i ra, M. ,  V i nas, I . ,  Colas, 0. ,  Anguera, M. ,  Usa l l ,  1 . ,  and Abad ias, M. (20 1 4) .  
E ffectiveness of a bacteriophage i n  reduc ing L isteria monocytogenes on fresh-cut 
fru its and fru i t  ju ices. Journal of Food Microbiology, 3 8, 1 3 7- 1 42 .  
Parker, RB .  ( 1 979). Prob iotics, the other ha l f  of the ant ib iot ics story. Journal of 
A nimal J utrition and Health, 29. 4-8 . 
Projan. . (2004) .  Phage- i nspired ant i b iot ics .  alional Biotechnology, 22, 1 67- 1 68 .  
Purdy. R .  . ,  Dancer, B .  . ,  Day, M .J . ,  and  St ickler, OJ.  ( 1 984). A novel technique for 
the enumeration of bacteriophage from water. FEMS Microbiology Letters 2 1 ,  89-92. 
Quiberon i ,  V . .  Suarez, AG.,  B inett i ,  J .A ., and Reinhei mer, A. (20 1 1 ) . Bacteriophage 
B iological  Aspects. Journal of Bacteriophage, 1 , 3 1 -45 .  
Raya, R . ,  Oot, A . ,  and Moore-Maley, B .  (20 1 1 ) . Natura l ly  res ident and exogenously 
appl ied T4- l i ke and T5 - l i ke bacteriophages can reduce Escherichia coli 0 1 5 7 : H 7  
leve ls i n  sheep. Journal of Applied and Environmental Microbiology, 76, 8 1 44-8 1 60 .  
Raya R. ,  Varey, R . ,  and Oot R .  (2006) . I solat ion and characterization of a new T­
even bacteriophage, CEV 1 ,  and determ inat ion of its potential  to reduce Escherichia 
coli 0 1 5 7 : H 7  levels i n  sheep . Journal of Applied and Environmental Microbiology, 
72, 6405-64 1 0. 
105 
Ricca, D. 1 . ,  and Coone) J .J . . (2000). creen ing environmenta l samples for source­
spec ific bacteriophage hosts using a method for the s imu ltaneous pouring of 1 2  petri 
plate . Journal of Indll. trial and Microhiological Biotechnology, 24 , 1 24- 1 26. 
R i \ as. L. .  Coffey . B . .  and McAu l i ffe, O. (20 1 0) .  //1 vivo and ex vivo evaluations of 
bacteriophage e I 1 12 and e41 I c for use in the control  of Escherichia coli 0 1 5 7 : H 7 . 
Journal of Applied and Environmental AJicrobiology. 76, 72 1 0-72 1 6. 
Rozema, E . ,  tephen . T . ,  and Bach. S .  (2009). Oral and rectal admin i strat ion of 
bacteriophages for control of Escherichia coli 0 I 5 7 : H 7  in feed lot catt le .  Journal of 
Food Protection, 72, 24 1 -250. 
Sch i l ler, L . ,  and Se l l in ,  J .  (20 1 0) .  Sleisenger & Fordtran 's Gastrointestinal and Liver 
Disease. 9th ed. Phi lade lph ia, USA,  SAUN DERS.  
heng, H . ,  Knecht, I . , Kudva, T . ,  and Hovdem C .  (2006). Appl ication Of 
bacteriophages to control i ntest ina l  Escherichia col i  0 1 5 7 : H 7  levels i n  rum inants. 
Journal of Microbiology, 72, 5359-5366.  
S imon, M .. and Taha, M .  (20 1 3 ). Poultry and products annual: UAE report . Duba i ,  
G A IN publ i cations. 
S ivas itham param, K.. Parker, C .A. ,  and Edwards, C .S .  ( J  979). Rh izosphere 
m icroorgan isms of  sem ina l  and nodal roots of wheat grown in pots. Journal of Soil 
Biology and Biochemistry, I I ,  1 5 5 - 1 60 .  
Sm ith,  H .  W. ,  and Huggins, R .  B .  ( 1 987) .  The control of  Experimenta l E .  co l i  
D iarrhea i n  calves by means o f  Bacteriophage. Journal of General Microbiology, 
1 33 , 1 1  J 1 - 1 1 26. 
Sodha, S., Griffin, P . ,  and H ughes J. (2009). Principles and Practice of Infectious 
Diseases. 7th ed. Ph i l ade lph ia, U SA, Church i l l  L iv ingstone. 
Sooth i l l , J . ,  H a\ k ins, c . ,  Anggard, E . ,  and Harper, D .  (2004) .  Therapeutic use of 
bacteriophages. Lancet Infectious Disease, 4, 544-545 .  
106 
tan ford, K. ,  Mc I i i  ter, M .. and iu, Y. (20 I 0). Oral de l ivery s stems for 
encapsulated bacteriophages targeted Escherichia coli 0 1 57 :  H 7  in feed lot catt le .  
JO/lrnal of Food Pratectiol1, 73,  1 304- 1 3 1 2 . 
u lakvel idze, . (2005).  Phage therapy: an attract ive option for deal i ng with 
ant ib iotic-re istant bacteria l  i nfections. Drug Discovery Today 1 5 , 807-809. 
u lab el idze, A., lav idze, Z., and Morris J .G .  (200 1 ). Bacteriophage Therapy. 
Ant im icrobial  Agent and Chernothempy, 45 ,  649-659.  
underland, J . ,  Lovering, A. ,  Tobin ,  c. ,  MacGowan, A . ,  Roe, J . ,  and Delsol,  A.  
(2004). Determ ination of a i lamyc in A and B in  p ig feces by so l i d  phase extraction 
and rever e-phase H PLC assay. International Journal of Antimicrobial Agents, 24, 
5 1 1 -5 1 4 .  
) kes, 1 .  K . ,  Lann i ng, S . ,  and W i l l iams, S.  T.  ( 1 98 1 ) . The effect of pH on so i l  
actinophage. Journal of General Jvficrobiology 1 22, 27 1 -280. 
Tartera, c.,  and Jofre, J .  ( 1 987) .  Bacteriophages act ive against Bacteroidesfragilis in 
ewage-pol l uted waters. Journal of Applied and Environmental Microbiology, 53 ,  
1 632-1 63 7 .  
Templeton, . S .  (2008) .  Gene and Cell Therapy: Therapeutic Mechanisms and 
Strategies, 3 rd ed . Boca Raton, USA, CRC Press. 
Thacker, P .O .  (2003) .  Set a m icrobe to k i l l  a m icrobe: drug res istance renews i nterest 
in phage therapy. Journal of American Medical Association, 290, 3 1 83-3 1 85 .  
Toro, H . ,  Price S B .  Mc Kee, AS . ,  H oerr, FJ . Kreh l ing, J . ,  Perdue, M . ,  and 
Bauermeister, L. (2005).  Use of bacteriophages in combinat ion w ith competi t ive 
exc l us ion to reduce Salmonella from i nfected ch ickens. A vian Diseases, 49, 1 1 8- 1 24 .  
Tsonos, J . ,  Vandenheuve l ,  D. ,  B riers, Y . ,  De  G reve, H . ,  Hemalsteens, J . , and  Lav igne, 
R. (20 1 3) .  Hurd les in bacteriophage therapy: Deconstruct ing the parameters 
Veterinary M icrobiology. Science, 1 5 , 1 24- 1 50 .  
107 
icker , J . ., and W i l l iams, . T. ( 1 987). An assessment of  p late i nocu lation 
procedures for the enu meration and isolation of soi l streptomycetes. },,[icrobiology 
Lellers, 35,  1 1 3- 1 1 7. 
Walton, R. B .  ( 1 95 1 ) . E ffect of  cations upon mUl t ip l ication of actinophage for 
S'reptolllyce. · griseus. Antibiotics Chemotherapy, I ,  5 1 8-522. 
Wegener, F . .  and Henrik C. (2003 ). Ant ib iot ics i n  animal feed and the i r  ro le  In 
res i tance development. Current Opinion in Microbiology, 6, 439-445 .  
Weld,  R . L  Butts, c . ,  and He inemann, J .A .  (2004). Model s  o f  phage growth and the i r  
app l icab i l i ty to  phage therapy. Journal of Theoretical Biology, 227, I - I I .  
W i l l iams, S .  T.,  and Lanning, S .  ( 1 984). Stlldies on the ecology of streptomycete 
phage in soil. In: Biological, Biochemical alld Biollledical Aspects of Actinomycetes. 
Orlando, U A, Academ ic  Press. 
W i l l iams, . T., Mort imer A. M. ,  and Manchester, L. ( 1 987). Ecology of soil 
bacteriophages. III: Phage Ecology. e\ York, U .S .A,  John Wi ley and Sons 
I ncorporation. 
W i l l iams, S .  T., Wel l i ngton, E .  M. H . ,  and T ip ler, L. S .  ( 1 980). The taxonomic 
imp l ications of the react ions of representat i ve ocardia stra ins  to acti nophage. 
Journal of General Microbiology, 1 1 9, 1 73- 1 78 .  
Wong, L .c . ,  S ieo, c . ,  S iang Tan, W. ,  Abdu l lah, N . , Ha i r -Bejo, M. ,  Abu, J . ,  and Y i n  
Wan H o ,  (20 1 4) .  Eval uation of a l yt i c  bacteriophage, cD s t  I ,  for b iocontrol o f  
Salmonella enterica serovar typhill1urium i n  ch ickens. I nternational Journal of Food 
Aficrobiology, 1 72, 92- ) 0 I .  
Wright, A. ,  Hawkins, C . H ., Anggard, E .  E . ,  and Harper, D .R. (2009). A contro l led 
c l i n ical  tria l  of a therapeut ic  bacteriophage preparat ion i n  chron ic oti t i s  due to 
ant i b iotic-res istant Pselldomonas aeruginosa. Journal of Clinical Otolmyngology, 34, 
349-3 5 7  
108 
\\ \\ \\1 . C I  nt i ficmethods .conl . Protocol for detect ion of co l i phage in  \ ater sample 
using Ea Phage med i um- 1 00, Ind iana, U A .  c ient i fic  methods I ncorporat ion .  
Yata, T. ,  iantar t , . ,  ong i i la i ,  . ,  and Haj i toLl , . (20 1 3) .  Bacteriophage: From 
Bacteria to a Slicce sjlll Targeted Systemic Gene De livelY for Cancer. Gene Therapy 
of Cancer Third Ed it ion, London, K, cademic Press. 
109 
ppendix  1 
1 - Pcptonc-. east extract  calc i u m  n i t rate ( pYCa) ( B radley et al. , 1 96 1 )  
Peptone 5 g  
Yea t xtra t 3 g 
a lc ium n i trate 0 .5  g 
D ist i l led water 1 000 m L  
gar 20.0 g 
1 10 
p pe n d i x  2 Protocol of Ea Ph age Ki t  
S c i  e n t i f  i c �Ej M e t  h o d s 
P rotocol for Det cction of Co l i p h a ge in Wa tcr a m ple U s i n g  
Easy p h age- I OO i\ Ied i u m 
Vcrsion 3, 4/20109 
1 .  Reagents and Suppli  s :  
1 . 1  Tryptic Soy Broth - teri le  1 X TSB (Not provideJ, prepare according to manu facturer's 
instructions.) 
1 .2 Bacterial  host cel ls  for male speci fic Coli phages (provided as a slant or  lyophi lized form 
of E. coli Famp/CN 1 3  upon request, fee may be appl ied) 
Log phasc E. coli Famp ho t cel ls  should be prepared the day before the assay (see EPA 
1\Iethod 1 602 for detai ls). Use an inoc ulation loop or other sterile transfer instrument to 
inoculatc sufficicnt TSB with the E. coli Famp (e.g. 40 mL w i l l  be enough for l O x  1 00 
mL water samples). Each 1 00 ml sample to be analyzed w i l l  require 3 . 5  ml of this 
bacterial  culture. A fter inoculation, incubate for 1 8-22 hours at J6°C ± 1 °C to produce 
log phase E coli Famp. 
Lse E. Coli C 1 3 for oll1atic c o l i phage. 
1 .3 Sterile reagent water for neg3tive control if perform (Not provided) 
1 .4 Steri le  EasyPhage med ium (Provided, 1 00 mL per bottle) 
Medium may settle, showing two l ayers during storage at 4°C. f ix the mcdium well  
before use (Do not shake v i gorously). Wam1 up the mcdium to room temperature or 3 5°C 
before use. Med ium can be used when it is  cold but w i l l  take longer to sol idity.  
1 .5 Bacteria Stain, steri le (provided) 
0.7 mL Bacteria tain is  needed per bottle of 1 00 mL Easy phage medIUm 
1 .6 Sterile pretreated petri dishes (Provided) 
Only pretreated petri d ishes should be used with Easypbage medium (regular Petri dishes 
w i l l  NOT work). 
1 .7 lV1S2 Po:.ilive Control (provided upon rcquest; rec may bc applied) 
Male-specific col i phage, MS2, stock solution is  provided for spiking the positive control .  
Use the amount according to the instructjons on the label and fol lowing the procedure i n  
Section 3 -Qual ity Assurance Procedures 
2. Procedures 
2 . 1 Warm up Easyphage and TSB to room temperature or 35°C. 
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2.2 uno rI bott le  of Fasyphage, add 1 00 ml \ [lter sample, 0.7 mL of Bacterin Stain, and 3.5 
mL log phas E. coli Famp or I 1 3  culture. i\li. the solution b} swirl ing the bottle 
·t:\,erai llmes (do not vortex to aVOId creating bubbles). Pipette 20 mL of the m ixture into 
each pretreated pctri dish for a t tnl of 1 0  dishes. 
Note: A Oer diSJ!.t!nsill,? 011 1 0  pelri dishes, ifrhere is any medium mi.J:l!Ire lea in the bo{(le, 
(b5Izellse 1-2 mL per dish 10 those 1 0  perri dishes umi/ al/ lhe mt-rture I UllIshed. On the 
other hand, sometimes, the last Petri dish may have Ie s rhnn 20mL. It is perfectlv Ok if 
Ihe l'oilime is at least 1 6  11IL. 
2.3 S\\ irl the dish gently several times to settle the bubbles on the edge of the dish. Let the 
medium mixture solidi fy on a horizontal bench for 1 h. Transfer al l  the dishes to incubator. 
Petri dishes should be incubated in the upright position. 
,\ltematiYe, the petri dishes can be placed directly into an incubator to let the medium 
sol id ify, but check that the incubator shelves are level .  A fter dispensing medium mixture 
to the 1 0  pretreated petri dishes, immediately stack up the dishes and careful ly move 
them to incubator. Petri dishes should be incubated in upright position. 
Note: Do /lOt move or transfer the petri dishes during gel solidification. 
2.� I ncubate Petri dishes at J6°C ± 1 °C for 1 6-24 hr. 
2.5 Count the blue plaques on the background of red bacterial lawn. Plaques are typically 
round, blue areas that lack the reddish color observed on the bacterial lawn. They may 
show up in different sizes and shapes, and all should be counted. 
J. Qual ity Assurance Procedures 
3 . 1 To demonstrate that the reagents and laboratory systems employed during the sample nln 
were performing as expected, analyze a negative and a positive control sample.  
3 2  egative Control :  Analyze one 1 00 tnL sample containing no col iphage (i .e.  1 00 mL 
sterile reagent water) according to the procedures 2. 1 -2.5 .  This sample must produce no 
plaque to demonstrate that the analytical run is valid. This control result is associated 
ilh a l l  samples analyzed during the analytical run. 
3.3 Positive Control :  Analyze one 1 00 mL sample containing viable coli phages (Le. 1 00 m L  
water sample spiked with pure coliphage stock solution). Lab strain male-specific 
coliphage such as MS2, ATCC# 1 5 597-B I can be used to serve as a positive control. 
Fil tered raw sewage also can be used (EPA Method 1 602). Add 1 00 mL of sterile 
reagent water to a 1 00 mL Easyphage bottle.  Tben spike sufficient amount (specified in 
the positive control label) stock solution of MS2 to the Easyphage medium mi>-."1Ure to 
produce a countable number o f  plaques. Add bacterial stain and E. coli Famp and process 
according to procedures 2. 1 -2.5.  Totnl plaque count for the 1 0  petri dishes is summed to 
be in the range of 1 00 to 1 000 pfu. 
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3.1 Thi positive control sample must produce plagues to demonstrntt: that the analytical run 
is valid. This positIve control resu lt is associated w ith all  samples analyzed dUring the 
analy tical nm 
ddltional Suggest ion : 
I .  For analYLtng field water sample lha l may have high background bacteria (such as river water, 
created waste \\aler etc.). adding Ampic i l l in  and SO'eptomyci n  to the Eas phage mixture is 
strongly recommended for male-specJfic coliphages. Add nal idixic acid for somatic coliphages. 
Stock ampicillin/streptomycin preparatioJl (100)( AmplStrep): 
Dissolve O. l5 g oj ampicillin sodium soli (Sigma A9518 or equivalenl) and 0. 15 g oj 
.streptomycin sulfate (Sigma S650l or equivalent) in l Oa IIIL oJreagent waler. Filler through 
O. 22-um-pore size membrane filter or syringe filler Jor sleri/rzation. Dispense in small voillmes 
(depending on how Jast yo II can fin ish using an aliquot) and store frozen at -20 'C Jar up to one 
year. For aile bortle oJEasyphage pillS waler sample wilhfinal vollime approximalely 200 mL, 
add 1 mL oj 1 OOX Amp/Strep during sample processing. 
Stock n alid ixic acid ( jama N4382, or eq u ivalent}-Please note: Nalidixic acir/ is considered 
IOxic. Wear suitable protective clothillg, gloves, alld eye/Jace protectioll andllse ill a chemical 
Jume flood. 
Dissolve I g of nalidixic acid sodium salt in 1 00 mL Ieagent \ ater. Filter through a sterile, 0.22-�lm-poIe­
size membrane filter assembly. Dispense 5 mL per 5-mL freezer vial, date vial, and store frozen at -20De 
for up to one year. Thaw at room temperature or rapidly in a J6De ± 1 .0De water bath. Mix well prior to 
usc. 
2. A fter incubation, there may be some condensate on the l id of the dishes. Dry the l ids with Kim 
wipe tissue paper ilnd start counting. 
3. It is suggested that MS2 or equivalent male speci fi c  Col iphage shou l d  be used to get fam i l iar 
with the procedures and used as positive control with water field samples. 
4 .  A light source from the top of the plate may be used i n  addition to a l ight box or a colony 
counter. The blue color of plaques wi l l  be more intense when the l ight  shines from the top of the 
plate. Sometimes, tiny b l ue p laques may not show up well if  this tiny plaque is  observed from 
the bottom of the dish but it w i l l  be very visible on the surface of the gel .  
5. This Easyphage- l 00 medium detection system is capable o f  producing quantitative results and 
qual ity control schemes for investigating the precision and accuracy of tile microbiological 
assays, such as initial and ongoing coliphage prec ision and recovery experiments. 
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Bacte r i a l  Sta i n  
F igure 6. 1 :  Bacterial Sta in  of the Eas Phage k i t .  
talD 
Figure 6 .2 :  Bacterial Sta in  of  the Easy Phage k it .  
1 14 
E ™ aSYPhage 1 00 
Medi un1 
F igure 6.3 : Easy Phage Med ium- I 00. 
I EasyPhage" k'edium t >r� .. � F - � """"" -bV ... tr¥ ---� c::- '-. "-" .. ..,� �-. 
F igure 6.4:  The Easy Phage K it. 
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Appe n d i x  3 
Figure 6.5 : A sample of ch icken feed . 
F igure 6.6:  The growth of  Escherichia coli on E M B  agar med ium.  
1 16 
F igure 6 .7 :  The growth of Salmonella typhimuriun1 on XLD agar med ium .  
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